id	sid	tid	token	lemma	pos
aji-10	1	1	_	_	PUNCT
aji-10	2	1	_	_	PUNCT
aji-10	3	1	_	_	PUNCT
aji-10	4	1	_	_	PUNCT
aji-10	5	1	_	_	PUNCT
aji-10	6	1	_	_	PUNCT
aji-10	7	1	_	_	PUNCT
aji-10	8	1	_	_	PUNCT
aji-10	9	1	_	_	PUNCT
aji-10	10	1	_	_	PUNCT
aji-10	11	1	_	_	PUNCT
aji-10	12	1	_	_	PUNCT
aji-10	13	1	_	_	PUNCT
aji-10	14	1	_	_	PUNCT
aji-10	15	1	_	_	PUNCT
aji-10	16	1	_	_	PUNCT
aji-10	17	1	_	_	PUNCT
aji-10	18	1	_	_	PUNCT
aji-10	19	1	_	_	PUNCT
aji-10	20	1	_	_	PUNCT
aji-10	21	1	_	_	PUNCT
aji-10	22	1	_	_	PUNCT
aji-10	23	1	_	_	PUNCT
aji-10	24	1	_	_	PUNCT
aji-10	25	1	_	_	PUNCT
aji-10	26	1	_	_	PUNCT
aji-10	27	1	_	_	PUNCT
aji-10	28	1	_	_	PUNCT
aji-10	29	1	_	_	PUNCT
aji-10	30	1	_	_	PUNCT
aji-10	31	1	_	_	PUNCT
aji-10	32	1	_	_	PUNCT
aji-10	33	1	_	_	PUNCT
aji-10	34	1	_	_	PUNCT
aji-10	35	1	_	_	PUNCT
aji-10	36	1	_	_	PUNCT
aji-10	37	1	_	_	PUNCT
aji-10	38	1	_	_	PUNCT
aji-10	39	1	_	_	PUNCT
aji-10	40	1	_	_	PUNCT
aji-10	41	1	_	_	PUNCT
aji-10	42	1	_	_	PUNCT
aji-10	43	1	_	_	PUNCT
aji-10	44	1	_	_	PUNCT
aji-10	45	1	_	_	PUNCT
aji-10	46	1	_	_	PUNCT
aji-10	47	1	_	_	PUNCT
aji-10	48	1	_	_	PUNCT
aji-10	49	1	_	_	PUNCT
aji-10	50	1	_	_	PUNCT
aji-10	51	1	_	_	PUNCT
aji-10	52	1	_	_	PUNCT
aji-10	53	1	_	_	PUNCT
aji-10	54	1	_	_	PUNCT
aji-10	55	1	_	_	PUNCT
aji-10	56	1	_	_	PUNCT
aji-10	57	1	_	_	PUNCT
aji-10	58	1	_	_	PUNCT
aji-10	59	1	_	_	PUNCT
aji-10	60	1	_	_	PUNCT
aji-10	61	1	_	_	PUNCT
aji-10	62	1	_	_	PUNCT
aji-10	63	1	_	_	PUNCT
aji-10	64	1	_	_	PUNCT
aji-10	65	1	_	_	PUNCT
aji-10	66	1	_	_	PUNCT
aji-10	67	1	_	_	PUNCT
aji-10	68	1	_	_	PUNCT
aji-10	69	1	_	_	PUNCT
aji-10	70	1	_	_	PUNCT
aji-10	71	1	_	_	PUNCT
aji-10	72	1	_	_	PUNCT
aji-10	73	1	_	_	PUNCT
aji-10	74	1	_	_	PUNCT
aji-10	75	1	_	_	PUNCT
aji-10	76	1	_	_	PUNCT
aji-10	77	1	_	_	PUNCT
aji-10	78	1	_	_	PUNCT
aji-10	79	1	_	_	PUNCT
aji-10	80	1	_	_	PUNCT
aji-10	81	1	_	_	PUNCT
aji-10	82	1	_	_	PUNCT
aji-10	83	1	_	_	PUNCT
aji-10	84	1	_	_	PUNCT
aji-10	85	1	_	_	PUNCT
aji-10	86	1	_	_	PUNCT
aji-10	87	1	_	_	PUNCT
aji-10	88	1	_	_	PUNCT
aji-10	89	1	_	_	PUNCT
aji-10	90	1	_	_	PUNCT
aji-10	91	1	_	_	PUNCT
aji-10	92	1	_	_	PUNCT
aji-10	93	1	_	_	PUNCT
aji-10	94	1	_	_	PUNCT
aji-10	95	1	_	_	PUNCT
aji-10	96	1	_	_	PUNCT
aji-10	97	1	_	_	PUNCT
aji-10	98	1	_	_	PUNCT
aji-10	99	1	_	_	PUNCT
aji-10	100	1	_	_	PUNCT
aji-10	101	1	_	_	PUNCT
aji-10	102	1	*	*	PUNCT
aji-10	102	2	corresponding	correspond	VERB
aji-10	102	3	author	author	NOUN
aji-10	102	4	:	:	PUNCT
aji-10	102	5	e	e	NOUN
aji-10	102	6	-	-	NOUN
aji-10	102	7	mail	mail	NOUN
aji-10	102	8	:	:	PUNCT
aji-10	103	1	hassanshora56@gmail.com	hassanshora56@gmail.com	X
aji-10	103	2	;	;	PUNCT
aji-10	103	3	asian	asian	ADJ
aji-10	103	4	journal	journal	NOUN
aji-10	103	5	of	of	ADP
aji-10	103	6	immunology	immunology	NOUN
aji-10	103	7	2(1	2(1	NUM
aji-10	103	8	):	):	PUNCT
aji-10	103	9	26	26	NUM
aji-10	103	10	-	-	SYM
aji-10	103	11	33	33	NUM
aji-10	103	12	,	,	PUNCT
aji-10	103	13	2019	2019	NUM
aji-10	103	14	;	;	PUNCT
aji-10	103	15	article	article	NOUN
aji-10	103	16	no.aji.53002	no.aji.53002	NOUN
aji-10	103	17	asthma	asthma	PROPN
aji-10	103	18	severity	severity	NOUN
aji-10	103	19	and	and	CCONJ
aji-10	103	20	serum	serum	NOUN
aji-10	103	21	leptin	leptin	NOUN
aji-10	103	22	level	level	NOUN
aji-10	103	23	in	in	ADP
aji-10	103	24	obese	obese	ADJ
aji-10	103	25	egyptian	egyptian	ADJ
aji-10	103	26	children	child	NOUN
aji-10	103	27	enas	enas	PROPN
aji-10	103	28	f.	f.	PROPN
aji-10	103	29	elngar1	elngar1	PROPN
aji-10	103	30	,	,	PUNCT
aji-10	103	31	osama	osama	PROPN
aji-10	103	32	a.	a.	NOUN
aji-10	103	33	zekry1	zekry1	PROPN
aji-10	103	34	,	,	PUNCT
aji-10	103	35	mamdouh	mamdouh	NOUN
aji-10	103	36	m.	m.	NOUN
aji-10	103	37	ali1	ali1	PROPN
aji-10	103	38	and	and	CCONJ
aji-10	103	39	hassan	hassan	PROPN
aji-10	103	40	a.	a.	PROPN
aji-10	103	41	shora1	shora1	PROPN
aji-10	103	42	*	*	SYM
aji-10	103	43	1	1	NUM
aji-10	103	44	department	department	NOUN
aji-10	103	45	of	of	ADP
aji-10	103	46	pediatrics	pediatric	NOUN
aji-10	103	47	and	and	CCONJ
aji-10	103	48	neonatology	neonatology	NOUN
aji-10	103	49	,	,	PUNCT
aji-10	103	50	faculty	faculty	NOUN
aji-10	103	51	of	of	ADP
aji-10	103	52	medicine	medicine	NOUN
aji-10	103	53	,	,	PUNCT
aji-10	103	54	suez	suez	PROPN
aji-10	103	55	canal	canal	PROPN
aji-10	103	56	university	university	PROPN
aji-10	103	57	and	and	CCONJ
aji-10	103	58	port	port	NOUN
aji-10	103	59	-	-	PUNCT
aji-10	103	60	said	say	VERB
aji-10	103	61	university	university	NOUN
aji-10	103	62	,	,	PUNCT
aji-10	103	63	egypt	egypt	PROPN
aji-10	103	64	.	.	PUNCT
aji-10	104	1	authors	author	NOUN
aji-10	104	2	’	’	PART
aji-10	104	3	contributions	contribution	NOUN
aji-10	104	4	this	this	DET
aji-10	104	5	work	work	NOUN
aji-10	104	6	was	be	AUX
aji-10	104	7	carried	carry	VERB
aji-10	104	8	out	out	ADP
aji-10	104	9	in	in	ADP
aji-10	104	10	collaboration	collaboration	NOUN
aji-10	104	11	among	among	ADP
aji-10	104	12	all	all	DET
aji-10	104	13	authors	author	NOUN
aji-10	104	14	.	.	PUNCT
aji-10	105	1	author	author	NOUN
aji-10	105	2	efe	efe	PROPN
aji-10	105	3	designed	design	VERB
aji-10	105	4	the	the	DET
aji-10	105	5	study	study	NOUN
aji-10	105	6	,	,	PUNCT
aji-10	105	7	performed	perform	VERB
aji-10	105	8	the	the	DET
aji-10	105	9	statistical	statistical	ADJ
aji-10	105	10	analysis	analysis	NOUN
aji-10	105	11	,	,	PUNCT
aji-10	105	12	wrote	write	VERB
aji-10	105	13	the	the	DET
aji-10	105	14	protocol	protocol	NOUN
aji-10	105	15	and	and	CCONJ
aji-10	105	16	wrote	write	VERB
aji-10	105	17	the	the	DET
aji-10	105	18	first	first	ADJ
aji-10	105	19	draft	draft	NOUN
aji-10	105	20	of	of	ADP
aji-10	105	21	the	the	DET
aji-10	105	22	manuscript	manuscript	NOUN
aji-10	105	23	,	,	PUNCT
aji-10	105	24	authors	author	NOUN
aji-10	105	25	oaz	oaz	ADV
aji-10	105	26	and	and	CCONJ
aji-10	105	27	mma	mma	PROPN
aji-10	105	28	managed	manage	VERB
aji-10	105	29	the	the	DET
aji-10	105	30	analyses	analysis	NOUN
aji-10	105	31	of	of	ADP
aji-10	105	32	the	the	DET
aji-10	105	33	study	study	NOUN
aji-10	105	34	.	.	PUNCT
aji-10	106	1	author	author	NOUN
aji-10	106	2	has	have	AUX
aji-10	106	3	managed	manage	VERB
aji-10	106	4	the	the	DET
aji-10	106	5	literature	literature	NOUN
aji-10	106	6	searches	search	NOUN
aji-10	106	7	and	and	CCONJ
aji-10	106	8	contributed	contribute	VERB
aji-10	106	9	in	in	ADP
aji-10	106	10	writing	write	VERB
aji-10	106	11	the	the	DET
aji-10	106	12	final	final	ADJ
aji-10	106	13	manuscript	manuscript	NOUN
aji-10	106	14	.	.	PUNCT
aji-10	107	1	all	all	DET
aji-10	107	2	authors	author	NOUN
aji-10	107	3	read	read	VERB
aji-10	107	4	and	and	CCONJ
aji-10	107	5	approved	approve	VERB
aji-10	107	6	the	the	DET
aji-10	107	7	final	final	ADJ
aji-10	107	8	manuscript	manuscript	NOUN
aji-10	107	9	.	.	PUNCT
aji-10	108	1	article	article	NOUN
aji-10	108	2	information	information	PROPN
aji-10	108	3	editor(s	editor(s	PROPN
aji-10	108	4	):	):	PUNCT
aji-10	108	5	(	(	PUNCT
aji-10	108	6	1	1	X
aji-10	108	7	)	)	PUNCT
aji-10	108	8	dr	dr	PROPN
aji-10	108	9	.	.	PROPN
aji-10	108	10	darko	darko	PROPN
aji-10	108	11	nozic	nozic	PROPN
aji-10	108	12	,	,	PUNCT
aji-10	108	13	professor	professor	NOUN
aji-10	108	14	,	,	PUNCT
aji-10	108	15	higher	high	ADJ
aji-10	108	16	medical	medical	ADJ
aji-10	108	17	school	school	NOUN
aji-10	108	18	in	in	ADP
aji-10	108	19	belgrade	belgrade	PROPN
aji-10	108	20	,	,	PUNCT
aji-10	108	21	university	university	PROPN
aji-10	108	22	of	of	ADP
aji-10	108	23	belgrade	belgrade	PROPN
aji-10	108	24	,	,	PUNCT
aji-10	108	25	serbia	serbia	PROPN
aji-10	108	26	.	.	PUNCT
aji-10	109	1	reviewers	reviewer	NOUN
aji-10	109	2	:	:	PUNCT
aji-10	109	3	(	(	PUNCT
aji-10	109	4	1	1	X
aji-10	109	5	)	)	PUNCT
aji-10	109	6	hanan	hanan	PROPN
aji-10	109	7	mohamed	mohamed	PROPN
aji-10	109	8	hamed	hamed	PROPN
aji-10	109	9	,	,	PUNCT
aji-10	109	10	national	national	ADJ
aji-10	109	11	research	research	NOUN
aji-10	109	12	centre	centre	PROPN
aji-10	109	13	,	,	PUNCT
aji-10	109	14	egypt	egypt	PROPN
aji-10	109	15	.	.	PUNCT
aji-10	110	1	(	(	PUNCT
aji-10	110	2	2	2	X
aji-10	110	3	)	)	PUNCT
aji-10	110	4	gayatri	gayatri	PROPN
aji-10	110	5	c.	c.	PROPN
aji-10	110	6	gawade	gawade	PROPN
aji-10	110	7	,	,	PUNCT
aji-10	110	8	bharati	bharati	PROPN
aji-10	110	9	vidyapeeth	vidyapeeth	PROPN
aji-10	110	10	dental	dental	PROPN
aji-10	110	11	college	college	NOUN
aji-10	110	12	and	and	CCONJ
aji-10	110	13	hospital	hospital	NOUN
aji-10	110	14	,	,	PUNCT
aji-10	110	15	india	india	PROPN
aji-10	110	16	.	.	PUNCT
aji-10	111	1	complete	complete	ADJ
aji-10	111	2	peer	peer	NOUN
aji-10	111	3	review	review	NOUN
aji-10	111	4	history	history	NOUN
aji-10	111	5	:	:	PUNCT
aji-10	111	6	http://www.sdiarticle4.com/review-history/53002	http://www.sdiarticle4.com/review-history/53002	NOUN
aji-10	111	7	received	receive	VERB
aji-10	111	8	22	22	NUM
aji-10	111	9	september	september	PROPN
aji-10	111	10	2019	2019	NUM
aji-10	111	11	accepted	accept	VERB
aji-10	111	12	28	28	NUM
aji-10	111	13	november	november	PROPN
aji-10	111	14	2019	2019	NUM
aji-10	111	15	published	publish	VERB
aji-10	111	16	04	04	NUM
aji-10	111	17	december	december	PROPN
aji-10	111	18	2019	2019	NUM
aji-10	111	19	abstract	abstract	ADJ
aji-10	111	20	background	background	NOUN
aji-10	111	21	:	:	PUNCT
aji-10	111	22	the	the	DET
aji-10	111	23	relation	relation	NOUN
aji-10	111	24	between	between	ADP
aji-10	111	25	leptin	leptin	NOUN
aji-10	111	26	and	and	CCONJ
aji-10	111	27	asthma	asthma	NOUN
aji-10	111	28	is	be	AUX
aji-10	111	29	still	still	ADV
aji-10	111	30	unclear	unclear	ADJ
aji-10	111	31	especially	especially	ADV
aji-10	111	32	in	in	ADP
aji-10	111	33	obese	obese	ADJ
aji-10	111	34	children	child	NOUN
aji-10	111	35	.	.	PUNCT
aji-10	112	1	we	we	PRON
aji-10	112	2	hypothesized	hypothesize	VERB
aji-10	112	3	that	that	SCONJ
aji-10	112	4	high	high	ADJ
aji-10	112	5	serum	serum	NOUN
aji-10	112	6	leptin	leptin	NOUN
aji-10	112	7	concentrations	concentration	NOUN
aji-10	112	8	would	would	AUX
aji-10	112	9	also	also	ADV
aji-10	112	10	be	be	AUX
aji-10	112	11	associated	associate	VERB
aji-10	112	12	with	with	ADP
aji-10	112	13	asthma	asthma	NOUN
aji-10	112	14	in	in	ADP
aji-10	112	15	obese	obese	ADJ
aji-10	112	16	egyptian	egyptian	ADJ
aji-10	112	17	children	child	NOUN
aji-10	112	18	.	.	PUNCT
aji-10	113	1	we	we	PRON
aji-10	113	2	aimed	aim	VERB
aji-10	113	3	to	to	PART
aji-10	113	4	evaluate	evaluate	VERB
aji-10	113	5	serum	serum	NOUN
aji-10	113	6	leptin	leptin	NOUN
aji-10	113	7	concentrations	concentration	NOUN
aji-10	113	8	in	in	ADP
aji-10	113	9	asthmatic	asthmatic	ADJ
aji-10	113	10	obese	obese	NOUN
aji-10	113	11	and	and	CCONJ
aji-10	113	12	none	none	NOUN
aji-10	113	13	obese	obese	ADJ
aji-10	113	14	children	child	NOUN
aji-10	113	15	to	to	PART
aji-10	113	16	investigate	investigate	VERB
aji-10	113	17	their	their	PRON
aji-10	113	18	association	association	NOUN
aji-10	113	19	with	with	ADP
aji-10	113	20	asthma	asthma	NOUN
aji-10	113	21	and	and	CCONJ
aji-10	113	22	degree	degree	NOUN
aji-10	113	23	of	of	ADP
aji-10	113	24	asthma	asthma	NOUN
aji-10	113	25	severity	severity	NOUN
aji-10	113	26	.	.	PUNCT
aji-10	114	1	subjects	subject	NOUN
aji-10	114	2	and	and	CCONJ
aji-10	114	3	methods	method	NOUN
aji-10	114	4	:	:	PUNCT
aji-10	114	5	the	the	DET
aji-10	114	6	study	study	NOUN
aji-10	114	7	was	be	AUX
aji-10	114	8	carried	carry	VERB
aji-10	114	9	out	out	ADP
aji-10	114	10	on	on	ADP
aji-10	114	11	56	56	NUM
aji-10	114	12	children	child	NOUN
aji-10	114	13	attended	attend	VERB
aji-10	114	14	pediatric	pediatric	ADJ
aji-10	114	15	outpatient	outpatient	NOUN
aji-10	114	16	clinic	clinic	NOUN
aji-10	114	17	of	of	ADP
aji-10	114	18	suez	suez	PROPN
aji-10	114	19	canal	canal	PROPN
aji-10	114	20	university	university	PROPN
aji-10	114	21	hospital	hospital	NOUN
aji-10	114	22	on	on	ADP
aji-10	114	23	jan	jan	PROPN
aji-10	114	24	,	,	PUNCT
aji-10	114	25	2016	2016	NUM
aji-10	114	26	to	to	ADP
aji-10	114	27	dec	dec	PROPN
aji-10	114	28	2016	2016	NUM
aji-10	114	29	.	.	PUNCT
aji-10	115	1	they	they	PRON
aji-10	115	2	were	be	AUX
aji-10	115	3	divided	divide	VERB
aji-10	115	4	into	into	ADP
aji-10	115	5	three	three	NUM
aji-10	115	6	groups	group	NOUN
aji-10	115	7	(	(	PUNCT
aji-10	115	8	group	group	NOUN
aji-10	115	9	1	1	NUM
aji-10	115	10	)	)	PUNCT
aji-10	115	11	asthmatic	asthmatic	ADJ
aji-10	115	12	obese	obese	ADJ
aji-10	115	13	children	child	NOUN
aji-10	115	14	involved	involve	VERB
aji-10	115	15	16	16	NUM
aji-10	115	16	child	child	NOUN
aji-10	115	17	(	(	PUNCT
aji-10	115	18	group	group	NOUN
aji-10	115	19	2	2	NUM
aji-10	115	20	)	)	PUNCT
aji-10	115	21	asthmatic	asthmatic	ADJ
aji-10	115	22	nonobese	nonobese	ADJ
aji-10	115	23	child	child	NOUN
aji-10	115	24	;	;	PUNCT
aji-10	115	25	20	20	NUM
aji-10	115	26	(	(	PUNCT
aji-10	115	27	group	group	NOUN
aji-10	115	28	3	3	NUM
aji-10	115	29	)	)	PUNCT
aji-10	115	30	20	20	NUM
aji-10	115	31	non	non	X
aji-10	115	32	asthmatic	asthmatic	ADJ
aji-10	115	33	child	child	NOUN
aji-10	115	34	as	as	ADP
aji-10	115	35	control	control	NOUN
aji-10	115	36	.	.	PUNCT
aji-10	116	1	diagnosis	diagnosis	NOUN
aji-10	116	2	of	of	ADP
aji-10	116	3	asthma	asthma	NOUN
aji-10	116	4	was	be	AUX
aji-10	116	5	done	do	VERB
aji-10	116	6	according	accord	VERB
aji-10	116	7	to	to	ADP
aji-10	116	8	global	global	ADJ
aji-10	116	9	initiative	initiative	NOUN
aji-10	116	10	of	of	ADP
aji-10	116	11	asthma	asthma	NOUN
aji-10	116	12	.	.	PUNCT
aji-10	117	1	serum	serum	NOUN
aji-10	117	2	leptin	leptin	NOUN
aji-10	117	3	level	level	NOUN
aji-10	117	4	was	be	AUX
aji-10	117	5	assessed	assess	VERB
aji-10	117	6	in	in	ADP
aji-10	117	7	all	all	DET
aji-10	117	8	study	study	NOUN
aji-10	117	9	groups	group	NOUN
aji-10	117	10	by	by	ADP
aji-10	117	11	elisa	elisa	PROPN
aji-10	117	12	.	.	PUNCT
aji-10	118	1	results	result	NOUN
aji-10	118	2	:	:	PUNCT
aji-10	118	3	serum	serum	NOUN
aji-10	118	4	leptin	leptin	NOUN
aji-10	118	5	levels	level	NOUN
aji-10	118	6	in	in	ADP
aji-10	118	7	obese	obese	ADJ
aji-10	118	8	asthmatic	asthmatic	ADJ
aji-10	118	9	patients	patient	NOUN
aji-10	118	10	was	be	AUX
aji-10	118	11	91.3±9.3	91.3±9.3	NUM
aji-10	118	12	ng	ng	PROPN
aji-10	118	13	/	/	SYM
aji-10	118	14	ml	ml	X
aji-10	118	15	,	,	PUNCT
aji-10	118	16	while	while	SCONJ
aji-10	118	17	in	in	ADP
aji-10	118	18	non	non	ADJ
aji-10	118	19	-	-	ADJ
aji-10	118	20	obese	obese	ADJ
aji-10	118	21	asthmatics	asthmatic	NOUN
aji-10	118	22	it	it	PRON
aji-10	118	23	was	be	AUX
aji-10	118	24	87.8±5.6	87.8±5.6	NUM
aji-10	118	25	ng	ng	NOUN
aji-10	118	26	/	/	SYM
aji-10	118	27	ml	ml	PROPN
aji-10	118	28	,	,	PUNCT
aji-10	118	29	finally	finally	ADV
aji-10	118	30	in	in	ADP
aji-10	118	31	non	non	ADJ
aji-10	118	32	-	-	ADJ
aji-10	118	33	asthmatic	asthmatic	ADJ
aji-10	118	34	control	control	NOUN
aji-10	118	35	it	it	PRON
aji-10	118	36	was71.3±8.2	was71.3±8.2	VERB
aji-10	118	37	ng	ng	PROPN
aji-10	118	38	/	/	SYM
aji-10	118	39	ml	ml	PROPN
aji-10	118	40	(	(	PUNCT
aji-10	118	41	p	p	NOUN
aji-10	118	42	value	value	NOUN
aji-10	118	43	0.175	0.175	NUM
aji-10	118	44	)	)	PUNCT
aji-10	118	45	.	.	PUNCT
aji-10	119	1	there	there	PRON
aji-10	119	2	was	be	VERB
aji-10	119	3	positive	positive	ADJ
aji-10	119	4	significant	significant	ADJ
aji-10	119	5	correlation	correlation	NOUN
aji-10	119	6	between	between	ADP
aji-10	119	7	serum	serum	NOUN
aji-10	119	8	leptin	leptin	NOUN
aji-10	119	9	levels	level	NOUN
aji-10	119	10	and	and	CCONJ
aji-10	119	11	asthma	asthma	NOUN
aji-10	119	12	severity	severity	NOUN
aji-10	119	13	(	(	PUNCT
aji-10	119	14	p	p	X
aji-10	119	15	=	=	X
aji-10	119	16	<	<	X
aji-10	119	17	0.001	0.001	NUM
aji-10	119	18	)	)	PUNCT
aji-10	119	19	.	.	PUNCT
aji-10	120	1	there	there	PRON
aji-10	120	2	was	be	VERB
aji-10	120	3	also	also	ADV
aji-10	120	4	significant	significant	ADJ
aji-10	120	5	negative	negative	ADJ
aji-10	120	6	association	association	NOUN
aji-10	120	7	of	of	ADP
aji-10	120	8	leptin	leptin	NOUN
aji-10	120	9	with	with	ADP
aji-10	120	10	peak	peak	NOUN
aji-10	120	11	expiratory	expiratory	NOUN
aji-10	120	12	flow	flow	NOUN
aji-10	120	13	rate	rate	NOUN
aji-10	120	14	results	result	NOUN
aji-10	120	15	;	;	PUNCT
aji-10	120	16	there	there	PRON
aji-10	120	17	was	be	VERB
aji-10	120	18	also	also	ADV
aji-10	120	19	significant	significant	ADJ
aji-10	120	20	relation	relation	NOUN
aji-10	120	21	between	between	ADP
aji-10	120	22	serum	serum	NOUN
aji-10	120	23	leptin	leptin	NOUN
aji-10	120	24	levels	level	NOUN
aji-10	120	25	and	and	CCONJ
aji-10	120	26	history	history	NOUN
aji-10	120	27	of	of	ADP
aji-10	120	28	allergy	allergy	NOUN
aji-10	120	29	as	as	ADP
aji-10	120	30	original	original	ADJ
aji-10	120	31	research	research	NOUN
aji-10	120	32	article	article	NOUN
aji-10	120	33	elngar	elngar	NOUN
aji-10	120	34	et	et	PROPN
aji-10	120	35	al	al	PROPN
aji-10	120	36	.	.	PROPN
aji-10	120	37	;	;	PUNCT
aji-10	120	38	aji	aji	PROPN
aji-10	120	39	,	,	PUNCT
aji-10	120	40	2(1	2(1	NUM
aji-10	120	41	):	):	PUNCT
aji-10	120	42	26	26	NUM
aji-10	120	43	-	-	SYM
aji-10	120	44	33	33	NUM
aji-10	120	45	,	,	PUNCT
aji-10	120	46	2019	2019	NUM
aji-10	120	47	;	;	PUNCT
aji-10	120	48	article	article	NOUN
aji-10	120	49	no.aji.53002	no.aji.53002	NOUN
aji-10	120	50	27	27	NUM
aji-10	120	51	well	well	ADV
aji-10	120	52	as	as	ADP
aji-10	120	53	family	family	NOUN
aji-10	120	54	history	history	NOUN
aji-10	120	55	of	of	ADP
aji-10	120	56	asthma	asthma	NOUN
aji-10	120	57	(	(	PUNCT
aji-10	120	58	p	p	X
aji-10	120	59	=	=	X
aji-10	120	60	<	<	X
aji-10	120	61	0.001	0.001	NUM
aji-10	120	62	)	)	PUNCT
aji-10	120	63	.	.	PUNCT
aji-10	121	1	there	there	PRON
aji-10	121	2	was	be	VERB
aji-10	121	3	significantly	significantly	ADV
aji-10	121	4	higher	high	ADJ
aji-10	121	5	body	body	NOUN
aji-10	121	6	mass	mass	NOUN
aji-10	121	7	index	index	NOUN
aji-10	121	8	in	in	ADP
aji-10	121	9	asthmatics	asthmatic	NOUN
aji-10	121	10	than	than	ADP
aji-10	121	11	non	non	NOUN
aji-10	121	12	-	-	NOUN
aji-10	121	13	asthmatics	asthmatic	NOUN
aji-10	121	14	(	(	PUNCT
aji-10	121	15	p	p	NOUN
aji-10	121	16	=	=	NOUN
aji-10	121	17	0.004	0.004	NUM
aji-10	121	18	)	)	PUNCT
aji-10	121	19	.	.	PUNCT
aji-10	122	1	conclusion	conclusion	NOUN
aji-10	122	2	:	:	PUNCT
aji-10	122	3	leptin	leptin	NOUN
aji-10	122	4	is	be	AUX
aji-10	122	5	playing	play	VERB
aji-10	122	6	an	an	DET
aji-10	122	7	important	important	ADJ
aji-10	122	8	role	role	NOUN
aji-10	122	9	in	in	ADP
aji-10	122	10	assessment	assessment	NOUN
aji-10	122	11	of	of	ADP
aji-10	122	12	asthma	asthma	NOUN
aji-10	122	13	severity	severity	NOUN
aji-10	122	14	and	and	CCONJ
aji-10	122	15	is	be	AUX
aji-10	122	16	the	the	DET
aji-10	122	17	most	most	ADV
aji-10	122	18	predictive	predictive	ADJ
aji-10	122	19	factor	factor	NOUN
aji-10	122	20	for	for	ADP
aji-10	122	21	asthma	asthma	NOUN
aji-10	122	22	severity	severity	NOUN
aji-10	122	23	when	when	SCONJ
aji-10	122	24	compared	compare	VERB
aji-10	122	25	to	to	ADP
aji-10	122	26	body	body	NOUN
aji-10	122	27	mass	mass	PROPN
aji-10	122	28	index	index	NOUN
aji-10	122	29	,	,	PUNCT
aji-10	122	30	family	family	NOUN
aji-10	122	31	history	history	NOUN
aji-10	122	32	of	of	ADP
aji-10	122	33	asthma	asthma	NOUN
aji-10	122	34	and	and	CCONJ
aji-10	122	35	history	history	NOUN
aji-10	122	36	of	of	ADP
aji-10	122	37	allergy	allergy	NOUN
aji-10	122	38	.	.	PUNCT
aji-10	123	1	keywords	keyword	NOUN
aji-10	123	2	:	:	PUNCT
aji-10	123	3	asthma	asthma	NOUN
aji-10	123	4	;	;	PUNCT
aji-10	123	5	leptin	leptin	NOUN
aji-10	123	6	;	;	PUNCT
aji-10	123	7	asthma	asthma	NOUN
aji-10	123	8	severity	severity	NOUN
aji-10	123	9	;	;	PUNCT
aji-10	123	10	body	body	NOUN
aji-10	123	11	mass	mass	PROPN
aji-10	123	12	index	index	NOUN
aji-10	123	13	.	.	PUNCT
aji-10	124	1	abbreviations	abbreviation	NOUN
aji-10	124	2	bmi	bmi	VERB
aji-10	124	3	:	:	PUNCT
aji-10	124	4	body	body	NOUN
aji-10	124	5	mass	mass	PROPN
aji-10	124	6	index	index	NOUN
aji-10	124	7	;	;	PUNCT
aji-10	124	8	pefr	pefr	VERB
aji-10	124	9	:	:	PUNCT
aji-10	124	10	peak	peak	NOUN
aji-10	124	11	expiratory	expiratory	NOUN
aji-10	124	12	flow	flow	NOUN
aji-10	124	13	rate	rate	NOUN
aji-10	124	14	test	test	NOUN
aji-10	124	15	;	;	PUNCT
aji-10	124	16	elisa	elisa	NOUN
aji-10	124	17	:	:	PUNCT
aji-10	124	18	enzyme	enzyme	NOUN
aji-10	124	19	-	-	PUNCT
aji-10	124	20	linked	link	VERB
aji-10	124	21	immunosorbent	immunosorbent	NOUN
aji-10	124	22	assay	assay	NOUN
aji-10	124	23	;	;	PUNCT
aji-10	124	24	1	1	X
aji-10	124	25	.	.	X
aji-10	124	26	introduction	introduction	NOUN
aji-10	124	27	asthma	asthma	NOUN
aji-10	124	28	afflicts	afflict	VERB
aji-10	124	29	339	339	NUM
aji-10	124	30	million	million	NUM
aji-10	124	31	people	people	NOUN
aji-10	124	32	worldwide	worldwide	ADV
aji-10	124	33	and	and	CCONJ
aji-10	124	34	8.3	8.3	NUM
aji-10	124	35	%	%	NOUN
aji-10	124	36	of	of	ADP
aji-10	124	37	us	us	PROPN
aji-10	124	38	children	child	NOUN
aji-10	124	39	and	and	CCONJ
aji-10	124	40	is	be	AUX
aji-10	124	41	considered	consider	VERB
aji-10	124	42	the	the	DET
aji-10	124	43	most	most	ADV
aji-10	124	44	common	common	ADJ
aji-10	124	45	disease	disease	NOUN
aji-10	124	46	of	of	ADP
aji-10	124	47	children	child	NOUN
aji-10	124	48	.	.	PUNCT
aji-10	125	1	the	the	DET
aji-10	125	2	annual	annual	ADJ
aji-10	125	3	healthcare	healthcare	NOUN
aji-10	125	4	expenditures	expenditure	NOUN
aji-10	125	5	for	for	ADP
aji-10	125	6	asthma	asthma	NOUN
aji-10	125	7	is	be	AUX
aji-10	125	8	estimated	estimate	VERB
aji-10	125	9	$	$	SYM
aji-10	125	10	81	81	NUM
aji-10	125	11	billion	billion	NUM
aji-10	125	12	in	in	ADP
aji-10	125	13	us	we	PRON
aji-10	125	14	and	and	CCONJ
aji-10	125	15	eur72	eur72	VERB
aji-10	125	16	billion	billion	NUM
aji-10	125	17	in	in	ADP
aji-10	125	18	europe	europe	PROPN
aji-10	125	19	since	since	SCONJ
aji-10	125	20	it	it	PRON
aji-10	125	21	is	be	AUX
aji-10	125	22	a	a	DET
aji-10	125	23	major	major	ADJ
aji-10	125	24	reason	reason	NOUN
aji-10	125	25	for	for	ADP
aji-10	125	26	pediatric	pediatric	ADJ
aji-10	125	27	emergency	emergency	NOUN
aji-10	125	28	room	room	NOUN
aji-10	125	29	visits	visit	NOUN
aji-10	125	30	,	,	PUNCT
aji-10	125	31	admissions	admission	NOUN
aji-10	125	32	in	in	ADP
aji-10	125	33	hospitals	hospital	NOUN
aji-10	125	34	’	'	PUNCT
aji-10	125	35	pediatric	pediatric	ADJ
aji-10	125	36	wards	ward	NOUN
aji-10	125	37	,	,	PUNCT
aji-10	125	38	abstenance	abstenance	NOUN
aji-10	125	39	from	from	ADP
aji-10	125	40	schools	school	NOUN
aji-10	125	41	in	in	ADP
aji-10	125	42	addition	addition	NOUN
aji-10	125	43	to	to	ADP
aji-10	125	44	the	the	DET
aji-10	125	45	economic	economic	ADJ
aji-10	125	46	loss	loss	NOUN
aji-10	125	47	due	due	ADJ
aji-10	125	48	to	to	ADP
aji-10	125	49	decreased	decrease	VERB
aji-10	125	50	parental	parental	ADJ
aji-10	125	51	work	work	NOUN
aji-10	126	1	[	[	X
aji-10	126	2	1	1	NUM
aji-10	126	3	-	-	SYM
aji-10	126	4	3	3	NUM
aji-10	126	5	]	]	PUNCT
aji-10	126	6	.	.	PUNCT
aji-10	127	1	bronchial	bronchial	ADJ
aji-10	127	2	asthma	asthma	NOUN
aji-10	127	3	is	be	AUX
aji-10	127	4	a	a	DET
aji-10	127	5	chronic	chronic	ADJ
aji-10	127	6	inflammation	inflammation	NOUN
aji-10	127	7	of	of	ADP
aji-10	127	8	the	the	DET
aji-10	127	9	bronchial	bronchial	ADJ
aji-10	127	10	tree	tree	NOUN
aji-10	127	11	characterized	characterize	VERB
aji-10	127	12	,	,	PUNCT
aji-10	127	13	by	by	ADP
aji-10	127	14	completely	completely	ADV
aji-10	127	15	or	or	CCONJ
aji-10	127	16	partially	partially	ADV
aji-10	127	17	reversible	reversible	ADJ
aji-10	127	18	airway	airway	NOUN
aji-10	127	19	obstruction	obstruction	NOUN
aji-10	127	20	,	,	PUNCT
aji-10	127	21	which	which	PRON
aji-10	127	22	may	may	AUX
aji-10	127	23	improve	improve	VERB
aji-10	127	24	spontaneously	spontaneously	ADV
aji-10	127	25	or	or	CCONJ
aji-10	127	26	by	by	ADP
aji-10	127	27	specific	specific	ADJ
aji-10	127	28	therapy	therapy	NOUN
aji-10	127	29	.	.	PUNCT
aji-10	128	1	airway	airway	NOUN
aji-10	128	2	hyper	hyper	NOUN
aji-10	128	3	-	-	NOUN
aji-10	128	4	responsiveness	responsiveness	NOUN
aji-10	128	5	is	be	AUX
aji-10	128	6	a	a	DET
aji-10	128	7	narrowing	narrowing	NOUN
aji-10	128	8	of	of	ADP
aji-10	128	9	the	the	DET
aji-10	128	10	airways	airway	NOUN
aji-10	128	11	due	due	ADP
aji-10	128	12	to	to	ADP
aji-10	128	13	a	a	DET
aji-10	128	14	variety	variety	NOUN
aji-10	128	15	of	of	ADP
aji-10	128	16	stimuli	stimulus	NOUN
aji-10	128	17	,	,	PUNCT
aji-10	128	18	such	such	ADJ
aji-10	128	19	as	as	ADP
aji-10	128	20	allergens	allergen	NOUN
aji-10	128	21	and	and	CCONJ
aji-10	128	22	nonspecific	nonspecific	ADJ
aji-10	128	23	triggers	trigger	NOUN
aji-10	128	24	and	and	CCONJ
aji-10	128	25	infections	infection	NOUN
aji-10	128	26	[	[	X
aji-10	128	27	4	4	NUM
aji-10	128	28	]	]	PUNCT
aji-10	128	29	.	.	PUNCT
aji-10	129	1	the	the	DET
aji-10	129	2	prevalence	prevalence	NOUN
aji-10	129	3	of	of	ADP
aji-10	129	4	asthma	asthma	NOUN
aji-10	129	5	and	and	CCONJ
aji-10	129	6	allergies	allergy	NOUN
aji-10	129	7	is	be	AUX
aji-10	129	8	increasing	increase	VERB
aji-10	129	9	in	in	ADP
aji-10	129	10	both	both	CCONJ
aji-10	129	11	western	western	ADJ
aji-10	129	12	and	and	CCONJ
aji-10	129	13	developing	develop	VERB
aji-10	129	14	countries	country	NOUN
aji-10	129	15	.	.	PUNCT
aji-10	130	1	despite	despite	SCONJ
aji-10	130	2	a	a	DET
aji-10	130	3	large	large	ADJ
aji-10	130	4	volume	volume	NOUN
aji-10	130	5	of	of	ADP
aji-10	130	6	clinical	clinical	ADJ
aji-10	130	7	and	and	CCONJ
aji-10	130	8	epidemiological	epidemiological	ADJ
aji-10	130	9	research	research	NOUN
aji-10	130	10	within	within	ADP
aji-10	130	11	affected	affected	ADJ
aji-10	130	12	populations	population	NOUN
aji-10	130	13	,	,	PUNCT
aji-10	130	14	the	the	DET
aji-10	130	15	etiology	etiology	NOUN
aji-10	130	16	and	and	CCONJ
aji-10	130	17	risk	risk	NOUN
aji-10	130	18	factors	factor	NOUN
aji-10	130	19	of	of	ADP
aji-10	130	20	these	these	DET
aji-10	130	21	conditions	condition	NOUN
aji-10	130	22	remains	remain	VERB
aji-10	130	23	poorly	poorly	ADV
aji-10	130	24	understood	understand	VERB
aji-10	130	25	[	[	X
aji-10	130	26	5	5	NUM
aji-10	130	27	]	]	PUNCT
aji-10	130	28	.	.	PUNCT
aji-10	131	1	several	several	ADJ
aji-10	131	2	epidemiological	epidemiological	ADJ
aji-10	131	3	studies	study	NOUN
aji-10	131	4	have	have	AUX
aji-10	131	5	shown	show	VERB
aji-10	131	6	that	that	SCONJ
aji-10	131	7	the	the	DET
aji-10	131	8	prevalence	prevalence	NOUN
aji-10	131	9	of	of	ADP
aji-10	131	10	bronchial	bronchial	ADJ
aji-10	131	11	asthma	asthma	NOUN
aji-10	131	12	and	and	CCONJ
aji-10	131	13	obesity	obesity	NOUN
aji-10	131	14	is	be	AUX
aji-10	131	15	increasing	increase	VERB
aji-10	131	16	concomitantly	concomitantly	ADV
aji-10	131	17	worldwide	worldwide	ADV
aji-10	131	18	among	among	ADP
aji-10	131	19	children	child	NOUN
aji-10	131	20	and	and	CCONJ
aji-10	131	21	young	young	ADJ
aji-10	131	22	adults	adult	NOUN
aji-10	132	1	[	[	X
aji-10	132	2	6	6	NUM
aji-10	132	3	]	]	PUNCT
aji-10	132	4	.	.	PUNCT
aji-10	133	1	obesity	obesity	NOUN
aji-10	133	2	may	may	AUX
aji-10	133	3	be	be	AUX
aji-10	133	4	associated	associate	VERB
aji-10	133	5	with	with	ADP
aji-10	133	6	respiratory	respiratory	ADJ
aji-10	133	7	symptoms	symptom	NOUN
aji-10	133	8	via	via	ADP
aji-10	133	9	cardiorespiratory	cardiorespiratory	NOUN
aji-10	133	10	deconditioning	deconditioning	NOUN
aji-10	133	11	,	,	PUNCT
aji-10	133	12	physiological	physiological	ADJ
aji-10	133	13	restriction	restriction	NOUN
aji-10	133	14	of	of	ADP
aji-10	133	15	the	the	DET
aji-10	133	16	chest	chest	NOUN
aji-10	133	17	wall	wall	NOUN
aji-10	133	18	by	by	ADP
aji-10	133	19	excess	excess	ADJ
aji-10	133	20	adipose	adipose	ADJ
aji-10	133	21	tissue	tissue	NOUN
aji-10	133	22	,	,	PUNCT
aji-10	133	23	or	or	CCONJ
aji-10	133	24	comorbidities	comorbiditie	NOUN
aji-10	133	25	,	,	PUNCT
aji-10	133	26	including	include	VERB
aji-10	133	27	gastro	gastro	ADJ
aji-10	133	28	esophageal	esophageal	ADJ
aji-10	133	29	reflux	reflux	NOUN
aji-10	133	30	and	and	CCONJ
aji-10	133	31	sleep	sleep	NOUN
aji-10	133	32	-	-	PUNCT
aji-10	133	33	disordered	disorder	VERB
aji-10	133	34	breathing	breathing	NOUN
aji-10	133	35	[	[	X
aji-10	133	36	7	7	NUM
aji-10	133	37	]	]	PUNCT
aji-10	133	38	.	.	PUNCT
aji-10	134	1	obesity	obesity	NOUN
aji-10	134	2	is	be	AUX
aji-10	134	3	characterized	characterize	VERB
aji-10	134	4	by	by	ADP
aji-10	134	5	chronic	chronic	ADJ
aji-10	134	6	low	low	ADJ
aji-10	134	7	-	-	PUNCT
aji-10	134	8	grade	grade	NOUN
aji-10	134	9	systemic	systemic	ADJ
aji-10	134	10	inflammation	inflammation	NOUN
aji-10	134	11	.	.	PUNCT
aji-10	135	1	obese	obese	ADJ
aji-10	135	2	adipose	adipose	ADJ
aji-10	135	3	tissue	tissue	NOUN
aji-10	135	4	is	be	AUX
aji-10	135	5	infiltrated	infiltrate	VERB
aji-10	135	6	by	by	ADP
aji-10	135	7	macrophages	macrophage	NOUN
aji-10	135	8	that	that	PRON
aji-10	135	9	are	be	AUX
aji-10	135	10	a	a	DET
aji-10	135	11	source	source	NOUN
aji-10	135	12	of	of	ADP
aji-10	135	13	inflammatory	inflammatory	ADJ
aji-10	135	14	cytokines	cytokine	NOUN
aji-10	135	15	[	[	X
aji-10	135	16	8	8	NUM
aji-10	135	17	]	]	PUNCT
aji-10	135	18	,	,	PUNCT
aji-10	135	19	more	more	ADJ
aji-10	135	20	than	than	ADP
aji-10	135	21	50	50	NUM
aji-10	135	22	different	different	ADJ
aji-10	135	23	adipocytokines	adipocytokine	NOUN
aji-10	135	24	are	be	AUX
aji-10	135	25	secreted	secrete	VERB
aji-10	135	26	by	by	ADP
aji-10	135	27	adipocytes	adipocyte	NOUN
aji-10	135	28	.	.	PUNCT
aji-10	136	1	adipocytokines	adipocytokine	NOUN
aji-10	136	2	are	be	AUX
aji-10	136	3	proteins	protein	NOUN
aji-10	136	4	that	that	PRON
aji-10	136	5	help	help	VERB
aji-10	136	6	regulate	regulate	VERB
aji-10	136	7	various	various	ADJ
aji-10	136	8	body	body	NOUN
aji-10	136	9	functions	function	NOUN
aji-10	136	10	[	[	X
aji-10	136	11	9	9	NUM
aji-10	136	12	]	]	PUNCT
aji-10	136	13	.	.	PUNCT
aji-10	137	1	serum	serum	PROPN
aji-10	137	2	leptin	leptin	PROPN
aji-10	137	3	is	be	AUX
aji-10	137	4	pro	pro	ADV
aji-10	137	5	inflammatory	inflammatory	ADJ
aji-10	137	6	adipocytokine	adipocytokine	NOUN
aji-10	137	7	that	that	PRON
aji-10	137	8	affects	affect	VERB
aji-10	137	9	both	both	CCONJ
aji-10	137	10	innate	innate	ADJ
aji-10	137	11	and	and	CCONJ
aji-10	137	12	adaptive	adaptive	ADJ
aji-10	137	13	immune	immune	ADJ
aji-10	137	14	responses	response	NOUN
aji-10	137	15	,	,	PUNCT
aji-10	137	16	and	and	CCONJ
aji-10	137	17	its	its	PRON
aji-10	137	18	serum	serum	NOUN
aji-10	137	19	levels	level	NOUN
aji-10	137	20	are	be	AUX
aji-10	137	21	markedly	markedly	ADV
aji-10	137	22	increased	increase	VERB
aji-10	137	23	in	in	ADP
aji-10	137	24	obesity	obesity	NOUN
aji-10	137	25	[	[	X
aji-10	137	26	10	10	NUM
aji-10	137	27	]	]	PUNCT
aji-10	137	28	.	.	PUNCT
aji-10	138	1	leptin	leptin	PROPN
aji-10	138	2	is	be	AUX
aji-10	138	3	one	one	NUM
aji-10	138	4	of	of	ADP
aji-10	138	5	the	the	DET
aji-10	138	6	adipose	adipose	ADJ
aji-10	138	7	tissuederived	tissuederive	VERB
aji-10	138	8	energy	energy	NOUN
aji-10	138	9	-	-	PUNCT
aji-10	138	10	regulating	regulate	VERB
aji-10	138	11	hormones	hormone	NOUN
aji-10	138	12	and	and	CCONJ
aji-10	138	13	a	a	DET
aji-10	138	14	product	product	NOUN
aji-10	138	15	of	of	ADP
aji-10	138	16	the	the	DET
aji-10	138	17	obesity	obesity	NOUN
aji-10	138	18	gene	gene	NOUN
aji-10	138	19	.	.	PUNCT
aji-10	139	1	circulating	circulate	VERB
aji-10	139	2	leptin	leptin	NOUN
aji-10	139	3	is	be	AUX
aji-10	139	4	positively	positively	ADV
aji-10	139	5	correlated	correlate	VERB
aji-10	139	6	with	with	ADP
aji-10	139	7	body	body	NOUN
aji-10	139	8	fat	fat	ADJ
aji-10	139	9	percentage	percentage	NOUN
aji-10	139	10	and	and	CCONJ
aji-10	139	11	body	body	NOUN
aji-10	139	12	fat	fat	ADJ
aji-10	139	13	mass	mass	PROPN
aji-10	139	14	.	.	PUNCT
aji-10	140	1	in	in	ADP
aji-10	140	2	addition	addition	NOUN
aji-10	140	3	to	to	ADP
aji-10	140	4	its	its	PRON
aji-10	140	5	primary	primary	ADJ
aji-10	140	6	effects	effect	NOUN
aji-10	140	7	on	on	ADP
aji-10	140	8	energy	energy	NOUN
aji-10	140	9	regulation	regulation	NOUN
aji-10	140	10	,	,	PUNCT
aji-10	140	11	which	which	PRON
aji-10	140	12	it	it	PRON
aji-10	140	13	exerts	exert	VERB
aji-10	140	14	by	by	ADP
aji-10	140	15	inhibiting	inhibit	VERB
aji-10	140	16	food	food	NOUN
aji-10	140	17	intake	intake	NOUN
aji-10	140	18	and	and	CCONJ
aji-10	140	19	increasing	increase	VERB
aji-10	140	20	energy	energy	NOUN
aji-10	140	21	expenditure	expenditure	NOUN
aji-10	140	22	,	,	PUNCT
aji-10	140	23	leptin	leptin	NOUN
aji-10	140	24	has	have	AUX
aji-10	140	25	been	be	AUX
aji-10	140	26	found	find	VERB
aji-10	140	27	to	to	PART
aji-10	140	28	play	play	VERB
aji-10	140	29	a	a	DET
aji-10	140	30	regulatory	regulatory	ADJ
aji-10	140	31	role	role	NOUN
aji-10	140	32	within	within	ADP
aji-10	140	33	the	the	DET
aji-10	140	34	immune	immune	ADJ
aji-10	140	35	system	system	NOUN
aji-10	140	36	[	[	X
aji-10	140	37	11	11	NUM
aji-10	140	38	]	]	PUNCT
aji-10	140	39	.	.	PUNCT
aji-10	141	1	the	the	DET
aji-10	141	2	regulatory	regulatory	ADJ
aji-10	141	3	capacity	capacity	NOUN
aji-10	141	4	of	of	ADP
aji-10	141	5	leptin	leptin	NOUN
aji-10	141	6	is	be	AUX
aji-10	141	7	associated	associate	VERB
aji-10	141	8	not	not	PART
aji-10	141	9	only	only	ADV
aji-10	141	10	with	with	ADP
aji-10	141	11	adaptive	adaptive	ADJ
aji-10	141	12	immunity	immunity	NOUN
aji-10	141	13	but	but	CCONJ
aji-10	141	14	also	also	ADV
aji-10	141	15	with	with	ADP
aji-10	141	16	the	the	DET
aji-10	141	17	innate	innate	ADJ
aji-10	141	18	system	system	NOUN
aji-10	141	19	[	[	X
aji-10	141	20	12	12	NUM
aji-10	141	21	]	]	PUNCT
aji-10	141	22	.	.	PUNCT
aji-10	142	1	leptin	leptin	PROPN
aji-10	142	2	promotes	promote	VERB
aji-10	142	3	the	the	DET
aji-10	142	4	production	production	NOUN
aji-10	142	5	of	of	ADP
aji-10	142	6	nitric	nitric	ADJ
aji-10	142	7	oxide	oxide	NOUN
aji-10	142	8	and	and	CCONJ
aji-10	142	9	pro	pro	ADJ
aji-10	142	10	-	-	ADJ
aji-10	142	11	inflammatory	inflammatory	ADJ
aji-10	142	12	cytokines	cytokine	NOUN
aji-10	142	13	in	in	ADP
aji-10	142	14	macrophages	macrophage	NOUN
aji-10	142	15	and	and	CCONJ
aji-10	142	16	monocytes	monocyte	VERB
aji-10	142	17	[	[	X
aji-10	142	18	10	10	NUM
aji-10	142	19	]	]	PUNCT
aji-10	142	20	.	.	PUNCT
aji-10	143	1	the	the	DET
aji-10	143	2	aim	aim	NOUN
aji-10	143	3	of	of	ADP
aji-10	143	4	this	this	DET
aji-10	143	5	study	study	NOUN
aji-10	143	6	was	be	AUX
aji-10	143	7	to	to	PART
aji-10	143	8	evaluate	evaluate	VERB
aji-10	143	9	serum	serum	NOUN
aji-10	143	10	leptin	leptin	NOUN
aji-10	143	11	concentrations	concentration	NOUN
aji-10	143	12	in	in	ADP
aji-10	143	13	asthmatic	asthmatic	ADJ
aji-10	143	14	obese	obese	NOUN
aji-10	143	15	and	and	CCONJ
aji-10	143	16	none	none	NOUN
aji-10	143	17	obese	obese	ADJ
aji-10	143	18	children	child	NOUN
aji-10	143	19	and	and	CCONJ
aji-10	143	20	its	its	PRON
aji-10	143	21	association	association	NOUN
aji-10	143	22	with	with	ADP
aji-10	143	23	degree	degree	NOUN
aji-10	143	24	of	of	ADP
aji-10	143	25	asthma	asthma	NOUN
aji-10	143	26	severity	severity	NOUN
aji-10	143	27	.	.	PUNCT
aji-10	144	1	what	what	PRON
aji-10	144	2	is	be	AUX
aji-10	144	3	known	know	VERB
aji-10	144	4	?	?	PUNCT
aji-10	145	1			X
aji-10	145	2	serum	serum	NOUN
aji-10	145	3	leptin	leptin	NOUN
aji-10	145	4	is	be	AUX
aji-10	145	5	pro	pro	ADJ
aji-10	145	6	inflammatory	inflammatory	ADJ
aji-10	145	7	cytokine	cytokine	NOUN
aji-10	145	8	that	that	PRON
aji-10	145	9	affects	affect	VERB
aji-10	145	10	both	both	CCONJ
aji-10	145	11	innate	innate	ADJ
aji-10	145	12	and	and	CCONJ
aji-10	145	13	adaptive	adaptive	ADJ
aji-10	145	14	immune	immune	ADJ
aji-10	145	15	responses	response	NOUN
aji-10	145	16	,	,	PUNCT
aji-10	145	17	and	and	CCONJ
aji-10	145	18	serum	serum	NOUN
aji-10	145	19	levels	level	NOUN
aji-10	145	20	are	be	AUX
aji-10	145	21	markedly	markedly	ADV
aji-10	145	22	increased	increase	VERB
aji-10	145	23	in	in	ADP
aji-10	145	24	obesity	obesity	NOUN
aji-10	145	25	.	.	PUNCT
aji-10	146	1			X
aji-10	146	2	circulating	circulate	VERB
aji-10	146	3	leptin	leptin	NOUN
aji-10	146	4	is	be	AUX
aji-10	146	5	positively	positively	ADV
aji-10	146	6	correlated	correlate	VERB
aji-10	146	7	with	with	ADP
aji-10	146	8	body	body	NOUN
aji-10	146	9	fat	fat	ADJ
aji-10	146	10	percentage	percentage	NOUN
aji-10	146	11	and	and	CCONJ
aji-10	146	12	body	body	NOUN
aji-10	146	13	fat	fat	ADJ
aji-10	146	14	mass	mass	PROPN
aji-10	146	15	.	.	PUNCT
aji-10	147	1	what	what	PRON
aji-10	147	2	is	be	AUX
aji-10	147	3	new	new	ADJ
aji-10	147	4	?	?	PUNCT
aji-10	148	1			NOUN
aji-10	148	2	leptin	leptin	NOUN
aji-10	148	3	is	be	AUX
aji-10	148	4	playing	play	VERB
aji-10	148	5	an	an	DET
aji-10	148	6	important	important	ADJ
aji-10	148	7	role	role	NOUN
aji-10	148	8	in	in	ADP
aji-10	148	9	assessment	assessment	NOUN
aji-10	148	10	of	of	ADP
aji-10	148	11	asthma	asthma	NOUN
aji-10	148	12	severity	severity	NOUN
aji-10	148	13	.	.	PUNCT
aji-10	149	1			X
aji-10	149	2	there	there	PRON
aji-10	149	3	is	be	VERB
aji-10	149	4	a	a	DET
aji-10	149	5	significant	significant	ADJ
aji-10	149	6	relation	relation	NOUN
aji-10	149	7	between	between	ADP
aji-10	149	8	serum	serum	NOUN
aji-10	149	9	leptin	leptin	NOUN
aji-10	149	10	levels	level	NOUN
aji-10	149	11	and	and	CCONJ
aji-10	149	12	history	history	NOUN
aji-10	149	13	of	of	ADP
aji-10	149	14	allergy	allergy	PROPN
aji-10	149	15	as	as	ADV
aji-10	149	16	well	well	ADV
aji-10	149	17	as	as	ADP
aji-10	149	18	family	family	NOUN
aji-10	149	19	history	history	NOUN
aji-10	149	20	of	of	ADP
aji-10	149	21	asthma	asthma	NOUN
aji-10	149	22	.	.	PUNCT
aji-10	150	1	2	2	X
aji-10	150	2	.	.	X
aji-10	150	3	materials	material	NOUN
aji-10	150	4	and	and	CCONJ
aji-10	150	5	methods	method	NOUN
aji-10	150	6	this	this	DET
aji-10	150	7	study	study	NOUN
aji-10	150	8	is	be	AUX
aji-10	150	9	observational	observational	ADJ
aji-10	150	10	cross	cross	ADJ
aji-10	150	11	-	-	ADJ
aji-10	150	12	sectional	sectional	ADJ
aji-10	150	13	case	case	NOUN
aji-10	150	14	control	control	NOUN
aji-10	150	15	.	.	PUNCT
aji-10	151	1	this	this	DET
aji-10	151	2	study	study	NOUN
aji-10	151	3	was	be	AUX
aji-10	151	4	conducted	conduct	VERB
aji-10	151	5	among	among	ADP
aji-10	151	6	asthmatic	asthmatic	ADJ
aji-10	151	7	children	child	NOUN
aji-10	151	8	in	in	ADP
aji-10	151	9	pediatric	pediatric	ADJ
aji-10	151	10	outpatients	outpatient	NOUN
aji-10	151	11	clinic	clinic	NOUN
aji-10	151	12	elngar	elngar	NOUN
aji-10	151	13	et	et	PROPN
aji-10	151	14	al	al	PROPN
aji-10	151	15	.	.	PROPN
aji-10	151	16	;	;	PUNCT
aji-10	151	17	aji	aji	PROPN
aji-10	151	18	,	,	PUNCT
aji-10	151	19	2(1	2(1	NUM
aji-10	151	20	):	):	PUNCT
aji-10	151	21	26	26	NUM
aji-10	151	22	-	-	SYM
aji-10	151	23	33	33	NUM
aji-10	151	24	,	,	PUNCT
aji-10	151	25	2019	2019	NUM
aji-10	151	26	;	;	PUNCT
aji-10	151	27	article	article	NOUN
aji-10	151	28	no.aji.53002	no.aji.53002	NOUN
aji-10	151	29	28	28	NUM
aji-10	151	30	in	in	ADP
aji-10	151	31	suez	suez	PROPN
aji-10	151	32	canal	canal	PROPN
aji-10	151	33	university	university	PROPN
aji-10	151	34	hospital	hospital	NOUN
aji-10	151	35	.	.	PUNCT
aji-10	152	1	control	control	PROPN
aji-10	152	2	group	group	PROPN
aji-10	152	3	was	be	AUX
aji-10	152	4	normal	normal	ADJ
aji-10	152	5	healthy	healthy	ADJ
aji-10	152	6	children	child	NOUN
aji-10	152	7	.	.	PUNCT
aji-10	153	1	fifty	fifty	NUM
aji-10	153	2	-	-	PUNCT
aji-10	153	3	six	six	NUM
aji-10	153	4	children	child	NOUN
aji-10	153	5	were	be	AUX
aji-10	153	6	included	include	VERB
aji-10	153	7	;	;	PUNCT
aji-10	153	8	20	20	NUM
aji-10	153	9	non	non	X
aji-10	153	10	asthmatic	asthmatic	ADJ
aji-10	153	11	children	child	NOUN
aji-10	153	12	(	(	PUNCT
aji-10	153	13	control	control	NOUN
aji-10	153	14	group	group	NOUN
aji-10	153	15	)	)	PUNCT
aji-10	153	16	and	and	CCONJ
aji-10	153	17	36	36	NUM
aji-10	153	18	asthmatic	asthmatic	ADJ
aji-10	153	19	children	child	NOUN
aji-10	153	20	;	;	PUNCT
aji-10	153	21	16	16	NUM
aji-10	153	22	obese	obese	VERB
aji-10	153	23	asthmatic	asthmatic	ADJ
aji-10	153	24	and	and	CCONJ
aji-10	153	25	20	20	NUM
aji-10	153	26	non	non	NOUN
aji-10	153	27	obese	obese	NOUN
aji-10	153	28	asthmatic	asthmatic	ADJ
aji-10	153	29	,	,	PUNCT
aji-10	153	30	all	all	PRON
aji-10	153	31	aged	aged	ADJ
aji-10	153	32	above	above	ADP
aji-10	153	33	3	3	NUM
aji-10	153	34	years	year	NOUN
aji-10	153	35	old	old	ADJ
aji-10	153	36	.	.	PUNCT
aji-10	154	1	diagnosis	diagnosis	NOUN
aji-10	154	2	of	of	ADP
aji-10	154	3	asthma	asthma	NOUN
aji-10	154	4	was	be	AUX
aji-10	154	5	done	do	VERB
aji-10	154	6	according	accord	VERB
aji-10	154	7	to	to	ADP
aji-10	154	8	global	global	ADJ
aji-10	154	9	initiative	initiative	NOUN
aji-10	154	10	of	of	ADP
aji-10	154	11	asthma	asthma	NOUN
aji-10	154	12	(	(	PUNCT
aji-10	154	13	gina	gina	PROPN
aji-10	154	14	2015	2015	NUM
aji-10	154	15	)	)	PUNCT
aji-10	154	16	.	.	PUNCT
aji-10	155	1	obese	obese	ADJ
aji-10	155	2	children	child	NOUN
aji-10	155	3	were	be	AUX
aji-10	155	4	identified	identify	VERB
aji-10	155	5	as	as	ADP
aji-10	155	6	children	child	NOUN
aji-10	155	7	with	with	ADP
aji-10	155	8	body	body	NOUN
aji-10	155	9	mass	mass	NOUN
aji-10	155	10	index	index	NOUN
aji-10	155	11	above	above	ADP
aji-10	155	12	95th	95th	ADJ
aji-10	155	13	percentile	percentile	NOUN
aji-10	155	14	for	for	ADP
aji-10	155	15	their	their	PRON
aji-10	155	16	age	age	NOUN
aji-10	155	17	according	accord	VERB
aji-10	155	18	to	to	ADP
aji-10	155	19	egyptian	egyptian	ADJ
aji-10	155	20	growth	growth	NOUN
aji-10	155	21	charts	chart	NOUN
aji-10	155	22	.	.	PUNCT
aji-10	156	1	inclusion	inclusion	NOUN
aji-10	156	2	criteria	criterion	NOUN
aji-10	156	3	:	:	PUNCT
aji-10	156	4	asthmatic	asthmatic	ADJ
aji-10	156	5	children	child	NOUN
aji-10	156	6	above	above	ADP
aji-10	156	7	3	3	NUM
aji-10	156	8	years	year	NOUN
aji-10	156	9	old	old	ADJ
aji-10	156	10	who	who	PRON
aji-10	156	11	did	do	AUX
aji-10	156	12	not	not	PART
aji-10	156	13	receive	receive	VERB
aji-10	156	14	steroid	steroid	NOUN
aji-10	156	15	treatment	treatment	NOUN
aji-10	156	16	are	be	AUX
aji-10	156	17	included	include	VERB
aji-10	156	18	in	in	ADP
aji-10	156	19	the	the	DET
aji-10	156	20	study	study	NOUN
aji-10	156	21	without	without	ADP
aji-10	156	22	injury	injury	NOUN
aji-10	156	23	of	of	ADP
aji-10	156	24	vital	vital	ADJ
aji-10	156	25	organs	organ	NOUN
aji-10	156	26	including	include	VERB
aji-10	156	27	heart	heart	NOUN
aji-10	156	28	,	,	PUNCT
aji-10	156	29	liver	liver	NOUN
aji-10	156	30	and	and	CCONJ
aji-10	156	31	kidney	kidney	NOUN
aji-10	156	32	.	.	PUNCT
aji-10	157	1	exclusion	exclusion	NOUN
aji-10	157	2	criteria	criterion	NOUN
aji-10	157	3	:	:	PUNCT
aji-10	157	4	children	child	NOUN
aji-10	157	5	who	who	PRON
aji-10	157	6	receive	receive	VERB
aji-10	157	7	treatment	treatment	NOUN
aji-10	157	8	with	with	ADP
aji-10	157	9	steroid	steroid	NOUN
aji-10	157	10	either	either	CCONJ
aji-10	157	11	by	by	ADP
aji-10	157	12	inhalation	inhalation	NOUN
aji-10	157	13	or	or	CCONJ
aji-10	157	14	systemic	systemic	ADJ
aji-10	157	15	route	route	NOUN
aji-10	157	16	or	or	CCONJ
aji-10	157	17	children	child	NOUN
aji-10	157	18	with	with	ADP
aji-10	157	19	infection	infection	NOUN
aji-10	157	20	and	and	CCONJ
aji-10	157	21	severe	severe	ADJ
aji-10	157	22	allergic	allergic	ADJ
aji-10	157	23	reactions	reaction	NOUN
aji-10	157	24	are	be	AUX
aji-10	157	25	excluded	exclude	VERB
aji-10	157	26	from	from	ADP
aji-10	157	27	the	the	DET
aji-10	157	28	study	study	NOUN
aji-10	157	29	.	.	PUNCT
aji-10	158	1	the	the	DET
aji-10	158	2	ethical	ethical	PROPN
aji-10	158	3	committee	committee	PROPN
aji-10	158	4	of	of	ADP
aji-10	158	5	suez	suez	PROPN
aji-10	158	6	canal	canal	PROPN
aji-10	158	7	university	university	PROPN
aji-10	158	8	hospital	hospital	NOUN
aji-10	158	9	approved	approve	VERB
aji-10	158	10	the	the	DET
aji-10	158	11	study	study	NOUN
aji-10	158	12	and	and	CCONJ
aji-10	158	13	signed	sign	VERB
aji-10	158	14	informed	informed	ADJ
aji-10	158	15	consent	consent	NOUN
aji-10	158	16	of	of	ADP
aji-10	158	17	children	child	NOUN
aji-10	158	18	’s	’s	PART
aji-10	158	19	guardians	guardian	NOUN
aji-10	158	20	is	be	AUX
aji-10	158	21	obtained	obtain	VERB
aji-10	158	22	.	.	PUNCT
aji-10	159	1	detailed	detailed	ADJ
aji-10	159	2	history	history	NOUN
aji-10	159	3	and	and	CCONJ
aji-10	159	4	full	full	ADJ
aji-10	159	5	clinical	clinical	ADJ
aji-10	159	6	examination	examination	NOUN
aji-10	159	7	was	be	AUX
aji-10	159	8	done	do	VERB
aji-10	159	9	.	.	PUNCT
aji-10	160	1	2.1	2.1	NUM
aji-10	160	2	pulmonary	pulmonary	ADJ
aji-10	160	3	function	function	NOUN
aji-10	160	4	test	test	NOUN
aji-10	160	5	it	it	PRON
aji-10	160	6	was	be	AUX
aji-10	160	7	done	do	VERB
aji-10	160	8	by	by	ADP
aji-10	160	9	peak	peak	NOUN
aji-10	160	10	expiratory	expiratory	NOUN
aji-10	160	11	flow	flow	NOUN
aji-10	160	12	rate	rate	NOUN
aji-10	160	13	test	test	NOUN
aji-10	160	14	(	(	PUNCT
aji-10	160	15	pefr	pefr	PROPN
aji-10	160	16	)	)	PUNCT
aji-10	160	17	for	for	ADP
aji-10	160	18	children	child	NOUN
aji-10	160	19	above	above	ADP
aji-10	160	20	five	five	NUM
aji-10	160	21	years	year	NOUN
aji-10	160	22	old	old	ADJ
aji-10	160	23	.	.	PUNCT
aji-10	161	1	2.2	2.2	NUM
aji-10	161	2	leptin	leptin	NOUN
aji-10	161	3	assessment	assessment	NOUN
aji-10	161	4	five	five	NUM
aji-10	161	5	ml	ml	NOUN
aji-10	161	6	blood	blood	NOUN
aji-10	161	7	samples	sample	NOUN
aji-10	161	8	was	be	AUX
aji-10	161	9	collected	collect	VERB
aji-10	161	10	by	by	ADP
aji-10	161	11	a	a	DET
aji-10	161	12	skilled	skilled	ADJ
aji-10	161	13	and	and	CCONJ
aji-10	161	14	qualified	qualified	ADJ
aji-10	161	15	technician	technician	NOUN
aji-10	161	16	at	at	ADP
aji-10	161	17	the	the	DET
aji-10	161	18	outpatient	outpatient	NOUN
aji-10	161	19	clinic	clinic	NOUN
aji-10	161	20	around	around	ADP
aji-10	161	21	8	8	NUM
aji-10	161	22	a.m.	a.m.	NOUN
aji-10	161	23	in	in	ADP
aji-10	161	24	the	the	DET
aji-10	161	25	morning	morning	NOUN
aji-10	161	26	following	follow	VERB
aji-10	161	27	an	an	DET
aji-10	161	28	overnight	overnight	ADJ
aji-10	161	29	fast	fast	NOUN
aji-10	161	30	.	.	PUNCT
aji-10	162	1	after	after	ADP
aji-10	162	2	collection	collection	NOUN
aji-10	162	3	,	,	PUNCT
aji-10	162	4	the	the	DET
aji-10	162	5	blood	blood	NOUN
aji-10	162	6	samples	sample	NOUN
aji-10	162	7	was	be	AUX
aji-10	162	8	centrifuged	centrifuge	VERB
aji-10	162	9	for	for	ADP
aji-10	162	10	10	10	NUM
aji-10	162	11	minutes	minute	NOUN
aji-10	162	12	and	and	CCONJ
aji-10	162	13	serum	serum	NOUN
aji-10	162	14	leptin	leptin	NOUN
aji-10	162	15	stored	store	VERB
aji-10	162	16	at	at	ADP
aji-10	162	17	−80	−80	PROPN
aji-10	162	18	c.	c.	PROPN
aji-10	162	19	the	the	DET
aji-10	162	20	materials	material	NOUN
aji-10	162	21	used	use	VERB
aji-10	162	22	for	for	ADP
aji-10	162	23	collection	collection	NOUN
aji-10	162	24	was	be	AUX
aji-10	162	25	disposable	disposable	ADJ
aji-10	162	26	,	,	PUNCT
aji-10	162	27	adequately	adequately	ADV
aji-10	162	28	labeled	label	VERB
aji-10	162	29	,	,	PUNCT
aji-10	162	30	and	and	CCONJ
aji-10	162	31	of	of	ADP
aji-10	162	32	recognized	recognize	VERB
aji-10	162	33	quality	quality	NOUN
aji-10	162	34	.	.	PUNCT
aji-10	163	1	leptin	leptin	NOUN
aji-10	163	2	levels	level	NOUN
aji-10	163	3	measured	measure	VERB
aji-10	163	4	using	use	VERB
aji-10	163	5	a	a	DET
aji-10	163	6	commercially	commercially	ADV
aji-10	163	7	available	available	ADJ
aji-10	163	8	enzyme	enzyme	NOUN
aji-10	163	9	-	-	PUNCT
aji-10	163	10	linked	link	VERB
aji-10	163	11	immunosorbent	immunosorbent	NOUN
aji-10	163	12	assay	assay	PROPN
aji-10	163	13	(	(	PUNCT
aji-10	163	14	elisa	elisa	NOUN
aji-10	163	15	)	)	PUNCT
aji-10	163	16	kit	kit	NOUN
aji-10	163	17	according	accord	VERB
aji-10	163	18	to	to	ADP
aji-10	163	19	the	the	DET
aji-10	163	20	manufacturer	manufacturer	NOUN
aji-10	163	21	's	's	PART
aji-10	163	22	instructions	instruction	NOUN
aji-10	163	23	and	and	CCONJ
aji-10	163	24	standard	standard	ADJ
aji-10	163	25	guidelines	guideline	NOUN
aji-10	163	26	.	.	PUNCT
aji-10	164	1	statistical	statistical	ADJ
aji-10	164	2	analysis	analysis	NOUN
aji-10	164	3	was	be	AUX
aji-10	164	4	performed	perform	VERB
aji-10	164	5	using	use	VERB
aji-10	164	6	spss	spss	PROPN
aji-10	164	7	for	for	ADP
aji-10	164	8	windows	window	NOUN
aji-10	164	9	statistical	statistical	ADJ
aji-10	164	10	package	package	NOUN
aji-10	164	11	,	,	PUNCT
aji-10	164	12	version	version	NOUN
aji-10	164	13	20	20	NUM
aji-10	164	14	.	.	PUNCT
aji-10	165	1	(	(	PUNCT
aji-10	165	2	spss	spss	PROPN
aji-10	165	3	,	,	PUNCT
aji-10	165	4	inc	inc	PROPN
aji-10	165	5	.	.	PROPN
aji-10	165	6	,	,	PUNCT
aji-10	165	7	chicago	chicago	PROPN
aji-10	165	8	,	,	PUNCT
aji-10	165	9	ill	ill	PROPN
aji-10	165	10	.	.	PROPN
aji-10	165	11	,	,	PUNCT
aji-10	165	12	usa	usa	PROPN
aji-10	165	13	)	)	PUNCT
aji-10	165	14	.	.	PUNCT
aji-10	166	1	data	datum	NOUN
aji-10	166	2	were	be	AUX
aji-10	166	3	expressed	express	VERB
aji-10	166	4	as	as	ADP
aji-10	166	5	mean	mean	NOUN
aji-10	166	6	±	±	NUM
aji-10	166	7	sd	sd	NOUN
aji-10	166	8	.	.	PUNCT
aji-10	167	1	student	student	PROPN
aji-10	167	2	’s	’s	PART
aji-10	167	3	t	t	PROPN
aji-10	167	4	test	test	NOUN
aji-10	167	5	,	,	PUNCT
aji-10	167	6	mannwhitney	mannwhitney	NOUN
aji-10	167	7	u	u	PROPN
aji-10	167	8	test	test	NOUN
aji-10	167	9	and	and	CCONJ
aji-10	167	10	χ	χ	DET
aji-10	167	11	2	2	NUM
aji-10	167	12	test	test	NOUN
aji-10	167	13	were	be	AUX
aji-10	167	14	used	use	VERB
aji-10	167	15	for	for	ADP
aji-10	167	16	comparing	compare	VERB
aji-10	167	17	mean	mean	ADJ
aji-10	167	18	values	value	NOUN
aji-10	167	19	.	.	PUNCT
aji-10	168	1	a	a	DET
aji-10	168	2	p	p	NOUN
aji-10	168	3	value	value	NOUN
aji-10	168	4	<	<	NOUN
aji-10	168	5	0.05	0.05	NUM
aji-10	168	6	was	be	AUX
aji-10	168	7	considered	consider	VERB
aji-10	168	8	statistically	statistically	ADV
aji-10	168	9	significant	significant	ADJ
aji-10	168	10	.	.	PUNCT
aji-10	169	1	3	3	X
aji-10	169	2	.	.	NOUN
aji-10	169	3	results	result	VERB
aji-10	169	4	3.1	3.1	NUM
aji-10	169	5	demographic	demographic	ADJ
aji-10	169	6	data	datum	NOUN
aji-10	169	7	this	this	DET
aji-10	169	8	study	study	NOUN
aji-10	169	9	was	be	AUX
aji-10	169	10	carried	carry	VERB
aji-10	169	11	out	out	ADP
aji-10	169	12	on	on	ADP
aji-10	169	13	fifty	fifty	NUM
aji-10	169	14	-	-	PUNCT
aji-10	169	15	six	six	NUM
aji-10	169	16	children	child	NOUN
aji-10	169	17	divided	divide	VERB
aji-10	169	18	as	as	ADP
aji-10	169	19	;	;	PUNCT
aji-10	169	20	20	20	NUM
aji-10	169	21	non	non	X
aji-10	169	22	asthmatic	asthmatic	ADJ
aji-10	169	23	children	child	NOUN
aji-10	169	24	(	(	PUNCT
aji-10	169	25	control	control	NOUN
aji-10	169	26	group	group	NOUN
aji-10	169	27	)	)	PUNCT
aji-10	169	28	and	and	CCONJ
aji-10	169	29	36	36	NUM
aji-10	169	30	asthmatic	asthmatic	ADJ
aji-10	169	31	children	child	NOUN
aji-10	169	32	;	;	PUNCT
aji-10	170	1	16	16	NUM
aji-10	170	2	obese	obese	VERB
aji-10	170	3	asthmatic	asthmatic	ADJ
aji-10	170	4	and	and	CCONJ
aji-10	170	5	20	20	NUM
aji-10	170	6	non	non	NOUN
aji-10	170	7	obese	obese	NOUN
aji-10	170	8	asthmatic	asthmatic	ADJ
aji-10	170	9	,	,	PUNCT
aji-10	170	10	all	all	PRON
aji-10	170	11	aged	aged	ADJ
aji-10	170	12	above	above	ADP
aji-10	170	13	3	3	NUM
aji-10	170	14	years	year	NOUN
aji-10	170	15	old	old	ADJ
aji-10	170	16	,	,	PUNCT
aji-10	170	17	the	the	DET
aji-10	170	18	mean	mean	ADJ
aji-10	170	19	bmi	bmi	NOUN
aji-10	170	20	in	in	ADP
aji-10	170	21	was	be	AUX
aji-10	170	22	21.3±5.8	21.3±5.8	NUM
aji-10	170	23	and	and	CCONJ
aji-10	170	24	16.6±2.4	16.6±2.4	NUM
aji-10	170	25	in	in	ADP
aji-10	170	26	asthmatic	asthmatic	ADJ
aji-10	170	27	and	and	CCONJ
aji-10	170	28	nonasthmatic	nonasthmatic	ADJ
aji-10	170	29	groups	group	NOUN
aji-10	170	30	respectively	respectively	ADV
aji-10	170	31	.	.	PUNCT
aji-10	171	1	the	the	DET
aji-10	171	2	mean	mean	ADJ
aji-10	171	3	age	age	NOUN
aji-10	171	4	of	of	ADP
aji-10	171	5	asthmatic	asthmatic	ADJ
aji-10	171	6	group	group	NOUN
aji-10	171	7	was	be	AUX
aji-10	171	8	7.3±3.3	7.3±3.3	NUM
aji-10	171	9	while	while	SCONJ
aji-10	171	10	it	it	PRON
aji-10	171	11	was	be	AUX
aji-10	171	12	8.5±3.6	8.5±3.6	PROPN
aji-10	171	13	in	in	ADP
aji-10	171	14	non	non	ADJ
aji-10	171	15	-	-	ADJ
aji-10	171	16	asthmatic	asthmatic	ADJ
aji-10	171	17	group	group	NOUN
aji-10	171	18	,	,	PUNCT
aji-10	171	19	all	all	DET
aji-10	171	20	these	these	DET
aji-10	171	21	data	datum	NOUN
aji-10	171	22	are	be	AUX
aji-10	171	23	summarized	summarize	VERB
aji-10	171	24	in	in	ADP
aji-10	171	25	table	table	NOUN
aji-10	171	26	1	1	NUM
aji-10	171	27	.	.	PUNCT
aji-10	171	28	serum	serum	NOUN
aji-10	171	29	leptin	leptin	PROPN
aji-10	171	30	was	be	AUX
aji-10	171	31	significantly	significantly	ADV
aji-10	171	32	higher	high	ADJ
aji-10	171	33	in	in	ADP
aji-10	171	34	asthmatics	asthmatic	NOUN
aji-10	171	35	than	than	ADP
aji-10	171	36	non	non	NOUN
aji-10	171	37	-	-	NOUN
aji-10	171	38	asthmatics	asthmatic	NOUN
aji-10	171	39	(	(	PUNCT
aji-10	171	40	p=<0.001	p=<0.001	NOUN
aji-10	171	41	)	)	PUNCT
aji-10	171	42	,	,	PUNCT
aji-10	171	43	but	but	CCONJ
aji-10	171	44	there	there	PRON
aji-10	171	45	was	be	VERB
aji-10	171	46	no	no	DET
aji-10	171	47	significant	significant	ADJ
aji-10	171	48	relation	relation	NOUN
aji-10	171	49	between	between	ADP
aji-10	171	50	serum	serum	NOUN
aji-10	171	51	leptin	leptin	NOUN
aji-10	171	52	in	in	ADP
aji-10	171	53	obese	obese	ADJ
aji-10	171	54	asthmatic	asthmatic	ADJ
aji-10	171	55	and	and	CCONJ
aji-10	171	56	non	non	ADJ
aji-10	171	57	-	-	ADJ
aji-10	171	58	obese	obese	ADJ
aji-10	171	59	asthmatic	asthmatic	ADJ
aji-10	171	60	(	(	PUNCT
aji-10	171	61	p=0.175	p=0.175	NOUN
aji-10	171	62	)	)	PUNCT
aji-10	171	63	as	as	SCONJ
aji-10	171	64	shown	show	VERB
aji-10	171	65	in	in	ADP
aji-10	171	66	table	table	NOUN
aji-10	171	67	2	2	NUM
aji-10	171	68	.	.	PUNCT
aji-10	171	69	relation	relation	NOUN
aji-10	171	70	of	of	ADP
aji-10	171	71	serum	serum	NOUN
aji-10	171	72	leptin	leptin	NOUN
aji-10	171	73	and	and	CCONJ
aji-10	171	74	degree	degree	NOUN
aji-10	171	75	of	of	ADP
aji-10	171	76	asthma	asthma	NOUN
aji-10	171	77	severity	severity	NOUN
aji-10	171	78	:	:	PUNCT
aji-10	171	79	table	table	NOUN
aji-10	171	80	3	3	NUM
aji-10	171	81	shows	show	VERB
aji-10	171	82	significantly	significantly	ADV
aji-10	171	83	higher	high	ADJ
aji-10	171	84	serum	serum	NOUN
aji-10	171	85	leptin	leptin	NOUN
aji-10	171	86	in	in	ADP
aji-10	171	87	severe	severe	ADJ
aji-10	171	88	asthmatics	asthmatic	NOUN
aji-10	171	89	97.6±8.5	97.6±8.5	NUM
aji-10	171	90	,	,	PUNCT
aji-10	171	91	than	than	ADP
aji-10	171	92	moderate	moderate	ADJ
aji-10	171	93	89.3±4.6	89.3±4.6	NUM
aji-10	171	94	and	and	CCONJ
aji-10	171	95	mild	mild	ADJ
aji-10	171	96	asthmatics	asthmatic	NOUN
aji-10	171	97	82.0±3.2	82.0±3.2	NUM
aji-10	171	98	(	(	PUNCT
aji-10	171	99	p	p	NOUN
aji-10	171	100	=	=	X
aji-10	171	101	<	<	X
aji-10	171	102	0.001	0.001	NUM
aji-10	171	103	)	)	PUNCT
aji-10	171	104	respectively	respectively	ADV
aji-10	171	105	.	.	PUNCT
aji-10	171	106	table	table	NOUN
aji-10	171	107	1	1	NUM
aji-10	171	108	.	.	X
aji-10	171	109	socio	socio	VERB
aji-10	171	110	demographic	demographic	ADJ
aji-10	171	111	parameters	parameter	NOUN
aji-10	171	112	of	of	ADP
aji-10	171	113	study	study	NOUN
aji-10	171	114	groups	group	NOUN
aji-10	171	115	p	p	PROPN
aji-10	171	116	value	value	NOUN
aji-10	171	117	non	non	ADJ
aji-10	171	118	-	-	ADJ
aji-10	171	119	obese	obese	ADJ
aji-10	171	120	asthmatics	asthmatic	NOUN
aji-10	171	121	(	(	PUNCT
aji-10	171	122	20	20	X
aji-10	171	123	)	)	PUNCT
aji-10	171	124	obese	obese	ADJ
aji-10	171	125	asthmatics	asthmatic	NOUN
aji-10	171	126	(	(	PUNCT
aji-10	171	127	16	16	NUM
aji-10	171	128	)	)	PUNCT
aji-10	171	129	p	p	NOUN
aji-10	171	130	value	value	NOUN
aji-10	171	131	nonasthmatic	nonasthmatic	ADJ
aji-10	171	132	(	(	PUNCT
aji-10	171	133	20	20	NUM
aji-10	171	134	)	)	PUNCT
aji-10	171	135	asthmatic	asthmatic	ADJ
aji-10	171	136	(	(	PUNCT
aji-10	171	137	36	36	NUM
aji-10	171	138	)	)	PUNCT
aji-10	171	139	0.201	0.201	NUM
aji-10	171	140	8.5±3.6	8.5±3.6	NUM
aji-10	171	141	7.3±3.3	7.3±3.3	NUM
aji-10	171	142	age	age	NOUN
aji-10	171	143	(	(	PUNCT
aji-10	171	144	years	year	NOUN
aji-10	171	145	)	)	PUNCT
aji-10	171	146	0.584	0.584	NUM
aji-10	172	1	30.8±14.5	30.8±14.5	NUM
aji-10	172	2	33.0±15.5	33.0±15.5	NUM
aji-10	172	3	body	body	NOUN
aji-10	172	4	weight	weight	NOUN
aji-10	172	5	0.081	0.081	NUM
aji-10	172	6	132.3±21.4	132.3±21.4	NUM
aji-10	172	7	122.0±19.8	122.0±19.8	PROPN
aji-10	172	8	height	height	NOUN
aji-10	172	9	0.004	0.004	NUM
aji-10	172	10	*	*	SYM
aji-10	172	11	16.6±2.4	16.6±2.4	NUM
aji-10	172	12	21.3±5.8	21.3±5.8	NUM
aji-10	172	13	bmi	bmi	NOUN
aji-10	172	14	sex	sex	NOUN
aji-10	172	15	0.577	0.577	NUM
aji-10	172	16	11(55.0	11(55.0	NUM
aji-10	172	17	%	%	NOUN
aji-10	172	18	)	)	PUNCT
aji-10	172	19	17(47.2	17(47.2	NUM
aji-10	172	20	%	%	NOUN
aji-10	172	21	)	)	PUNCT
aji-10	172	22	males	male	VERB
aji-10	172	23	0.201	0.201	NUM
aji-10	172	24	9(45.0	9(45.0	NUM
aji-10	172	25	%	%	NOUN
aji-10	172	26	)	)	PUNCT
aji-10	172	27	19(52.8	19(52.8	NUM
aji-10	172	28	%	%	NOUN
aji-10	172	29	)	)	PUNCT
aji-10	172	30	females	female	NOUN
aji-10	172	31	0.175	0.175	NUM
aji-10	172	32	87.8±5.6	87.8±5.6	NUM
aji-10	172	33	91.3±9.3	91.3±9.3	NUM
aji-10	172	34	<	<	NOUN
aji-10	172	35	0.001	0.001	NUM
aji-10	172	36	*	*	SYM
aji-10	172	37	71.3±8.2	71.3±8.2	NUM
aji-10	172	38	89.3±7.6	89.3±7.6	NUM
aji-10	172	39	serum	serum	PROPN
aji-10	172	40	leptin	leptin	PROPN
aji-10	172	41	data	datum	NOUN
aji-10	172	42	was	be	AUX
aji-10	172	43	presented	present	VERB
aji-10	172	44	as	as	SCONJ
aji-10	172	45	means	mean	VERB
aji-10	172	46	±	±	NUM
aji-10	172	47	sd	sd	NOUN
aji-10	172	48	or	or	CCONJ
aji-10	172	49	no	no	INTJ
aji-10	172	50	.	.	PUNCT
aji-10	173	1	and	and	CCONJ
aji-10	173	2	%	%	INTJ
aji-10	173	3	*	*	PUNCT
aji-10	173	4	statistically	statistically	ADV
aji-10	173	5	significant	significant	ADJ
aji-10	173	6	p	p	X
aji-10	173	7	<	<	NOUN
aji-10	173	8	0.05	0.05	NUM
aji-10	173	9	;	;	PUNCT
aji-10	173	10	≠	≠	PROPN
aji-10	173	11	or	or	CCONJ
aji-10	173	12	for	for	ADP
aji-10	173	13	sex	sex	NOUN
aji-10	173	14	(	(	PUNCT
aji-10	173	15	male	male	NOUN
aji-10	173	16	/	/	SYM
aji-10	173	17	female	female	NOUN
aji-10	173	18	)	)	PUNCT
aji-10	173	19	elngar	elngar	NOUN
aji-10	173	20	et	et	PROPN
aji-10	173	21	al	al	PROPN
aji-10	173	22	.	.	PROPN
aji-10	173	23	;	;	PUNCT
aji-10	173	24	aji	aji	PROPN
aji-10	173	25	,	,	PUNCT
aji-10	173	26	2(1	2(1	NUM
aji-10	173	27	):	):	PUNCT
aji-10	173	28	26	26	NUM
aji-10	173	29	-	-	SYM
aji-10	173	30	33	33	NUM
aji-10	173	31	,	,	PUNCT
aji-10	173	32	2019	2019	NUM
aji-10	173	33	;	;	PUNCT
aji-10	174	1	article	article	NOUN
aji-10	174	2	no.aji.53002	no.aji.53002	NOUN
aji-10	174	3	29	29	NUM
aji-10	174	4	table	table	NOUN
aji-10	174	5	2	2	NUM
aji-10	174	6	.	.	PUNCT
aji-10	174	7	relation	relation	NOUN
aji-10	174	8	of	of	ADP
aji-10	174	9	serum	serum	NOUN
aji-10	174	10	leptin	leptin	NOUN
aji-10	174	11	and	and	CCONJ
aji-10	174	12	degree	degree	NOUN
aji-10	174	13	of	of	ADP
aji-10	174	14	asthma	asthma	NOUN
aji-10	174	15	severity	severity	PROPN
aji-10	174	16	p	p	NOUN
aji-10	174	17	value	value	NOUN
aji-10	174	18	asthma	asthma	NOUN
aji-10	174	19	severity	severity	NOUN
aji-10	174	20	severe	severe	ADJ
aji-10	174	21	(	(	PUNCT
aji-10	174	22	8)	8)	NUM
aji-10	174	23	moderate	moderate	ADJ
aji-10	174	24	(	(	PUNCT
aji-10	174	25	19	19	NUM
aji-10	174	26	)	)	PUNCT
aji-10	174	27	mild	mild	ADJ
aji-10	174	28	(	(	PUNCT
aji-10	174	29	9	9	NUM
aji-10	174	30	)	)	PUNCT
aji-10	174	31	<	<	NOUN
aji-10	174	32	0.001	0.001	NUM
aji-10	174	33	*	*	SYM
aji-10	174	34	97.6±8.5	97.6±8.5	NUM
aji-10	174	35	89.3±4.6	89.3±4.6	NUM
aji-10	174	36	82.0±3.2	82.0±3.2	NUM
aji-10	174	37	serum	serum	NOUN
aji-10	174	38	leptin	leptin	NOUN
aji-10	174	39	table	table	NOUN
aji-10	174	40	3	3	NUM
aji-10	174	41	.	.	X
aji-10	174	42	relation	relation	NOUN
aji-10	174	43	between	between	ADP
aji-10	174	44	serum	serum	NOUN
aji-10	174	45	leptin	leptin	NOUN
aji-10	174	46	levels	level	NOUN
aji-10	174	47	and	and	CCONJ
aji-10	174	48	history	history	NOUN
aji-10	174	49	of	of	ADP
aji-10	174	50	allergy	allergy	NOUN
aji-10	174	51	p	p	PROPN
aji-10	174	52	value	value	NOUN
aji-10	174	53	serum	serum	NOUN
aji-10	174	54	leptin	leptin	NOUN
aji-10	174	55	(	(	PUNCT
aji-10	174	56	mean	mean	PROPN
aji-10	174	57	±	±	NUM
aji-10	174	58	sd	sd	NOUN
aji-10	174	59	)	)	PUNCT
aji-10	174	60	negative	negative	ADJ
aji-10	174	61	positive	positive	ADJ
aji-10	174	62	010.0	010.0	NUM
aji-10	174	63	*	*	PUNCT
aji-10	174	64	79.5±12.2	79.5±12.2	NUM
aji-10	174	65	87.7±9.0	87.7±9.0	NUM
aji-10	174	66	history	history	NOUN
aji-10	174	67	of	of	ADP
aji-10	174	68	allergy	allergy	NOUN
aji-10	174	69	<	<	X
aji-10	174	70	0100	0100	NUM
aji-10	174	71	.	.	PUNCT
aji-10	174	72	.	.	PUNCT
aji-10	175	1	*	*	PUNCT
aji-10	175	2	75.7±9.7	75.7±9.7	NUM
aji-10	175	3	91.2±7.4	91.2±7.4	NUM
aji-10	175	4	family	family	NOUN
aji-10	175	5	history	history	NOUN
aji-10	175	6	of	of	ADP
aji-10	175	7	asthma	asthma	NOUN
aji-10	175	8	table	table	NOUN
aji-10	175	9	4	4	NUM
aji-10	175	10	.	.	PUNCT
aji-10	175	11	comparison	comparison	NOUN
aji-10	175	12	between	between	ADP
aji-10	175	13	serum	serum	NOUN
aji-10	175	14	leptin	leptin	NOUN
aji-10	175	15	in	in	ADP
aji-10	175	16	study	study	NOUN
aji-10	175	17	groups	group	NOUN
aji-10	175	18	serum	serum	VERB
aji-10	175	19	leptin	leptin	NOUN
aji-10	175	20	group	group	NOUN
aji-10	175	21	p	p	PROPN
aji-10	175	22	value	value	NOUN
aji-10	175	23	p	p	NOUN
aji-10	175	24	value	value	NOUN
aji-10	175	25	asthmatics	asthmatic	NOUN
aji-10	175	26	(	(	PUNCT
aji-10	175	27	36	36	NUM
aji-10	175	28	)	)	PUNCT
aji-10	175	29	non	non	NOUN
aji-10	175	30	-	-	NOUN
aji-10	175	31	asthmatics	asthmatic	NOUN
aji-10	175	32	(	(	PUNCT
aji-10	175	33	20	20	X
aji-10	175	34	)	)	PUNCT
aji-10	175	35	obese	obese	ADJ
aji-10	175	36	asthmatics	asthmatic	NOUN
aji-10	175	37	(	(	PUNCT
aji-10	175	38	16	16	NUM
aji-10	175	39	)	)	PUNCT
aji-10	175	40	non	non	ADJ
aji-10	175	41	-	-	ADJ
aji-10	175	42	obese	obese	ADJ
aji-10	175	43	asthmatics	asthmatic	NOUN
aji-10	175	44	(	(	PUNCT
aji-10	175	45	20	20	NUM
aji-10	175	46	)	)	PUNCT
aji-10	175	47	89.3±7.6	89.3±7.6	NUM
aji-10	175	48	71.3±8.2	71.3±8.2	NUM
aji-10	175	49	<	<	X
aji-10	175	50	0.001	0.001	NUM
aji-10	175	51	*	*	NOUN
aji-10	175	52	91.3±9.3	91.3±9.3	NUM
aji-10	175	53	87.8±5.6	87.8±5.6	NUM
aji-10	175	54	0.175	0.175	NUM
aji-10	175	55	*	*	PUNCT
aji-10	175	56	statistically	statistically	ADV
aji-10	175	57	significant	significant	ADJ
aji-10	175	58	at	at	ADP
aji-10	175	59	p<0.05	p<0.05	NOUN
aji-10	175	60	table	table	NOUN
aji-10	175	61	5	5	NUM
aji-10	175	62	.	.	PUNCT
aji-10	175	63	relation	relation	NOUN
aji-10	175	64	of	of	ADP
aji-10	175	65	clinical	clinical	ADJ
aji-10	175	66	parameters	parameter	NOUN
aji-10	175	67	of	of	ADP
aji-10	175	68	asthmatics	asthmatic	NOUN
aji-10	175	69	and	and	CCONJ
aji-10	175	70	asthma	asthma	NOUN
aji-10	175	71	severity	severity	NOUN
aji-10	175	72	asthma	asthma	NOUN
aji-10	175	73	severity	severity	PROPN
aji-10	175	74	p	p	NOUN
aji-10	175	75	value	value	NOUN
aji-10	175	76	mild	mild	ADJ
aji-10	175	77	(	(	PUNCT
aji-10	175	78	9	9	NUM
aji-10	175	79	)	)	PUNCT
aji-10	175	80	moderate	moderate	ADJ
aji-10	175	81	(	(	PUNCT
aji-10	175	82	19	19	NUM
aji-10	175	83	)	)	PUNCT
aji-10	175	84	severe	severe	ADJ
aji-10	175	85	(	(	PUNCT
aji-10	175	86	8)	8)	NUM
aji-10	175	87	age	age	NOUN
aji-10	175	88	(	(	PUNCT
aji-10	175	89	years	year	NOUN
aji-10	175	90	)	)	PUNCT
aji-10	175	91	7.7±3.6	7.7±3.6	PROPN
aji-10	175	92	7.5±3.6	7.5±3.6	NUM
aji-10	175	93	6.5±2.8	6.5±2.8	NUM
aji-10	175	94	0.776	0.776	NUM
aji-10	175	95	body	body	NOUN
aji-10	175	96	weight	weight	NOUN
aji-10	175	97	34.0±11.6	34.0±11.6	PROPN
aji-10	176	1	34.0±18.5	34.0±18.5	NUM
aji-10	176	2	29.6±12.5	29.6±12.5	NUM
aji-10	176	3	0.745	0.745	NUM
aji-10	176	4	height	height	NOUN
aji-10	176	5	126.1±21.1	126.1±21.1	NUM
aji-10	176	6	122.2±20.3	122.2±20.3	PROPN
aji-10	176	7	117.1±18.8	117.1±18.8	NOUN
aji-10	176	8	0.666	0.666	NUM
aji-10	176	9	bmi	bmi	NOUN
aji-10	176	10	21.3±6.0	21.3±6.0	NUM
aji-10	176	11	21.5±6.2	21.5±6.2	NUM
aji-10	176	12	20.9±5.5	20.9±5.5	NUM
aji-10	176	13	0.995	0.995	NUM
aji-10	176	14	sex	sex	NOUN
aji-10	176	15	males	male	NOUN
aji-10	176	16	6(66.7	6(66.7	NUM
aji-10	176	17	%	%	NOUN
aji-10	176	18	)	)	PUNCT
aji-10	176	19	7(36.8	7(36.8	NUM
aji-10	176	20	%	%	NOUN
aji-10	176	21	)	)	PUNCT
aji-10	176	22	4(50.0	4(50.0	NUM
aji-10	176	23	%	%	NOUN
aji-10	176	24	)	)	PUNCT
aji-10	176	25	0.338	0.338	NUM
aji-10	176	26	females	female	NOUN
aji-10	176	27	3(33.3	3(33.3	NUM
aji-10	176	28	%	%	NOUN
aji-10	176	29	)	)	PUNCT
aji-10	176	30	12(63.2	12(63.2	NUM
aji-10	176	31	%	%	NOUN
aji-10	176	32	)	)	PUNCT
aji-10	176	33	4(50.0	4(50.0	NUM
aji-10	176	34	%	%	NOUN
aji-10	176	35	)	)	PUNCT
aji-10	176	36	history	history	NOUN
aji-10	176	37	of	of	ADP
aji-10	176	38	allergy	allergy	NOUN
aji-10	176	39	3(33.3	3(33.3	NUM
aji-10	176	40	%	%	NOUN
aji-10	176	41	)	)	PUNCT
aji-10	176	42	8(42.1	8(42.1	NOUN
aji-10	176	43	%	%	NOUN
aji-10	176	44	)	)	PUNCT
aji-10	176	45	5(62.5	5(62.5	NUM
aji-10	176	46	%	%	NOUN
aji-10	176	47	)	)	PUNCT
aji-10	176	48	0.503	0.503	NUM
aji-10	176	49	family	family	NOUN
aji-10	176	50	history	history	NOUN
aji-10	176	51	of	of	ADP
aji-10	176	52	asthma	asthma	NOUN
aji-10	176	53	2(22.2	2(22.2	PROPN
aji-10	176	54	%	%	NOUN
aji-10	176	55	)	)	PUNCT
aji-10	176	56	14(73.7	14(73.7	NUM
aji-10	176	57	%	%	NOUN
aji-10	176	58	)	)	PUNCT
aji-10	176	59	8(100.0	8(100.0	NUM
aji-10	176	60	%	%	NOUN
aji-10	176	61	)	)	PUNCT
aji-10	176	62	0.002	0.002	NUM
aji-10	176	63	*	*	PUNCT
aji-10	176	64	serum	serum	NOUN
aji-10	176	65	leptin	leptin	NOUN
aji-10	176	66	82.0±3.2	82.0±3.2	NUM
aji-10	176	67	89.3±4.6	89.3±4.6	NUM
aji-10	176	68	97.6±8.5	97.6±8.5	NUM
aji-10	177	1	<	<	X
aji-10	177	2	0.001	0.001	NUM
aji-10	177	3	*	*	PUNCT
aji-10	177	4	pefr	pefr	VERB
aji-10	177	5	146.1±50.9	146.1±50.9	NUM
aji-10	177	6	140.2±67.9	140.2±67.9	NUM
aji-10	177	7	151.1±62.9	151.1±62.9	NUM
aji-10	177	8	0.824	0.824	NUM
aji-10	177	9	data	datum	NOUN
aji-10	177	10	was	be	AUX
aji-10	177	11	presented	present	VERB
aji-10	177	12	as	as	SCONJ
aji-10	177	13	means	mean	VERB
aji-10	177	14	±	±	NUM
aji-10	177	15	sd	sd	NOUN
aji-10	177	16	or	or	CCONJ
aji-10	177	17	no	no	INTJ
aji-10	177	18	.	.	PUNCT
aji-10	178	1	and	and	CCONJ
aji-10	178	2	%	%	INTJ
aji-10	178	3	;	;	PUNCT
aji-10	178	4	*	*	PUNCT
aji-10	178	5	statistically	statistically	ADV
aji-10	178	6	significant	significant	ADJ
aji-10	178	7	p	p	X
aji-10	178	8	<	<	NOUN
aji-10	178	9	0.05	0.05	NUM
aji-10	178	10	there	there	PRON
aji-10	178	11	was	be	VERB
aji-10	178	12	positive	positive	ADJ
aji-10	178	13	significant	significant	ADJ
aji-10	178	14	correlation	correlation	NOUN
aji-10	178	15	between	between	ADP
aji-10	178	16	serum	serum	NOUN
aji-10	178	17	leptin	leptin	NOUN
aji-10	178	18	levels	level	NOUN
aji-10	178	19	and	and	CCONJ
aji-10	178	20	asthma	asthma	NOUN
aji-10	178	21	severity	severity	NOUN
aji-10	178	22	(	(	PUNCT
aji-10	178	23	correlation	correlation	NOUN
aji-10	178	24	coefficient	coefficient	NOUN
aji-10	178	25	was	be	AUX
aji-10	178	26	0.862	0.862	NUM
aji-10	178	27	*	*	PUNCT
aji-10	178	28	and	and	CCONJ
aji-10	178	29	p	p	NOUN
aji-10	178	30	value	value	NOUN
aji-10	178	31	was	be	AUX
aji-10	178	32	<	<	X
aji-10	178	33	0.001	0.001	NUM
aji-10	178	34	)	)	PUNCT
aji-10	178	35	while	while	SCONJ
aji-10	178	36	it	it	PRON
aji-10	178	37	is	be	AUX
aji-10	178	38	demonstrated	demonstrate	VERB
aji-10	178	39	a	a	DET
aji-10	178	40	significant	significant	ADJ
aji-10	178	41	negative	negative	ADJ
aji-10	178	42	association	association	NOUN
aji-10	178	43	of	of	ADP
aji-10	178	44	leptin	leptin	NOUN
aji-10	178	45	with	with	ADP
aji-10	178	46	pefr	pefr	PROPN
aji-10	178	47	results	result	NOUN
aji-10	178	48	r=-0.468	r=-0.468	PROPN
aji-10	178	49	and	and	CCONJ
aji-10	178	50	p<0.001	p<0.001	PROPN
aji-10	178	51	.	.	PUNCT
aji-10	179	1	relation	relation	NOUN
aji-10	179	2	between	between	ADP
aji-10	179	3	serum	serum	NOUN
aji-10	179	4	leptin	leptin	NOUN
aji-10	179	5	levels	level	NOUN
aji-10	179	6	and	and	CCONJ
aji-10	179	7	history	history	NOUN
aji-10	179	8	of	of	ADP
aji-10	179	9	allergy	allergy	NOUN
aji-10	179	10	:	:	PUNCT
aji-10	179	11	table	table	NOUN
aji-10	179	12	2	2	NUM
aji-10	179	13	shows	show	VERB
aji-10	179	14	a	a	DET
aji-10	179	15	significant	significant	ADJ
aji-10	179	16	relation	relation	NOUN
aji-10	179	17	between	between	ADP
aji-10	179	18	serum	serum	NOUN
aji-10	179	19	leptin	leptin	NOUN
aji-10	179	20	levels	level	NOUN
aji-10	179	21	and	and	CCONJ
aji-10	179	22	history	history	NOUN
aji-10	179	23	of	of	ADP
aji-10	179	24	allergy	allergy	NOUN
aji-10	179	25	(	(	PUNCT
aji-10	179	26	p	p	NOUN
aji-10	179	27	=	=	NOUN
aji-10	179	28	0.019	0.019	NUM
aji-10	179	29	)	)	PUNCT
aji-10	179	30	as	as	ADV
aji-10	179	31	well	well	ADV
aji-10	179	32	as	as	ADP
aji-10	179	33	family	family	NOUN
aji-10	179	34	history	history	NOUN
aji-10	179	35	of	of	ADP
aji-10	179	36	asthma	asthma	NOUN
aji-10	179	37	(	(	PUNCT
aji-10	179	38	p	p	X
aji-10	179	39	=	=	X
aji-10	179	40	<	<	X
aji-10	179	41	0.001	0.001	NUM
aji-10	179	42	)	)	PUNCT
aji-10	179	43	.	.	PUNCT
aji-10	180	1	relation	relation	NOUN
aji-10	180	2	between	between	ADP
aji-10	180	3	body	body	NOUN
aji-10	180	4	mass	mass	NOUN
aji-10	180	5	index	index	NOUN
aji-10	180	6	and	and	CCONJ
aji-10	180	7	asthma	asthma	NOUN
aji-10	180	8	severity	severity	NOUN
aji-10	180	9	:	:	PUNCT
aji-10	180	10	table	table	NOUN
aji-10	180	11	3	3	NUM
aji-10	180	12	shows	show	VERB
aji-10	180	13	a	a	DET
aji-10	180	14	significant	significant	ADJ
aji-10	180	15	moderate	moderate	ADJ
aji-10	180	16	positive	positive	ADJ
aji-10	180	17	correlation	correlation	NOUN
aji-10	180	18	between	between	ADP
aji-10	180	19	body	body	NOUN
aji-10	180	20	mass	mass	NOUN
aji-10	180	21	index	index	NOUN
aji-10	180	22	and	and	CCONJ
aji-10	180	23	asthma	asthma	NOUN
aji-10	180	24	severity	severity	NOUN
aji-10	180	25	(	(	PUNCT
aji-10	180	26	rho=0.334	rho=0.334	PROPN
aji-10	180	27	,	,	PUNCT
aji-10	180	28	p=0.012	p=0.012	NUM
aji-10	180	29	)	)	PUNCT
aji-10	180	30	.	.	PUNCT
aji-10	181	1	table	table	NOUN
aji-10	181	2	4	4	NUM
aji-10	181	3	show	show	NOUN
aji-10	181	4	serum	serum	NOUN
aji-10	181	5	leptin	leptin	NOUN
aji-10	181	6	was	be	AUX
aji-10	181	7	significantly	significantly	ADV
aji-10	181	8	higher	high	ADJ
aji-10	181	9	in	in	ADP
aji-10	181	10	asthmatics	asthmatic	NOUN
aji-10	181	11	than	than	ADP
aji-10	181	12	nonasthmatics	nonasthmatic	NOUN
aji-10	181	13	(	(	PUNCT
aji-10	181	14	p=<0.001	p=<0.001	NOUN
aji-10	181	15	)	)	PUNCT
aji-10	181	16	there	there	PRON
aji-10	181	17	was	be	VERB
aji-10	181	18	significant	significant	ADJ
aji-10	181	19	negative	negative	ADJ
aji-10	181	20	association	association	NOUN
aji-10	181	21	between	between	ADP
aji-10	181	22	peak	peak	NOUN
aji-10	181	23	expiratory	expiratory	NOUN
aji-10	181	24	flow	flow	NOUN
aji-10	181	25	rate	rate	NOUN
aji-10	181	26	results	result	NOUN
aji-10	181	27	and	and	CCONJ
aji-10	181	28	asthma	asthma	NOUN
aji-10	181	29	severity	severity	NOUN
aji-10	181	30	.	.	PUNCT
aji-10	182	1	r=-0.427and	r=-0.427and	VERB
aji-10	182	2	p=0.001	p=0.001	PROPN
aji-10	182	3	.	.	PUNCT
aji-10	183	1	roc	roc	PROPN
aji-10	183	2	curve	curve	NOUN
aji-10	183	3	of	of	ADP
aji-10	183	4	serum	serum	NOUN
aji-10	183	5	leptin	leptin	NOUN
aji-10	183	6	for	for	ADP
aji-10	183	7	diagnosis	diagnosis	NOUN
aji-10	183	8	of	of	ADP
aji-10	183	9	severe	severe	ADJ
aji-10	183	10	asthma	asthma	NOUN
aji-10	183	11	showed	show	VERB
aji-10	183	12	serum	serum	NOUN
aji-10	183	13	leptin	leptin	NOUN
aji-10	183	14	was	be	AUX
aji-10	183	15	91.5	91.5	NUM
aji-10	183	16	%	%	NOUN
aji-10	183	17	accurate	accurate	ADJ
aji-10	183	18	in	in	ADP
aji-10	183	19	diagnosis	diagnosis	NOUN
aji-10	183	20	of	of	ADP
aji-10	183	21	severe	severe	ADJ
aji-10	183	22	asthma	asthma	NOUN
aji-10	183	23	(	(	PUNCT
aji-10	183	24	auc=0.915	auc=0.915	PROPN
aji-10	183	25	,	,	PUNCT
aji-10	183	26	p<0.001	p<0.001	PROPN
aji-10	183	27	)	)	PUNCT
aji-10	183	28	.	.	PUNCT
aji-10	184	1	at	at	ADP
aji-10	184	2	cutoff	cutoff	NOUN
aji-10	184	3	value	value	NOUN
aji-10	184	4	of	of	ADP
aji-10	184	5	75.5	75.5	NUM
aji-10	184	6	,	,	PUNCT
aji-10	184	7	serum	serum	NOUN
aji-10	184	8	leptin	leptin	NOUN
aji-10	184	9	was	be	AUX
aji-10	184	10	shown	show	VERB
aji-10	184	11	100	100	NUM
aji-10	184	12	%	%	NOUN
aji-10	184	13	sensitivity	sensitivity	NOUN
aji-10	184	14	and	and	CCONJ
aji-10	184	15	75	75	NUM
aji-10	184	16	%	%	NOUN
aji-10	184	17	specificity	specificity	NOUN
aji-10	184	18	for	for	ADP
aji-10	184	19	diagnosis	diagnosis	NOUN
aji-10	184	20	of	of	ADP
aji-10	184	21	severe	severe	ADJ
aji-10	184	22	asthma	asthma	NOUN
aji-10	184	23	.	.	PUNCT
aji-10	185	1	4	4	X
aji-10	185	2	.	.	X
aji-10	185	3	discussion	discussion	NOUN
aji-10	185	4	leptin	leptin	NOUN
aji-10	185	5	is	be	AUX
aji-10	185	6	an	an	DET
aji-10	185	7	obesity	obesity	NOUN
aji-10	185	8	gene	gene	NOUN
aji-10	185	9	product	product	NOUN
aji-10	185	10	derived	derive	VERB
aji-10	185	11	from	from	ADP
aji-10	185	12	adipocytes	adipocyte	NOUN
aji-10	185	13	and	and	CCONJ
aji-10	185	14	activates	activate	VERB
aji-10	185	15	proinflammtory	proinflammtory	ADJ
aji-10	185	16	adipocytokines	adipocytokine	NOUN
aji-10	185	17	including	include	VERB
aji-10	185	18	tumor	tumor	NOUN
aji-10	185	19	necrosis	necrosis	NOUN
aji-10	185	20	factor	factor	NOUN
aji-10	185	21	α	α	NOUN
aji-10	185	22	,	,	PUNCT
aji-10	185	23	interleukine-6	interleukine-6	PROPN
aji-10	185	24	and	and	CCONJ
aji-10	185	25	interferon	interferon	ADJ
aji-10	185	26	-	-	PUNCT
aji-10	185	27	γ	γ	NOUN
aji-10	185	28	.	.	PUNCT
aji-10	186	1	this	this	DET
aji-10	186	2	study	study	NOUN
aji-10	186	3	showed	show	VERB
aji-10	186	4	no	no	DET
aji-10	186	5	statistically	statistically	ADV
aji-10	186	6	significant	significant	ADJ
aji-10	186	7	difference	difference	NOUN
aji-10	186	8	between	between	ADP
aji-10	186	9	the	the	DET
aji-10	186	10	two	two	NUM
aji-10	186	11	study	study	NOUN
aji-10	186	12	groups	group	NOUN
aji-10	186	13	in	in	ADP
aji-10	186	14	terms	term	NOUN
aji-10	186	15	elngar	elngar	VERB
aji-10	186	16	et	et	PROPN
aji-10	186	17	al	al	PROPN
aji-10	186	18	.	.	PROPN
aji-10	186	19	;	;	PUNCT
aji-10	186	20	aji	aji	PROPN
aji-10	186	21	,	,	PUNCT
aji-10	186	22	2(1	2(1	NUM
aji-10	186	23	):	):	PUNCT
aji-10	186	24	26	26	NUM
aji-10	186	25	-	-	SYM
aji-10	186	26	33	33	NUM
aji-10	186	27	,	,	PUNCT
aji-10	186	28	2019	2019	NUM
aji-10	186	29	;	;	PUNCT
aji-10	186	30	article	article	NOUN
aji-10	186	31	no.aji.53002	no.aji.53002	NOUN
aji-10	186	32	30	30	NUM
aji-10	186	33	of	of	ADP
aji-10	186	34	socio	socio	NOUN
aji-10	186	35	demographic	demographic	ADJ
aji-10	186	36	characteristics	characteristic	NOUN
aji-10	186	37	(	(	PUNCT
aji-10	186	38	age	age	NOUN
aji-10	186	39	,	,	PUNCT
aji-10	186	40	body	body	NOUN
aji-10	186	41	weight	weight	NOUN
aji-10	186	42	,	,	PUNCT
aji-10	186	43	height	height	NOUN
aji-10	186	44	and	and	CCONJ
aji-10	186	45	sex	sex	NOUN
aji-10	186	46	)	)	PUNCT
aji-10	186	47	(	(	PUNCT
aji-10	186	48	p	p	X
aji-10	186	49	>	>	X
aji-10	186	50	0.05	0.05	NUM
aji-10	186	51	)	)	PUNCT
aji-10	186	52	.	.	PUNCT
aji-10	187	1	in	in	ADP
aji-10	187	2	addition	addition	NOUN
aji-10	187	3	,	,	PUNCT
aji-10	187	4	the	the	DET
aji-10	187	5	current	current	ADJ
aji-10	187	6	study	study	NOUN
aji-10	187	7	reported	report	VERB
aji-10	187	8	a	a	DET
aji-10	187	9	significant	significant	ADJ
aji-10	187	10	difference	difference	NOUN
aji-10	187	11	between	between	ADP
aji-10	187	12	asthmatic	asthmatic	ADJ
aji-10	187	13	and	and	CCONJ
aji-10	187	14	control	control	NOUN
aji-10	187	15	groups	group	NOUN
aji-10	187	16	in	in	ADP
aji-10	187	17	terms	term	NOUN
aji-10	187	18	of	of	ADP
aji-10	187	19	bmi	bmi	NOUN
aji-10	187	20	(	(	PUNCT
aji-10	187	21	21.3±5.8	21.3±5.8	NUM
aji-10	187	22	,	,	PUNCT
aji-10	187	23	16.6±2.4	16.6±2.4	NUM
aji-10	187	24	respectively	respectively	ADV
aji-10	187	25	,	,	PUNCT
aji-10	187	26	p	p	X
aji-10	187	27	=	=	NOUN
aji-10	187	28	0.004	0.004	NUM
aji-10	187	29	)	)	PUNCT
aji-10	187	30	.	.	PUNCT
aji-10	188	1	these	these	DET
aji-10	188	2	findings	finding	NOUN
aji-10	188	3	are	be	AUX
aji-10	188	4	similar	similar	ADJ
aji-10	188	5	to	to	ADP
aji-10	188	6	those	those	PRON
aji-10	188	7	reported	report	VERB
aji-10	188	8	by	by	ADP
aji-10	188	9	black	black	PROPN
aji-10	188	10	et	et	PROPN
aji-10	188	11	al	al	PROPN
aji-10	188	12	who	who	PRON
aji-10	188	13	also	also	ADV
aji-10	188	14	found	find	VERB
aji-10	188	15	a	a	DET
aji-10	188	16	significant	significant	ADJ
aji-10	188	17	difference	difference	NOUN
aji-10	188	18	between	between	ADP
aji-10	188	19	asthmatics	asthmatic	NOUN
aji-10	188	20	and	and	CCONJ
aji-10	188	21	control	control	NOUN
aji-10	188	22	groups	group	NOUN
aji-10	188	23	in	in	ADP
aji-10	188	24	terms	term	NOUN
aji-10	188	25	of	of	ADP
aji-10	188	26	bmi	bmi	NOUN
aji-10	188	27	[	[	X
aji-10	188	28	13	13	NUM
aji-10	188	29	]	]	PUNCT
aji-10	188	30	.	.	PUNCT
aji-10	189	1	furthermore	furthermore	ADV
aji-10	189	2	,	,	PUNCT
aji-10	189	3	a	a	DET
aji-10	189	4	recent	recent	ADJ
aji-10	189	5	meta	meta	ADJ
aji-10	189	6	-	-	PUNCT
aji-10	189	7	analytic	analytic	ADJ
aji-10	189	8	study	study	NOUN
aji-10	189	9	of	of	ADP
aji-10	189	10	18	18	NUM
aji-10	189	11	studies	study	NOUN
aji-10	189	12	which	which	PRON
aji-10	189	13	included	include	VERB
aji-10	189	14	73,252	73,252	NUM
aji-10	189	15	children	child	NOUN
aji-10	189	16	reported	report	VERB
aji-10	189	17	that	that	SCONJ
aji-10	189	18	overweight	overweight	NOUN
aji-10	189	19	or	or	CCONJ
aji-10	189	20	obesity	obesity	NOUN
aji-10	189	21	was	be	AUX
aji-10	189	22	a	a	DET
aji-10	189	23	significant	significant	ADJ
aji-10	189	24	risk	risk	NOUN
aji-10	189	25	factor	factor	NOUN
aji-10	189	26	for	for	ADP
aji-10	189	27	asthma	asthma	NOUN
aji-10	189	28	in	in	ADP
aji-10	189	29	obese	obese	ADJ
aji-10	189	30	children	child	NOUN
aji-10	190	1	[	[	X
aji-10	190	2	14	14	NUM
aji-10	190	3	]	]	PUNCT
aji-10	190	4	.	.	PUNCT
aji-10	191	1	however	however	ADV
aji-10	191	2	our	our	PRON
aji-10	191	3	study	study	NOUN
aji-10	191	4	revealed	reveal	VERB
aji-10	191	5	no	no	DET
aji-10	191	6	statistically	statistically	ADV
aji-10	191	7	significant	significant	ADJ
aji-10	191	8	difference	difference	NOUN
aji-10	191	9	in	in	ADP
aji-10	191	10	bmi	bmi	NOUN
aji-10	191	11	between	between	ADP
aji-10	191	12	obese	obese	NOUN
aji-10	191	13	and	and	CCONJ
aji-10	191	14	non	non	ADJ
aji-10	191	15	-	-	ADJ
aji-10	191	16	obese	obese	ADJ
aji-10	191	17	asthmatic	asthmatic	ADJ
aji-10	191	18	children	child	NOUN
aji-10	191	19	.	.	PUNCT
aji-10	192	1	the	the	DET
aji-10	192	2	present	present	ADJ
aji-10	192	3	study	study	NOUN
aji-10	192	4	showed	show	VERB
aji-10	192	5	that	that	SCONJ
aji-10	192	6	serum	serum	NOUN
aji-10	192	7	leptin	leptin	NOUN
aji-10	192	8	levels	level	NOUN
aji-10	192	9	of	of	ADP
aji-10	192	10	asthmatic	asthmatic	ADJ
aji-10	192	11	children	child	NOUN
aji-10	192	12	(	(	PUNCT
aji-10	192	13	89.3±7.6	89.3±7.6	PROPN
aji-10	192	14	ng	ng	PROPN
aji-10	192	15	/	/	SYM
aji-10	192	16	ml	ml	PROPN
aji-10	192	17	)	)	PUNCT
aji-10	192	18	were	be	AUX
aji-10	192	19	significantly	significantly	ADV
aji-10	192	20	higher	high	ADJ
aji-10	192	21	than	than	ADP
aji-10	192	22	those	those	PRON
aji-10	192	23	of	of	ADP
aji-10	192	24	healthy	healthy	ADJ
aji-10	192	25	control	control	NOUN
aji-10	192	26	(	(	PUNCT
aji-10	192	27	71.3±8.2	71.3±8.2	NOUN
aji-10	192	28	)	)	PUNCT
aji-10	192	29	p	p	NOUN
aji-10	192	30	-	-	PUNCT
aji-10	192	31	value	value	NOUN
aji-10	192	32	was	be	AUX
aji-10	192	33	<	<	X
aji-10	192	34	0.001	0.001	NUM
aji-10	192	35	.	.	PUNCT
aji-10	193	1	this	this	PRON
aji-10	193	2	coincides	coincide	VERB
aji-10	193	3	with	with	ADP
aji-10	193	4	the	the	DET
aji-10	193	5	study	study	NOUN
aji-10	193	6	done	do	VERB
aji-10	193	7	by	by	ADP
aji-10	193	8	about	about	ADP
aji-10	193	9	yousif	yousif	PROPN
aji-10	193	10	,	,	PUNCT
aji-10	193	11	et	et	PROPN
aji-10	193	12	al	al	PROPN
aji-10	193	13	.	.	PROPN
aji-10	193	14	who	who	PRON
aji-10	193	15	found	find	VERB
aji-10	193	16	a	a	DET
aji-10	193	17	statistically	statistically	ADV
aji-10	193	18	significant	significant	ADJ
aji-10	193	19	difference	difference	NOUN
aji-10	193	20	in	in	ADP
aji-10	193	21	serum	serum	NOUN
aji-10	193	22	leptin	leptin	NOUN
aji-10	193	23	values	value	NOUN
aji-10	193	24	between	between	ADP
aji-10	193	25	asthmatics	asthmatic	NOUN
aji-10	193	26	and	and	CCONJ
aji-10	193	27	controls	control	NOUN
aji-10	193	28	being	be	AUX
aji-10	193	29	higher	high	ADJ
aji-10	193	30	in	in	ADP
aji-10	193	31	asthmatics	asthmatic	NOUN
aji-10	193	32	regardless	regardless	ADV
aji-10	193	33	to	to	ADP
aji-10	193	34	the	the	DET
aji-10	193	35	body	body	NOUN
aji-10	193	36	weight	weight	NOUN
aji-10	193	37	(	(	PUNCT
aji-10	193	38	p=0.034	p=0.034	NOUN
aji-10	193	39	)	)	PUNCT
aji-10	194	1	[	[	X
aji-10	194	2	15	15	NUM
aji-10	194	3	]	]	PUNCT
aji-10	194	4	and	and	CCONJ
aji-10	194	5	also	also	ADV
aji-10	194	6	coincides	coincide	VERB
aji-10	194	7	with	with	ADP
aji-10	194	8	another	another	DET
aji-10	194	9	two	two	NUM
aji-10	194	10	studies	study	NOUN
aji-10	194	11	stated	state	VERB
aji-10	194	12	that	that	SCONJ
aji-10	194	13	even	even	ADV
aji-10	194	14	after	after	ADP
aji-10	194	15	controlling	control	VERB
aji-10	194	16	of	of	ADP
aji-10	194	17	body	body	NOUN
aji-10	194	18	mass	mass	PROPN
aji-10	194	19	index	index	PROPN
aji-10	194	20	,	,	PUNCT
aji-10	194	21	leptin	leptin	NOUN
aji-10	194	22	levels	level	NOUN
aji-10	194	23	were	be	AUX
aji-10	194	24	increased	increase	VERB
aji-10	194	25	in	in	ADP
aji-10	194	26	asthmatic	asthmatic	ADJ
aji-10	194	27	children	child	NOUN
aji-10	194	28	compared	compare	VERB
aji-10	194	29	to	to	ADP
aji-10	194	30	non	non	ADJ
aji-10	194	31	-	-	ADJ
aji-10	194	32	asthmatic	asthmatic	ADJ
aji-10	194	33	children	child	NOUN
aji-10	194	34	[	[	X
aji-10	194	35	16,17	16,17	NUM
aji-10	194	36	]	]	PUNCT
aji-10	194	37	(	(	PUNCT
aji-10	194	38	table	table	NOUN
aji-10	194	39	5	5	NUM
aji-10	194	40	)	)	PUNCT
aji-10	194	41	.	.	PUNCT
aji-10	195	1	our	our	PRON
aji-10	195	2	study	study	NOUN
aji-10	195	3	showed	show	VERB
aji-10	195	4	that	that	SCONJ
aji-10	195	5	there	there	PRON
aji-10	195	6	was	be	VERB
aji-10	195	7	no	no	DET
aji-10	195	8	significant	significant	ADJ
aji-10	195	9	difference	difference	NOUN
aji-10	195	10	between	between	ADP
aji-10	195	11	serum	serum	NOUN
aji-10	195	12	leptin	leptin	NOUN
aji-10	195	13	in	in	ADP
aji-10	195	14	obese	obese	ADJ
aji-10	195	15	asthmatics	asthmatic	NOUN
aji-10	195	16	and	and	CCONJ
aji-10	195	17	non	non	ADJ
aji-10	195	18	-	-	ADJ
aji-10	195	19	obese	obese	ADJ
aji-10	195	20	asthmatics	asthmatic	NOUN
aji-10	195	21	p=0.175	p=0.175	PUNCT
aji-10	195	22	and	and	CCONJ
aji-10	195	23	this	this	PRON
aji-10	195	24	is	be	AUX
aji-10	195	25	consistent	consistent	ADJ
aji-10	195	26	with	with	ADP
aji-10	195	27	results	result	NOUN
aji-10	195	28	reported	report	VERB
aji-10	195	29	by	by	ADP
aji-10	195	30	shore	shore	PROPN
aji-10	195	31	,	,	PUNCT
aji-10	195	32	et	et	PROPN
aji-10	195	33	al	al	PROPN
aji-10	195	34	.	.	PROPN
aji-10	195	35	who	who	PRON
aji-10	195	36	also	also	ADV
aji-10	195	37	found	find	VERB
aji-10	195	38	no	no	DET
aji-10	195	39	significant	significant	ADJ
aji-10	195	40	difference	difference	NOUN
aji-10	195	41	between	between	ADP
aji-10	195	42	the	the	DET
aji-10	195	43	two	two	NUM
aji-10	195	44	groups	group	NOUN
aji-10	195	45	(	(	PUNCT
aji-10	195	46	p	p	X
aji-10	195	47	>	>	X
aji-10	195	48	0.05	0.05	NUM
aji-10	195	49	)	)	PUNCT
aji-10	196	1	[	[	X
aji-10	196	2	18	18	NUM
aji-10	196	3	]	]	PUNCT
aji-10	196	4	.	.	PUNCT
aji-10	197	1	it	it	PRON
aji-10	197	2	was	be	AUX
aji-10	197	3	also	also	ADV
aji-10	197	4	reported	report	VERB
aji-10	197	5	by	by	ADP
aji-10	197	6	another	another	DET
aji-10	197	7	study	study	NOUN
aji-10	197	8	which	which	PRON
aji-10	197	9	demonstrated	demonstrate	VERB
aji-10	197	10	that	that	SCONJ
aji-10	197	11	no	no	DET
aji-10	197	12	differences	difference	NOUN
aji-10	197	13	in	in	ADP
aji-10	197	14	leptin	leptin	NOUN
aji-10	197	15	or	or	CCONJ
aji-10	197	16	adiponectin	adiponectin	NOUN
aji-10	197	17	levels	level	NOUN
aji-10	197	18	in	in	ADP
aji-10	197	19	obese	obese	ADJ
aji-10	197	20	and	and	CCONJ
aji-10	197	21	non	non	ADJ
aji-10	197	22	-	-	ADJ
aji-10	197	23	obese	obese	ADJ
aji-10	197	24	children	child	NOUN
aji-10	197	25	with	with	ADP
aji-10	197	26	asthma	asthma	NOUN
aji-10	197	27	[	[	X
aji-10	197	28	19	19	NUM
aji-10	197	29	]	]	PUNCT
aji-10	197	30	.	.	PUNCT
aji-10	198	1	as	as	SCONJ
aji-10	198	2	regard	regard	NOUN
aji-10	198	3	to	to	ADP
aji-10	198	4	bmi	bmi	PROPN
aji-10	198	5	,	,	PUNCT
aji-10	198	6	the	the	DET
aji-10	198	7	present	present	ADJ
aji-10	198	8	study	study	NOUN
aji-10	198	9	showed	show	VERB
aji-10	198	10	a	a	DET
aji-10	198	11	significant	significant	ADJ
aji-10	198	12	positive	positive	ADJ
aji-10	198	13	correlation	correlation	NOUN
aji-10	198	14	of	of	ADP
aji-10	198	15	leptin	leptin	NOUN
aji-10	198	16	and	and	CCONJ
aji-10	198	17	bmi	bmi	PROPN
aji-10	198	18	(	(	PUNCT
aji-10	198	19	r=	r=	ADJ
aji-10	198	20	0.434	0.434	NUM
aji-10	198	21	,	,	PUNCT
aji-10	198	22	p=0.001	p=0.001	NUM
aji-10	198	23	)	)	PUNCT
aji-10	198	24	(	(	PUNCT
aji-10	198	25	table	table	NOUN
aji-10	198	26	6	6	NUM
aji-10	198	27	)	)	PUNCT
aji-10	198	28	.	.	PUNCT
aji-10	199	1	this	this	DET
aji-10	199	2	result	result	NOUN
aji-10	199	3	is	be	AUX
aji-10	199	4	similar	similar	ADJ
aji-10	199	5	to	to	ADP
aji-10	199	6	the	the	DET
aji-10	199	7	results	result	NOUN
aji-10	199	8	reported	report	VERB
aji-10	199	9	by	by	ADP
aji-10	199	10	several	several	ADJ
aji-10	199	11	researchers	researcher	NOUN
aji-10	199	12	[	[	X
aji-10	199	13	20,21	20,21	NUM
aji-10	199	14	]	]	PUNCT
aji-10	199	15	.	.	PUNCT
aji-10	200	1	yosif	yosif	PROPN
aji-10	200	2	,	,	PUNCT
aji-10	200	3	et	et	PROPN
aji-10	200	4	al	al	PROPN
aji-10	200	5	.	.	PROPN
aji-10	200	6	suggested	suggest	VERB
aji-10	200	7	that	that	SCONJ
aji-10	200	8	bmi	bmi	PROPN
aji-10	200	9	is	be	AUX
aji-10	200	10	the	the	DET
aji-10	200	11	main	main	ADJ
aji-10	200	12	determinants	determinant	NOUN
aji-10	200	13	for	for	ADP
aji-10	200	14	the	the	DET
aji-10	200	15	variations	variation	NOUN
aji-10	200	16	of	of	ADP
aji-10	200	17	leptin	leptin	NOUN
aji-10	201	1	[	[	X
aji-10	201	2	22	22	NUM
aji-10	201	3	]	]	PUNCT
aji-10	201	4	.	.	PUNCT
aji-10	202	1	as	as	SCONJ
aji-10	202	2	demonstrated	demonstrate	VERB
aji-10	202	3	by	by	ADP
aji-10	202	4	french	french	ADJ
aji-10	202	5	epidemiological	epidemiological	ADJ
aji-10	202	6	study	study	NOUN
aji-10	202	7	on	on	ADP
aji-10	202	8	indirect	indirect	ADJ
aji-10	202	9	effects	effect	NOUN
aji-10	202	10	of	of	ADP
aji-10	202	11	leptin	leptin	NOUN
aji-10	202	12	on	on	ADP
aji-10	202	13	genetics	genetic	NOUN
aji-10	202	14	and	and	CCONJ
aji-10	202	15	environment	environment	NOUN
aji-10	202	16	of	of	ADP
aji-10	202	17	asthma	asthma	PROPN
aji-10	202	18	egea	egea	ADV
aji-10	202	19	revealed	reveal	VERB
aji-10	202	20	that	that	SCONJ
aji-10	202	21	leptin	leptin	NOUN
aji-10	202	22	partially	partially	ADV
aji-10	202	23	mediated	mediate	VERB
aji-10	202	24	the	the	DET
aji-10	202	25	association	association	NOUN
aji-10	202	26	between	between	ADP
aji-10	202	27	obesity	obesity	NOUN
aji-10	202	28	and	and	CCONJ
aji-10	202	29	persistent	persistent	ADJ
aji-10	202	30	asthma	asthma	NOUN
aji-10	202	31	over	over	ADP
aji-10	202	32	time	time	NOUN
aji-10	202	33	[	[	X
aji-10	202	34	23	23	NUM
aji-10	202	35	]	]	PUNCT
aji-10	202	36	.	.	PUNCT
aji-10	203	1	a	a	DET
aji-10	203	2	recent	recent	ADJ
aji-10	203	3	longitudinal	longitudinal	ADJ
aji-10	203	4	study	study	NOUN
aji-10	203	5	used	use	VERB
aji-10	203	6	new	new	ADJ
aji-10	203	7	mediation	mediation	NOUN
aji-10	203	8	analysis	analysis	NOUN
aji-10	203	9	to	to	PART
aji-10	203	10	detect	detect	VERB
aji-10	203	11	the	the	DET
aji-10	203	12	direct	direct	ADJ
aji-10	203	13	and	and	CCONJ
aji-10	203	14	indirect	indirect	ADJ
aji-10	203	15	effects	effect	NOUN
aji-10	203	16	mediated	mediate	VERB
aji-10	203	17	by	by	ADP
aji-10	203	18	leptin	leptin	NOUN
aji-10	203	19	in	in	ADP
aji-10	203	20	asthma	asthma	PROPN
aji-10	203	21	development	development	PROPN
aji-10	203	22	confirmed	confirm	VERB
aji-10	203	23	the	the	DET
aji-10	203	24	odds	odd	NOUN
aji-10	203	25	ratio	ratio	NOUN
aji-10	203	26	of	of	ADP
aji-10	203	27	direct	direct	ADJ
aji-10	203	28	effect	effect	NOUN
aji-10	203	29	were	be	AUX
aji-10	203	30	1.59	1.59	NUM
aji-10	203	31	(	(	PUNCT
aji-10	203	32	95	95	NUM
aji-10	203	33	%	%	NOUN
aji-10	203	34	ci	ci	NOUN
aji-10	203	35	:	:	PUNCT
aji-10	203	36	0.95	0.95	NUM
aji-10	203	37	-	-	SYM
aji-10	203	38	2.97	2.97	NUM
aji-10	203	39	)	)	PUNCT
aji-10	203	40	,	,	PUNCT
aji-10	203	41	2.06	2.06	NUM
aji-10	203	42	(	(	PUNCT
aji-10	203	43	1.06	1.06	NUM
aji-10	203	44	-	-	SYM
aji-10	203	45	4.00	4.00	NUM
aji-10	203	46	)	)	PUNCT
aji-10	203	47	and	and	CCONJ
aji-10	203	48	3.25	3.25	NUM
aji-10	203	49	(	(	PUNCT
aji-10	203	50	1.01	1.01	NUM
aji-10	203	51	-	-	SYM
aji-10	203	52	9.41	9.41	NUM
aji-10	203	53	)	)	PUNCT
aji-10	203	54	,	,	PUNCT
aji-10	203	55	respectively	respectively	ADV
aji-10	203	56	while	while	SCONJ
aji-10	203	57	the	the	DET
aji-10	203	58	indirect	indirect	ADJ
aji-10	203	59	effect	effect	NOUN
aji-10	203	60	mediated	mediate	VERB
aji-10	203	61	by	by	ADP
aji-10	203	62	leptin	leptin	NOUN
aji-10	203	63	odds	odd	NOUN
aji-10	203	64	ratio	ratio	NOUN
aji-10	203	65	were	be	AUX
aji-10	203	66	1.68	1.68	NUM
aji-10	203	67	(	(	PUNCT
aji-10	203	68	1.09	1.09	NUM
aji-10	203	69	-	-	NUM
aji-10	203	70	2.46	2.46	NUM
aji-10	203	71	)	)	PUNCT
aji-10	203	72	,	,	PUNCT
aji-10	203	73	1.55	1.55	NUM
aji-10	203	74	(	(	PUNCT
aji-10	203	75	0.99	0.99	NUM
aji-10	203	76	-	-	SYM
aji-10	203	77	2.57	2.57	NUM
aji-10	203	78	)	)	PUNCT
aji-10	203	79	and	and	CCONJ
aji-10	203	80	1.99	1.99	NUM
aji-10	203	81	(	(	PUNCT
aji-10	203	82	0.94	0.94	NUM
aji-10	203	83	-	-	SYM
aji-10	203	84	4.83	4.83	NUM
aji-10	203	85	)	)	PUNCT
aji-10	203	86	,	,	PUNCT
aji-10	203	87	respectively	respectively	ADV
aji-10	203	88	[	[	X
aji-10	203	89	24	24	NUM
aji-10	203	90	]	]	PUNCT
aji-10	203	91	.	.	PUNCT
aji-10	204	1	leptin	leptin	PROPN
aji-10	204	2	mediated	mediate	VERB
aji-10	204	3	its	its	PRON
aji-10	204	4	effects	effect	NOUN
aji-10	204	5	by	by	ADP
aji-10	204	6	augmenting	augment	VERB
aji-10	204	7	phagocytic	phagocytic	ADJ
aji-10	204	8	function	function	NOUN
aji-10	204	9	.	.	PUNCT
aji-10	205	1	table	table	NOUN
aji-10	205	2	6	6	NUM
aji-10	205	3	.	.	PUNCT
aji-10	205	4	socio	socio	VERB
aji-10	205	5	demographic	demographic	ADJ
aji-10	205	6	data	datum	NOUN
aji-10	205	7	of	of	ADP
aji-10	205	8	asthmatic	asthmatic	ADJ
aji-10	205	9	obese	obese	NOUN
aji-10	205	10	children	child	NOUN
aji-10	205	11	age	age	NOUN
aji-10	205	12	in	in	ADP
aji-10	205	13	year	year	NOUN
aji-10	205	14	weight(kg	weight(kg	NOUN
aji-10	205	15	)	)	PUNCT
aji-10	205	16	height(cm	height(cm	NOUN
aji-10	205	17	)	)	PUNCT
aji-10	205	18	bmi	bmi	VERB
aji-10	205	19	sex	sex	NOUN
aji-10	205	20	asthma	asthma	NOUN
aji-10	205	21	severity	severity	NOUN
aji-10	206	1	10	10	NUM
aji-10	206	2	47	47	NUM
aji-10	206	3	130	130	NUM
aji-10	206	4	27.8	27.8	NUM
aji-10	206	5	female	female	ADJ
aji-10	206	6	mild	mild	ADJ
aji-10	206	7	5	5	NUM
aji-10	206	8	34	34	NUM
aji-10	206	9	14	14	NUM
aji-10	206	10	26.2	26.2	NUM
aji-10	206	11	male	male	ADJ
aji-10	206	12	mild	mild	ADJ
aji-10	206	13	11	11	NUM
aji-10	206	14	36.5	36.5	NUM
aji-10	206	15	120	120	NUM
aji-10	206	16	25.3	25.3	NUM
aji-10	206	17	female	female	NOUN
aji-10	206	18	moderate	moderate	ADJ
aji-10	206	19	5	5	NUM
aji-10	206	20	28	28	NUM
aji-10	206	21	103	103	NUM
aji-10	206	22	26.4	26.4	NUM
aji-10	206	23	female	female	ADJ
aji-10	206	24	moderate	moderate	ADJ
aji-10	206	25	4	4	NUM
aji-10	206	26	31	31	NUM
aji-10	206	27	107	107	NUM
aji-10	206	28	27.1	27.1	NUM
aji-10	206	29	male	male	ADJ
aji-10	206	30	mild	mild	ADJ
aji-10	206	31	13	13	NUM
aji-10	206	32	66	66	NUM
aji-10	206	33	152	152	NUM
aji-10	206	34	28.6	28.6	NUM
aji-10	206	35	female	female	ADJ
aji-10	206	36	moderate	moderate	ADJ
aji-10	206	37	8	8	NUM
aji-10	206	38	45	45	NUM
aji-10	206	39	126	126	NUM
aji-10	206	40	28.3	28.3	NUM
aji-10	206	41	female	female	NOUN
aji-10	206	42	moderate	moderate	ADJ
aji-10	206	43	7	7	NUM
aji-10	206	44	37	37	NUM
aji-10	206	45	117	117	NUM
aji-10	206	46	27	27	NUM
aji-10	206	47	male	male	NOUN
aji-10	206	48	severe	severe	ADJ
aji-10	206	49	6	6	NUM
aji-10	206	50	37	37	NUM
aji-10	206	51	112	112	NUM
aji-10	206	52	29.5	29.5	NUM
aji-10	206	53	female	female	ADJ
aji-10	206	54	moderate	moderate	ADJ
aji-10	206	55	10	10	NUM
aji-10	206	56	47	47	NUM
aji-10	206	57	134	134	NUM
aji-10	206	58	26.2	26.2	NUM
aji-10	206	59	male	male	NOUN
aji-10	206	60	moderate	moderate	ADJ
aji-10	206	61	9	9	NUM
aji-10	206	62	50	50	NUM
aji-10	206	63	133	133	NUM
aji-10	206	64	28.3	28.3	NUM
aji-10	206	65	female	female	NOUN
aji-10	206	66	severe	severe	ADJ
aji-10	206	67	4	4	NUM
aji-10	206	68	25	25	NUM
aji-10	206	69	97	97	NUM
aji-10	206	70	26.6	26.6	NUM
aji-10	206	71	female	female	NOUN
aji-10	206	72	severe	severe	ADJ
aji-10	206	73	9	9	NUM
aji-10	206	74	43	43	NUM
aji-10	206	75	122	122	NUM
aji-10	206	76	28.9	28.9	NUM
aji-10	206	77	female	female	ADJ
aji-10	206	78	mild	mild	ADJ
aji-10	206	79	3.5	3.5	NUM
aji-10	206	80	25	25	NUM
aji-10	206	81	98	98	NUM
aji-10	206	82	26	26	NUM
aji-10	206	83	male	male	NOUN
aji-10	206	84	moderate	moderate	ADJ
aji-10	206	85	10.5	10.5	NUM
aji-10	206	86	58	58	NUM
aji-10	206	87	141	141	NUM
aji-10	206	88	29.2	29.2	NUM
aji-10	206	89	female	female	ADJ
aji-10	206	90	moderate	moderate	ADJ
aji-10	206	91	15	15	NUM
aji-10	206	92	80	80	NUM
aji-10	206	93	162	162	NUM
aji-10	206	94	29.7	29.7	NUM
aji-10	206	95	female	female	ADJ
aji-10	206	96	moderate	moderate	ADJ
aji-10	206	97	elngar	elngar	PROPN
aji-10	206	98	et	et	PROPN
aji-10	206	99	al	al	PROPN
aji-10	206	100	.	.	PROPN
aji-10	206	101	;	;	PUNCT
aji-10	206	102	aji	aji	PROPN
aji-10	206	103	,	,	PUNCT
aji-10	206	104	2(1	2(1	NUM
aji-10	206	105	):	):	PUNCT
aji-10	206	106	26	26	NUM
aji-10	206	107	-	-	SYM
aji-10	206	108	33	33	NUM
aji-10	206	109	,	,	PUNCT
aji-10	206	110	2019	2019	NUM
aji-10	206	111	;	;	PUNCT
aji-10	206	112	article	article	NOUN
aji-10	206	113	no.aji.53002	no.aji.53002	NOUN
aji-10	206	114	31	31	NUM
aji-10	206	115	fig	fig	NOUN
aji-10	206	116	.	.	PUNCT
aji-10	207	1	1	1	X
aji-10	207	2	.	.	X
aji-10	207	3	roc	roc	PROPN
aji-10	207	4	curve	curve	NOUN
aji-10	207	5	of	of	ADP
aji-10	207	6	serum	serum	NOUN
aji-10	207	7	leptin	leptin	NOUN
aji-10	207	8	for	for	ADP
aji-10	207	9	diagnosis	diagnosis	NOUN
aji-10	207	10	of	of	ADP
aji-10	207	11	asthma	asthma	NOUN
aji-10	207	12	severity	severity	NOUN
aji-10	207	13	proliferation	proliferation	NOUN
aji-10	207	14	and	and	CCONJ
aji-10	207	15	alternation	alternation	NOUN
aji-10	207	16	of	of	ADP
aji-10	207	17	macrophages	macrophage	NOUN
aji-10	207	18	and	and	CCONJ
aji-10	207	19	consequently	consequently	ADV
aji-10	207	20	led	lead	VERB
aji-10	207	21	to	to	ADP
aji-10	207	22	increased	increase	VERB
aji-10	207	23	secretion	secretion	NOUN
aji-10	207	24	of	of	ADP
aji-10	207	25	proinflammatory	proinflammatory	ADJ
aji-10	207	26	cytokines	cytokine	NOUN
aji-10	207	27	.	.	PUNCT
aji-10	208	1	the	the	DET
aji-10	208	2	latter	latter	ADJ
aji-10	208	3	include	include	VERB
aji-10	208	4	tumor	tumor	NOUN
aji-10	208	5	necrosis	necrosis	NOUN
aji-10	208	6	factor	factor	NOUN
aji-10	208	7	α	α	NOUN
aji-10	208	8	,	,	PUNCT
aji-10	208	9	reactive	reactive	ADJ
aji-10	208	10	oxygen	oxygen	NOUN
aji-10	208	11	species	specie	NOUN
aji-10	208	12	and	and	CCONJ
aji-10	208	13	interleukin	interleukin	NOUN
aji-10	208	14	6	6	NUM
aji-10	208	15	[	[	X
aji-10	208	16	25	25	NUM
aji-10	208	17	]	]	PUNCT
aji-10	208	18	.	.	PUNCT
aji-10	209	1	our	our	PRON
aji-10	209	2	study	study	NOUN
aji-10	209	3	results	result	NOUN
aji-10	209	4	showed	show	VERB
aji-10	209	5	that	that	SCONJ
aji-10	209	6	there	there	PRON
aji-10	209	7	was	be	VERB
aji-10	209	8	significantly	significantly	ADV
aji-10	209	9	negative	negative	ADJ
aji-10	209	10	correlation	correlation	NOUN
aji-10	209	11	between	between	ADP
aji-10	209	12	leptin	leptin	NOUN
aji-10	209	13	and	and	CCONJ
aji-10	209	14	pefr	pefr	ADJ
aji-10	209	15	results	result	NOUN
aji-10	209	16	in	in	ADP
aji-10	209	17	total	total	ADJ
aji-10	209	18	asthmatic	asthmatic	ADJ
aji-10	209	19	patients	patient	NOUN
aji-10	209	20	(	(	PUNCT
aji-10	209	21	r=0.468	r=0.468	NOUN
aji-10	209	22	and	and	CCONJ
aji-10	209	23	p=0.001	p=0.001	NUM
aji-10	209	24	)	)	PUNCT
aji-10	209	25	.	.	PUNCT
aji-10	210	1	this	this	DET
aji-10	210	2	result	result	NOUN
aji-10	210	3	agreed	agree	VERB
aji-10	210	4	with	with	ADP
aji-10	210	5	the	the	DET
aji-10	210	6	result	result	NOUN
aji-10	210	7	of	of	ADP
aji-10	210	8	sin	sin	NOUN
aji-10	210	9	and	and	CCONJ
aji-10	210	10	man	man	NOUN
aji-10	210	11	work	work	NOUN
aji-10	210	12	who	who	PRON
aji-10	210	13	also	also	ADV
aji-10	210	14	reported	report	VERB
aji-10	210	15	a	a	DET
aji-10	210	16	negative	negative	ADJ
aji-10	210	17	correlation	correlation	NOUN
aji-10	210	18	between	between	ADP
aji-10	210	19	serum	serum	NOUN
aji-10	210	20	leptin	leptin	NOUN
aji-10	210	21	levels	level	NOUN
aji-10	210	22	and	and	CCONJ
aji-10	210	23	pefr	pefr	VERB
aji-10	210	24	in	in	ADP
aji-10	210	25	asthmatic	asthmatic	ADJ
aji-10	210	26	patients	patient	NOUN
aji-10	210	27	(	(	PUNCT
aji-10	210	28	r=-0.521and	r=-0.521and	NOUN
aji-10	210	29	p=0.001	p=0.001	X
aji-10	210	30	)	)	PUNCT
aji-10	211	1	[	[	X
aji-10	211	2	26	26	NUM
aji-10	211	3	]	]	PUNCT
aji-10	211	4	.	.	PUNCT
aji-10	212	1	our	our	PRON
aji-10	212	2	study	study	NOUN
aji-10	212	3	also	also	ADV
aji-10	212	4	showed	show	VERB
aji-10	212	5	significant	significant	ADJ
aji-10	212	6	relation	relation	NOUN
aji-10	212	7	between	between	ADP
aji-10	212	8	serum	serum	NOUN
aji-10	212	9	leptin	leptin	NOUN
aji-10	212	10	levels	level	NOUN
aji-10	212	11	and	and	CCONJ
aji-10	212	12	history	history	NOUN
aji-10	212	13	of	of	ADP
aji-10	212	14	allergy	allergy	NOUN
aji-10	212	15	(	(	PUNCT
aji-10	212	16	p=0.019	p=0.019	X
aji-10	212	17	)	)	PUNCT
aji-10	212	18	as	as	ADV
aji-10	212	19	well	well	ADV
aji-10	212	20	as	as	ADP
aji-10	212	21	family	family	NOUN
aji-10	212	22	history	history	NOUN
aji-10	212	23	of	of	ADP
aji-10	212	24	asthma	asthma	NOUN
aji-10	212	25	(	(	PUNCT
aji-10	212	26	p=	p=	NOUN
aji-10	212	27	<	<	X
aji-10	212	28	0.001	0.001	NUM
aji-10	212	29	)	)	PUNCT
aji-10	212	30	.	.	PUNCT
aji-10	213	1	the	the	DET
aji-10	213	2	positive	positive	ADJ
aji-10	213	3	correlation	correlation	NOUN
aji-10	213	4	between	between	ADP
aji-10	213	5	history	history	NOUN
aji-10	213	6	of	of	ADP
aji-10	213	7	allergy	allergy	NOUN
aji-10	213	8	and	and	CCONJ
aji-10	213	9	serum	serum	NOUN
aji-10	213	10	leptin	leptin	NOUN
aji-10	213	11	level	level	NOUN
aji-10	213	12	is	be	AUX
aji-10	213	13	consistent	consistent	ADJ
aji-10	213	14	with	with	ADP
aji-10	213	15	these	these	DET
aji-10	213	16	results	result	NOUN
aji-10	213	17	reported	report	VERB
aji-10	213	18	by	by	ADP
aji-10	213	19	samra	samra	NOUN
aji-10	213	20	,	,	PUNCT
aji-10	213	21	et	et	PROPN
aji-10	213	22	al	al	PROPN
aji-10	213	23	.	.	PROPN
aji-10	214	1	as	as	SCONJ
aji-10	214	2	there	there	PRON
aji-10	214	3	was	be	VERB
aji-10	214	4	a	a	DET
aji-10	214	5	positive	positive	ADJ
aji-10	214	6	correlation	correlation	NOUN
aji-10	214	7	between	between	ADP
aji-10	214	8	leptin	leptin	NOUN
aji-10	214	9	levels	level	NOUN
aji-10	214	10	and	and	CCONJ
aji-10	214	11	history	history	NOUN
aji-10	214	12	of	of	ADP
aji-10	214	13	allergy	allergy	PROPN
aji-10	214	14	(	(	PUNCT
aji-10	214	15	p=0.0058	p=0.0058	X
aji-10	214	16	)	)	PUNCT
aji-10	215	1	[	[	X
aji-10	215	2	27	27	NUM
aji-10	215	3	]	]	PUNCT
aji-10	215	4	.	.	PUNCT
aji-10	216	1	concerning	concern	VERB
aji-10	216	2	the	the	DET
aji-10	216	3	severity	severity	NOUN
aji-10	216	4	of	of	ADP
aji-10	216	5	asthma	asthma	NOUN
aji-10	216	6	,	,	PUNCT
aji-10	216	7	this	this	DET
aji-10	216	8	study	study	NOUN
aji-10	216	9	showed	show	VERB
aji-10	216	10	that	that	SCONJ
aji-10	216	11	the	the	DET
aji-10	216	12	mean	mean	ADJ
aji-10	216	13	±	±	PROPN
aji-10	216	14	sd	sd	NOUN
aji-10	216	15	of	of	ADP
aji-10	216	16	serum	serum	NOUN
aji-10	216	17	leptin	leptin	NOUN
aji-10	216	18	in	in	ADP
aji-10	216	19	moderate	moderate	ADJ
aji-10	216	20	asthmatics	asthmatic	NOUN
aji-10	216	21	(	(	PUNCT
aji-10	216	22	89.3±4.6	89.3±4.6	PROPN
aji-10	216	23	ng	ng	PROPN
aji-10	216	24	/	/	SYM
aji-10	216	25	ml	ml	PROPN
aji-10	216	26	)	)	PUNCT
aji-10	216	27	was	be	AUX
aji-10	216	28	significantly	significantly	ADV
aji-10	216	29	higher	high	ADJ
aji-10	216	30	than	than	ADP
aji-10	216	31	that	that	PRON
aji-10	216	32	of	of	ADP
aji-10	216	33	mild	mild	ADJ
aji-10	216	34	asthmatics	asthmatic	NOUN
aji-10	216	35	(	(	PUNCT
aji-10	216	36	82.0±3.2	82.0±3.2	NUM
aji-10	216	37	ng	ng	PROPN
aji-10	216	38	/	/	SYM
aji-10	216	39	ml	ml	PROPN
aji-10	216	40	)	)	PUNCT
aji-10	216	41	p	p	X
aji-10	216	42	<	<	X
aji-10	216	43	0.001	0.001	NUM
aji-10	216	44	.	.	PUNCT
aji-10	217	1	these	these	DET
aji-10	217	2	results	result	NOUN
aji-10	217	3	were	be	AUX
aji-10	217	4	in	in	ADP
aji-10	217	5	accordance	accordance	NOUN
aji-10	217	6	with	with	ADP
aji-10	217	7	those	those	PRON
aji-10	217	8	reported	report	VERB
aji-10	217	9	by	by	ADP
aji-10	217	10	the	the	DET
aji-10	217	11	american	american	PROPN
aji-10	217	12	college	college	PROPN
aji-10	217	13	of	of	ADP
aji-10	217	14	allergy	allergy	PROPN
aji-10	217	15	,	,	PUNCT
aji-10	217	16	asthma	asthma	NOUN
aji-10	217	17	and	and	CCONJ
aji-10	217	18	immunology	immunology	NOUN
aji-10	217	19	study	study	NOUN
aji-10	217	20	[	[	X
aji-10	217	21	28	28	NUM
aji-10	217	22	]	]	PUNCT
aji-10	217	23	,	,	PUNCT
aji-10	217	24	that	that	PRON
aji-10	217	25	linked	link	VERB
aji-10	217	26	serum	serum	NOUN
aji-10	217	27	concentration	concentration	NOUN
aji-10	217	28	of	of	ADP
aji-10	217	29	leptin	leptin	NOUN
aji-10	217	30	to	to	ADP
aji-10	217	31	disease	disease	NOUN
aji-10	217	32	activity	activity	NOUN
aji-10	217	33	and	and	CCONJ
aji-10	217	34	severity	severity	NOUN
aji-10	217	35	,	,	PUNCT
aji-10	217	36	patients	patient	NOUN
aji-10	217	37	with	with	ADP
aji-10	217	38	intermittent	intermittent	ADJ
aji-10	217	39	asthma	asthma	NOUN
aji-10	217	40	had	have	VERB
aji-10	217	41	value	value	NOUN
aji-10	217	42	of	of	ADP
aji-10	217	43	8.9	8.9	NUM
aji-10	217	44	ng	ng	PROPN
aji-10	217	45	/	/	SYM
aji-10	217	46	dl	dl	PROPN
aji-10	217	47	,	,	PUNCT
aji-10	217	48	those	those	PRON
aji-10	217	49	with	with	ADP
aji-10	217	50	mild	mild	ADJ
aji-10	217	51	persistent	persistent	ADJ
aji-10	217	52	asthma	asthma	NOUN
aji-10	217	53	had	have	VERB
aji-10	217	54	levels	level	NOUN
aji-10	217	55	of	of	ADP
aji-10	217	56	14.5	14.5	NUM
aji-10	217	57	ng	ng	PROPN
aji-10	217	58	/	/	SYM
aji-10	217	59	dl	dl	PROPN
aji-10	217	60	and	and	CCONJ
aji-10	217	61	moderately	moderately	ADV
aji-10	217	62	persistent	persistent	ADJ
aji-10	217	63	asthma	asthma	NOUN
aji-10	217	64	patients	patient	NOUN
aji-10	217	65	had	have	VERB
aji-10	217	66	18.9	18.9	NUM
aji-10	217	67	ng	ng	PROPN
aji-10	217	68	/	/	SYM
aji-10	217	69	dl	dl	PROPN
aji-10	217	70	with	with	ADP
aji-10	217	71	p	p	NOUN
aji-10	217	72	-	-	PUNCT
aji-10	217	73	value	value	NOUN
aji-10	217	74	less	less	ADJ
aji-10	217	75	than	than	ADP
aji-10	217	76	0.05	0.05	NUM
aji-10	217	77	.	.	PUNCT
aji-10	218	1	shore	shore	PROPN
aji-10	218	2	et	et	PROPN
aji-10	218	3	al	al	PROPN
aji-10	218	4	.	.	PROPN
aji-10	218	5	suggested	suggest	VERB
aji-10	218	6	that	that	PRON
aji-10	218	7	increase	increase	NOUN
aji-10	218	8	serum	serum	NOUN
aji-10	218	9	leptin	leptin	NOUN
aji-10	218	10	can	can	AUX
aji-10	218	11	increase	increase	VERB
aji-10	218	12	airway	airway	NOUN
aji-10	218	13	hyperresponsivness	hyperresponsivness	NOUN
aji-10	218	14	and	and	CCONJ
aji-10	218	15	exacerbate	exacerbate	VERB
aji-10	218	16	asthma	asthma	NOUN
aji-10	219	1	[	[	X
aji-10	219	2	29	29	NUM
aji-10	219	3	]	]	PUNCT
aji-10	219	4	.	.	PUNCT
aji-10	220	1	our	our	PRON
aji-10	220	2	results	result	NOUN
aji-10	220	3	showed	show	VERB
aji-10	220	4	that	that	SCONJ
aji-10	220	5	the	the	DET
aji-10	220	6	sensitivity	sensitivity	NOUN
aji-10	220	7	of	of	ADP
aji-10	220	8	serum	serum	NOUN
aji-10	220	9	leptin	leptin	NOUN
aji-10	220	10	for	for	ADP
aji-10	220	11	diagnosis	diagnosis	NOUN
aji-10	220	12	of	of	ADP
aji-10	220	13	severe	severe	ADJ
aji-10	220	14	asthma	asthma	NOUN
aji-10	220	15	showed	show	VERB
aji-10	220	16	serum	serum	NOUN
aji-10	220	17	leptin	leptin	NOUN
aji-10	220	18	was	be	AUX
aji-10	220	19	91.5	91.5	NUM
aji-10	220	20	%	%	NOUN
aji-10	220	21	accurate	accurate	ADJ
aji-10	220	22	(	(	PUNCT
aji-10	220	23	p	p	X
aji-10	220	24	<	<	X
aji-10	220	25	0.001	0.001	NUM
aji-10	220	26	)	)	PUNCT
aji-10	220	27	.	.	PUNCT
aji-10	221	1	at	at	ADP
aji-10	221	2	cutoff	cutoff	NOUN
aji-10	221	3	value	value	NOUN
aji-10	221	4	of	of	ADP
aji-10	221	5	75.5	75.5	NUM
aji-10	221	6	,	,	PUNCT
aji-10	221	7	serum	serum	NOUN
aji-10	221	8	leptin	leptin	NOUN
aji-10	221	9	was	be	AUX
aji-10	221	10	shown	show	VERB
aji-10	221	11	100	100	NUM
aji-10	221	12	%	%	NOUN
aji-10	221	13	sensitivity	sensitivity	NOUN
aji-10	221	14	and	and	CCONJ
aji-10	221	15	75	75	NUM
aji-10	221	16	%	%	NOUN
aji-10	221	17	specificity	specificity	NOUN
aji-10	221	18	for	for	ADP
aji-10	221	19	diagnosis	diagnosis	NOUN
aji-10	221	20	of	of	ADP
aji-10	221	21	severe	severe	ADJ
aji-10	221	22	asthma	asthma	NOUN
aji-10	221	23	.	.	PUNCT
aji-10	222	1	these	these	DET
aji-10	222	2	findings	finding	NOUN
aji-10	222	3	were	be	AUX
aji-10	222	4	similar	similar	ADJ
aji-10	222	5	to	to	ADP
aji-10	222	6	those	those	PRON
aji-10	222	7	reported	report	VERB
aji-10	222	8	by	by	ADP
aji-10	222	9	tanju	tanju	PROPN
aji-10	222	10	et	et	PROPN
aji-10	222	11	al	al	PROPN
aji-10	222	12	who	who	PRON
aji-10	222	13	reported	report	VERB
aji-10	222	14	89	89	NUM
aji-10	222	15	%	%	NOUN
aji-10	222	16	accuracy	accuracy	NOUN
aji-10	222	17	of	of	ADP
aji-10	222	18	serum	serum	NOUN
aji-10	222	19	leptin	leptin	NOUN
aji-10	222	20	levels	level	NOUN
aji-10	222	21	in	in	ADP
aji-10	222	22	severe	severe	ADJ
aji-10	222	23	asthma	asthma	NOUN
aji-10	222	24	(	(	PUNCT
aji-10	222	25	p	p	X
aji-10	222	26	<	<	X
aji-10	222	27	0.001	0.001	NUM
aji-10	222	28	)	)	PUNCT
aji-10	222	29	.	.	PUNCT
aji-10	223	1	our	our	PRON
aji-10	223	2	results	result	NOUN
aji-10	223	3	suggest	suggest	VERB
aji-10	223	4	that	that	SCONJ
aji-10	223	5	leptin	leptin	NOUN
aji-10	223	6	is	be	AUX
aji-10	223	7	playing	play	VERB
aji-10	223	8	an	an	DET
aji-10	223	9	important	important	ADJ
aji-10	223	10	role	role	NOUN
aji-10	223	11	in	in	ADP
aji-10	223	12	diagnosis	diagnosis	NOUN
aji-10	223	13	and	and	CCONJ
aji-10	223	14	determining	determine	VERB
aji-10	223	15	the	the	DET
aji-10	223	16	severity	severity	NOUN
aji-10	223	17	of	of	ADP
aji-10	223	18	asthma	asthma	NOUN
aji-10	223	19	.	.	PUNCT
aji-10	224	1	the	the	DET
aji-10	224	2	study	study	NOUN
aji-10	224	3	showed	show	VERB
aji-10	224	4	also	also	ADV
aji-10	224	5	that	that	SCONJ
aji-10	224	6	leptin	leptin	NOUN
aji-10	224	7	is	be	AUX
aji-10	224	8	the	the	DET
aji-10	224	9	most	most	ADV
aji-10	224	10	predictive	predictive	ADJ
aji-10	224	11	factor	factor	NOUN
aji-10	224	12	for	for	ADP
aji-10	224	13	severity	severity	NOUN
aji-10	224	14	of	of	ADP
aji-10	224	15	asthma	asthma	NOUN
aji-10	224	16	when	when	SCONJ
aji-10	224	17	compared	compare	VERB
aji-10	224	18	to	to	ADP
aji-10	224	19	body	body	NOUN
aji-10	224	20	mass	mass	PROPN
aji-10	224	21	index	index	NOUN
aji-10	224	22	,	,	PUNCT
aji-10	224	23	family	family	NOUN
aji-10	224	24	history	history	NOUN
aji-10	224	25	of	of	ADP
aji-10	224	26	asthma	asthma	NOUN
aji-10	224	27	and	and	CCONJ
aji-10	224	28	history	history	NOUN
aji-10	224	29	of	of	ADP
aji-10	224	30	allergy	allergy	NOUN
aji-10	224	31	which	which	PRON
aji-10	224	32	has	have	VERB
aji-10	224	33	low	low	ADJ
aji-10	224	34	significant	significant	ADJ
aji-10	224	35	prediction	prediction	NOUN
aji-10	224	36	for	for	ADP
aji-10	224	37	severity	severity	NOUN
aji-10	224	38	of	of	ADP
aji-10	224	39	asthma	asthma	NOUN
aji-10	224	40	.	.	PUNCT
aji-10	225	1	5	5	X
aji-10	225	2	.	.	X
aji-10	225	3	conclusion	conclusion	NOUN
aji-10	225	4	asthma	asthma	NOUN
aji-10	225	5	in	in	ADP
aji-10	225	6	obese	obese	ADJ
aji-10	225	7	children	child	NOUN
aji-10	225	8	is	be	AUX
aji-10	225	9	significantly	significantly	ADV
aji-10	225	10	correlated	correlate	VERB
aji-10	225	11	with	with	ADP
aji-10	225	12	serum	serum	NOUN
aji-10	225	13	leptin	leptin	NOUN
aji-10	225	14	levels	level	NOUN
aji-10	225	15	and	and	CCONJ
aji-10	225	16	bmi	bmi	NOUN
aji-10	225	17	.	.	PUNCT
aji-10	226	1	so	so	ADV
aji-10	226	2	,	,	PUNCT
aji-10	226	3	high	high	ADJ
aji-10	226	4	leptin	leptin	NOUN
aji-10	226	5	levels	level	NOUN
aji-10	226	6	and	and	CCONJ
aji-10	226	7	bmi	bmi	NOUN
aji-10	226	8	may	may	AUX
aji-10	226	9	serve	serve	VERB
aji-10	226	10	as	as	ADP
aji-10	226	11	markers	marker	NOUN
aji-10	226	12	of	of	ADP
aji-10	226	13	asthma	asthma	NOUN
aji-10	226	14	severity	severity	NOUN
aji-10	226	15	in	in	ADP
aji-10	226	16	obese	obese	ADJ
aji-10	226	17	children	child	NOUN
aji-10	226	18	as	as	ADV
aji-10	226	19	well	well	ADV
aji-10	226	20	as	as	ADP
aji-10	226	21	potential	potential	ADJ
aji-10	226	22	future	future	ADJ
aji-10	226	23	therapeutic	therapeutic	ADJ
aji-10	226	24	targets	target	NOUN
aji-10	226	25	in	in	ADP
aji-10	226	26	the	the	DET
aji-10	226	27	era	era	NOUN
aji-10	226	28	of	of	ADP
aji-10	226	29	advanced	advanced	ADJ
aji-10	226	30	bionanotechnology.this	bionanotechnology.this	DET
aji-10	226	31	approach	approach	NOUN
aji-10	226	32	can	can	AUX
aji-10	226	33	be	be	AUX
aji-10	226	34	possible	possible	ADJ
aji-10	226	35	via	via	ADP
aji-10	226	36	targeting	target	VERB
aji-10	226	37	vital	vital	ADJ
aji-10	226	38	cell	cell	NOUN
aji-10	226	39	signaling	signal	VERB
aji-10	226	40	pathways	pathway	NOUN
aji-10	226	41	by	by	ADP
aji-10	226	42	novel	novel	ADJ
aji-10	226	43	ligands	ligand	NOUN
aji-10	226	44	that	that	PRON
aji-10	226	45	act	act	VERB
aji-10	226	46	as	as	ADP
aji-10	226	47	agonists	agonist	NOUN
aji-10	226	48	or	or	CCONJ
aji-10	226	49	antagonists	antagonist	NOUN
aji-10	226	50	for	for	ADP
aji-10	226	51	crucial	crucial	ADJ
aji-10	226	52	adaptor	adaptor	NOUN
aji-10	226	53	molecules	molecule	NOUN
aji-10	226	54	in	in	ADP
aji-10	226	55	asthma	asthma	NOUN
aji-10	226	56	pathogenesis	pathogenesi	NOUN
aji-10	226	57	mediated	mediate	VERB
aji-10	226	58	by	by	ADP
aji-10	226	59	leptin	leptin	NOUN
aji-10	226	60	such	such	ADJ
aji-10	226	61	as	as	ADP
aji-10	226	62	elngar	elngar	PROPN
aji-10	226	63	et	et	PROPN
aji-10	226	64	al	al	PROPN
aji-10	226	65	.	.	PROPN
aji-10	226	66	;	;	PUNCT
aji-10	226	67	aji	aji	PROPN
aji-10	226	68	,	,	PUNCT
aji-10	226	69	2(1	2(1	NUM
aji-10	226	70	):	):	PUNCT
aji-10	226	71	26	26	NUM
aji-10	226	72	-	-	SYM
aji-10	226	73	33	33	NUM
aji-10	226	74	,	,	PUNCT
aji-10	226	75	2019	2019	NUM
aji-10	226	76	;	;	PUNCT
aji-10	226	77	article	article	NOUN
aji-10	226	78	no.aji.53002	no.aji.53002	NOUN
aji-10	226	79	32	32	NUM
aji-10	226	80	parathyroid	parathyroid	ADJ
aji-10	226	81	-	-	PUNCT
aji-10	226	82	hormone	hormone	NOUN
aji-10	226	83	-	-	PUNCT
aji-10	226	84	related	relate	VERB
aji-10	226	85	protein	protein	NOUN
aji-10	226	86	(	(	PUNCT
aji-10	226	87	pthrp	pthrp	NOUN
aji-10	226	88	)	)	PUNCT
aji-10	226	89	and	and	CCONJ
aji-10	226	90	prostaglandin	prostaglandin	NOUN
aji-10	226	91	e2	e2	NOUN
aji-10	226	92	(	(	PUNCT
aji-10	226	93	pthrp	pthrp	NOUN
aji-10	226	94	/	/	SYM
aji-10	226	95	pparγ	pparγ	NOUN
aji-10	226	96	)	)	PUNCT
aji-10	226	97	signaling	signal	VERB
aji-10	226	98	pathway	pathway	NOUN
aji-10	226	99	inhibitors	inhibitor	NOUN
aji-10	226	100	.	.	PUNCT
aji-10	227	1	6	6	X
aji-10	227	2	.	.	X
aji-10	227	3	future	future	ADJ
aji-10	227	4	research	research	NOUN
aji-10	227	5	directions	direction	NOUN
aji-10	227	6	due	due	ADP
aji-10	227	7	to	to	ADP
aji-10	227	8	heterogeneity	heterogeneity	NOUN
aji-10	227	9	of	of	ADP
aji-10	227	10	obesity	obesity	NOUN
aji-10	227	11	related	relate	VERB
aji-10	227	12	asthma	asthma	NOUN
aji-10	227	13	in	in	ADP
aji-10	227	14	children	child	NOUN
aji-10	227	15	and	and	CCONJ
aji-10	227	16	its	its	PRON
aji-10	227	17	multifactorial	multifactorial	ADJ
aji-10	227	18	nature	nature	NOUN
aji-10	227	19	of	of	ADP
aji-10	227	20	the	the	DET
aji-10	227	21	disease	disease	NOUN
aji-10	227	22	with	with	ADP
aji-10	227	23	genetic	genetic	ADJ
aji-10	227	24	-	-	PUNCT
aji-10	227	25	environmental	environmental	ADJ
aji-10	227	26	interactions	interaction	NOUN
aji-10	227	27	,	,	PUNCT
aji-10	227	28	it	it	PRON
aji-10	227	29	is	be	AUX
aji-10	227	30	difficult	difficult	ADJ
aji-10	227	31	to	to	PART
aji-10	227	32	find	find	VERB
aji-10	227	33	out	out	ADP
aji-10	227	34	precise	precise	ADJ
aji-10	227	35	markers	marker	NOUN
aji-10	227	36	.	.	PUNCT
aji-10	228	1	however	however	ADV
aji-10	228	2	,	,	PUNCT
aji-10	228	3	emerging	emerge	VERB
aji-10	228	4	novel	novel	ADJ
aji-10	228	5	biomarkers	biomarker	NOUN
aji-10	228	6	for	for	ADP
aji-10	228	7	severe	severe	ADJ
aji-10	228	8	asthma	asthma	NOUN
aji-10	228	9	using	use	VERB
aji-10	228	10	multi	multi	ADJ
aji-10	228	11	-	-	ADJ
aji-10	228	12	omics	omics	ADJ
aji-10	228	13	technologies	technology	NOUN
aji-10	228	14	such	such	ADJ
aji-10	228	15	as	as	ADP
aji-10	228	16	proteomics	proteomic	NOUN
aji-10	228	17	,	,	PUNCT
aji-10	228	18	epigenetics	epigenetic	NOUN
aji-10	228	19	,	,	PUNCT
aji-10	228	20	transcriptomics	transcriptomic	NOUN
aji-10	228	21	,	,	PUNCT
aji-10	228	22	metagenomics	metagenomic	NOUN
aji-10	228	23	,	,	PUNCT
aji-10	228	24	gut	gut	NOUN
aji-10	228	25	microbiome	microbiome	NOUN
aji-10	228	26	and	and	CCONJ
aji-10	228	27	untargeted	untargeted	ADJ
aji-10	228	28	metabolomics	metabolomic	NOUN
aji-10	228	29	is	be	AUX
aji-10	228	30	a	a	DET
aji-10	228	31	promising	promising	ADJ
aji-10	228	32	approach	approach	NOUN
aji-10	228	33	.	.	PUNCT
aji-10	229	1	novel	novel	ADJ
aji-10	229	2	innovative	innovative	ADJ
aji-10	229	3	advances	advance	NOUN
aji-10	229	4	in	in	ADP
aji-10	229	5	quantum	quantum	ADJ
aji-10	229	6	computational	computational	ADJ
aji-10	229	7	sciences	science	NOUN
aji-10	229	8	,	,	PUNCT
aji-10	229	9	biostatistics	biostatistic	NOUN
aji-10	229	10	and	and	CCONJ
aji-10	229	11	molecular	molecular	ADJ
aji-10	229	12	bioinformatics	bioinformatic	NOUN
aji-10	229	13	of	of	ADP
aji-10	229	14	asthma	asthma	NOUN
aji-10	229	15	are	be	AUX
aji-10	229	16	needed	need	VERB
aji-10	229	17	for	for	ADP
aji-10	229	18	appropriate	appropriate	ADJ
aji-10	229	19	phenotypic	phenotypic	ADJ
aji-10	229	20	subclassification	subclassification	NOUN
aji-10	229	21	and	and	CCONJ
aji-10	229	22	searching	search	VERB
aji-10	229	23	for	for	ADP
aji-10	229	24	more	more	ADV
aji-10	229	25	precise	precise	ADJ
aji-10	229	26	future	future	ADJ
aji-10	229	27	digital	digital	ADJ
aji-10	229	28	biomarkers	biomarker	NOUN
aji-10	229	29	and	and	CCONJ
aji-10	229	30	enabling	enable	VERB
aji-10	229	31	progress	progress	NOUN
aji-10	229	32	of	of	ADP
aji-10	229	33	precision	precision	NOUN
aji-10	229	34	medicine	medicine	NOUN
aji-10	229	35	for	for	ADP
aji-10	229	36	asthma	asthma	NOUN
aji-10	229	37	.	.	PUNCT
aji-10	230	1	consent	consent	VERB
aji-10	230	2	informed	informed	ADJ
aji-10	230	3	consent	consent	NOUN
aji-10	230	4	was	be	AUX
aji-10	230	5	obtained	obtain	VERB
aji-10	230	6	from	from	ADP
aji-10	230	7	all	all	DET
aji-10	230	8	individual	individual	ADJ
aji-10	230	9	participants	participant	NOUN
aji-10	230	10	included	include	VERB
aji-10	230	11	in	in	ADP
aji-10	230	12	the	the	DET
aji-10	230	13	study	study	NOUN
aji-10	230	14	.	.	PUNCT
aji-10	231	1	ethical	ethical	ADJ
aji-10	231	2	approval	approval	NOUN
aji-10	231	3	all	all	DET
aji-10	231	4	procedures	procedure	NOUN
aji-10	231	5	performed	perform	VERB
aji-10	231	6	in	in	ADP
aji-10	231	7	this	this	DET
aji-10	231	8	study	study	NOUN
aji-10	231	9	were	be	AUX
aji-10	231	10	in	in	ADP
aji-10	231	11	accordance	accordance	NOUN
aji-10	231	12	with	with	ADP
aji-10	231	13	the	the	DET
aji-10	231	14	ethical	ethical	ADJ
aji-10	231	15	standards	standard	NOUN
aji-10	231	16	of	of	ADP
aji-10	231	17	the	the	DET
aji-10	231	18	institutional	institutional	ADJ
aji-10	231	19	and	and	CCONJ
aji-10	231	20	national	national	ADJ
aji-10	231	21	research	research	NOUN
aji-10	231	22	committee	committee	NOUN
aji-10	231	23	and	and	CCONJ
aji-10	231	24	with	with	ADP
aji-10	231	25	the	the	DET
aji-10	231	26	1964	1964	NUM
aji-10	231	27	helsinki	helsinki	PROPN
aji-10	231	28	declaration	declaration	PROPN
aji-10	231	29	and	and	CCONJ
aji-10	231	30	its	its	PRON
aji-10	231	31	later	later	ADJ
aji-10	231	32	amendments	amendment	NOUN
aji-10	231	33	.	.	PUNCT
aji-10	232	1	competing	compete	VERB
aji-10	232	2	interests	interest	NOUN
aji-10	232	3	authors	author	NOUN
aji-10	232	4	have	have	AUX
aji-10	232	5	declared	declare	VERB
aji-10	232	6	that	that	SCONJ
aji-10	232	7	no	no	DET
aji-10	232	8	competing	compete	VERB
aji-10	232	9	interests	interest	NOUN
aji-10	232	10	exist	exist	VERB
aji-10	232	11	.	.	PUNCT
aji-10	233	1	references	reference	NOUN
aji-10	233	2	1	1	NUM
aji-10	233	3	.	.	PUNCT
aji-10	233	4	centers	center	NOUN
aji-10	233	5	for	for	ADP
aji-10	233	6	disease	disease	NOUN
aji-10	233	7	control	control	NOUN
aji-10	233	8	and	and	CCONJ
aji-10	233	9	prevention	prevention	NOUN
aji-10	233	10	.	.	PUNCT
aji-10	234	1	vital	vital	ADJ
aji-10	234	2	signs	sign	NOUN
aji-10	234	3	:	:	PUNCT
aji-10	234	4	asthma	asthma	NOUN
aji-10	234	5	prevalence	prevalence	NOUN
aji-10	234	6	,	,	PUNCT
aji-10	234	7	disease	disease	NOUN
aji-10	234	8	characteristics	characteristic	NOUN
aji-10	234	9	,	,	PUNCT
aji-10	234	10	and	and	CCONJ
aji-10	234	11	self	self	NOUN
aji-10	234	12	-	-	PUNCT
aji-10	234	13	management	management	NOUN
aji-10	234	14	education	education	NOUN
aji-10	234	15	:	:	PUNCT
aji-10	234	16	united	united	PROPN
aji-10	234	17	states	states	PROPN
aji-10	234	18	.	.	PUNCT
aji-10	235	1	2001	2001	NUM
aji-10	235	2	-	-	SYM
aji-10	235	3	2009	2009	NUM
aji-10	235	4	.	.	PUNCT
aji-10	236	1	mmwr	mmwr	ADJ
aji-10	236	2	morb	morb	NOUN
aji-10	236	3	mortal	mortal	ADJ
aji-10	236	4	wkly	wkly	PROPN
aji-10	236	5	rep	rep	PROPN
aji-10	236	6	.	.	PROPN
aji-10	236	7	2011;60:547–52	2011;60:547–52	NUM
aji-10	236	8	.	.	PUNCT
aji-10	237	1	available	available	ADJ
aji-10	237	2	:	:	PUNCT
aji-10	237	3	https://www.cdc.gov	https://www.cdc.gov	NOUN
aji-10	237	4	/	/	SYM
aji-10	237	5	mmwr	mmwr	NOUN
aji-10	237	6	/	/	SYM
aji-10	237	7	previ	previ	ADJ
aji-10	237	8	ew	ew	NOUN
aji-10	237	9	/	/	SYM
aji-10	237	10	mmwrhtml	mmwrhtml	NOUN
aji-10	237	11	/	/	SYM
aji-10	237	12	mm6017a4.htm	mm6017a4.htm	NOUN
aji-10	237	13	2	2	NUM
aji-10	237	14	.	.	NOUN
aji-10	237	15	akinbami	akinbami	PROPN
aji-10	237	16	lj	lj	PROPN
aji-10	237	17	,	,	PUNCT
aji-10	237	18	moorman	moorman	PROPN
aji-10	237	19	je	je	PROPN
aji-10	237	20	,	,	PUNCT
aji-10	237	21	garbe	garbe	PROPN
aji-10	237	22	pl	pl	PROPN
aji-10	237	23	,	,	PUNCT
aji-10	237	24	sondik	sondik	PROPN
aji-10	237	25	ej	ej	PROPN
aji-10	237	26	.	.	PROPN
aji-10	237	27	status	status	NOUN
aji-10	237	28	of	of	ADP
aji-10	237	29	childhood	childhood	NOUN
aji-10	237	30	asthma	asthma	NOUN
aji-10	237	31	in	in	ADP
aji-10	237	32	the	the	DET
aji-10	237	33	united	united	PROPN
aji-10	237	34	states	states	PROPN
aji-10	237	35	,	,	PUNCT
aji-10	237	36	1980–2007	1980–2007	NUM
aji-10	237	37	.	.	PUNCT
aji-10	238	1	pediatrics	pediatric	NOUN
aji-10	238	2	.	.	PUNCT
aji-10	239	1	2009;123(suppl3):s131–45	2009;123(suppl3):s131–45	X
aji-10	239	2	.	.	PUNCT
aji-10	240	1	doi	doi	NOUN
aji-10	240	2	:	:	PUNCT
aji-10	240	3	10.1542	10.1542	NUM
aji-10	240	4	/	/	SYM
aji-10	240	5	peds.2008	peds.2008	NOUN
aji-10	240	6	-	-	PUNCT
aji-10	240	7	2233c	2233c	NUM
aji-10	240	8	3	3	NUM
aji-10	240	9	.	.	NOUN
aji-10	240	10	akinbami	akinbami	PROPN
aji-10	240	11	lj	lj	PROPN
aji-10	240	12	,	,	PUNCT
aji-10	240	13	simon	simon	PROPN
aji-10	240	14	ae	ae	PROPN
aji-10	240	15	,	,	PUNCT
aji-10	240	16	rossen	rossen	PROPN
aji-10	240	17	lm	lm	PROPN
aji-10	240	18	.	.	PUNCT
aji-10	241	1	changing	change	VERB
aji-10	241	2	trends	trend	NOUN
aji-10	241	3	in	in	ADP
aji-10	241	4	asthma	asthma	NOUN
aji-10	241	5	prevalence	prevalence	NOUN
aji-10	241	6	among	among	ADP
aji-10	241	7	children	child	NOUN
aji-10	241	8	.	.	PUNCT
aji-10	241	9	pediatrics	pediatric	NOUN
aji-10	241	10	.	.	PUNCT
aji-10	242	1	2016	2016	NUM
aji-10	242	2	;	;	PUNCT
aji-10	242	3	137	137	NUM
aji-10	242	4	:	:	PUNCT
aji-10	242	5	e20152354	e20152354	PROPN
aji-10	242	6	.	.	PROPN
aji-10	242	7	doi	doi	PROPN
aji-10	242	8	:	:	PUNCT
aji-10	242	9	10.1542	10.1542	NUM
aji-10	242	10	/	/	SYM
aji-10	242	11	peds.2015	peds.2015	VERB
aji-10	242	12	-	-	NOUN
aji-10	242	13	2354	2354	NUM
aji-10	242	14	4	4	NUM
aji-10	242	15	.	.	PUNCT
aji-10	243	1	global	global	ADJ
aji-10	243	2	initiative	initiative	NOUN
aji-10	243	3	for	for	ADP
aji-10	243	4	asthma	asthma	NOUN
aji-10	243	5	.	.	PUNCT
aji-10	244	1	global	global	ADJ
aji-10	244	2	strategy	strategy	NOUN
aji-10	244	3	for	for	ADP
aji-10	244	4	asthma	asthma	NOUN
aji-10	244	5	management	management	NOUN
aji-10	244	6	and	and	CCONJ
aji-10	244	7	prevention	prevention	NOUN
aji-10	244	8	;	;	PUNCT
aji-10	244	9	2016	2016	NUM
aji-10	244	10	.	.	PUNCT
aji-10	245	1	5	5	NUM
aji-10	245	2	.	.	X
aji-10	245	3	subbarao	subbarao	NOUN
aji-10	245	4	p	p	NOUN
aji-10	245	5	,	,	PUNCT
aji-10	245	6	mandhane	mandhane	PROPN
aji-10	245	7	pj	pj	PROPN
aji-10	245	8	,	,	PUNCT
aji-10	245	9	sears	sears	PROPN
aji-10	245	10	mr	mr	PROPN
aji-10	245	11	.	.	PROPN
aji-10	245	12	asthma	asthma	PROPN
aji-10	245	13	:	:	PUNCT
aji-10	246	1	epidemiology	epidemiology	NOUN
aji-10	246	2	,	,	PUNCT
aji-10	246	3	etiology	etiology	NOUN
aji-10	246	4	and	and	CCONJ
aji-10	246	5	risk	risk	NOUN
aji-10	246	6	factors	factor	NOUN
aji-10	246	7	.	.	PUNCT
aji-10	247	1	can	can	AUX
aji-10	247	2	med	med	VERB
aji-10	247	3	assoc	assoc	PROPN
aji-10	247	4	j	j	PROPN
aji-10	247	5	;	;	PUNCT
aji-10	247	6	2009;181(9):e181–90	2009;181(9):e181–90	NUM
aji-10	247	7	.	.	PUNCT
aji-10	248	1	6	6	NUM
aji-10	248	2	.	.	X
aji-10	249	1	desai	desai	PROPN
aji-10	249	2	d	d	X
aji-10	249	3	,	,	PUNCT
aji-10	249	4	newby	newby	ADV
aji-10	249	5	c	c	NOUN
aji-10	249	6	,	,	PUNCT
aji-10	249	7	symon	symon	PROPN
aji-10	249	8	fa	fa	PROPN
aji-10	249	9	,	,	PUNCT
aji-10	249	10	haldar	haldar	NOUN
aji-10	249	11	p	p	NOUN
aji-10	249	12	,	,	PUNCT
aji-10	249	13	shah	shah	PROPN
aji-10	249	14	s	s	PROPN
aji-10	249	15	,	,	PUNCT
aji-10	249	16	gupta	gupta	PROPN
aji-10	249	17	s	s	PART
aji-10	249	18	,	,	PUNCT
aji-10	249	19	et	et	PROPN
aji-10	249	20	al	al	PROPN
aji-10	249	21	.	.	PROPN
aji-10	249	22	elevated	elevate	VERB
aji-10	249	23	sputum	sputum	NOUN
aji-10	249	24	interleukin-5	interleukin-5	PROPN
aji-10	249	25	and	and	CCONJ
aji-10	249	26	submucosal	submucosal	PROPN
aji-10	249	27	eosinophilia	eosinophilia	PROPN
aji-10	249	28	in	in	ADP
aji-10	249	29	obese	obese	ADJ
aji-10	249	30	individuals	individual	NOUN
aji-10	249	31	with	with	ADP
aji-10	249	32	severe	severe	ADJ
aji-10	249	33	asthma	asthma	NOUN
aji-10	249	34	.	.	PUNCT
aji-10	250	1	am	be	AUX
aji-10	250	2	j	j	PROPN
aji-10	250	3	respir	respir	NOUN
aji-10	250	4	crit	crit	PROPN
aji-10	250	5	care	care	NOUN
aji-10	250	6	med	med	PROPN
aji-10	250	7	.	.	PUNCT
aji-10	251	1	united	united	PROPN
aji-10	251	2	states	states	PROPN
aji-10	251	3	.	.	PUNCT
aji-10	252	1	2013;188(6):657–63	2013;188(6):657–63	NUM
aji-10	252	2	.	.	NOUN
aji-10	252	3	7	7	NUM
aji-10	252	4	.	.	X
aji-10	252	5	black	black	PROPN
aji-10	252	6	mh	mh	PROPN
aji-10	252	7	,	,	PUNCT
aji-10	252	8	smith	smith	PROPN
aji-10	252	9	n	n	CCONJ
aji-10	252	10	,	,	PUNCT
aji-10	252	11	porter	porter	NOUN
aji-10	252	12	ah	ah	INTJ
aji-10	252	13	,	,	PUNCT
aji-10	252	14	jacobsen	jacobsen	PROPN
aji-10	252	15	sj	sj	PROPN
aji-10	252	16	,	,	PUNCT
aji-10	252	17	koebnick	koebnick	PROPN
aji-10	252	18	c.	c.	PROPN
aji-10	252	19	higher	high	ADJ
aji-10	252	20	prevalence	prevalence	NOUN
aji-10	252	21	of	of	ADP
aji-10	252	22	obesity	obesity	NOUN
aji-10	252	23	among	among	ADP
aji-10	252	24	children	child	NOUN
aji-10	252	25	with	with	ADP
aji-10	252	26	asthma	asthma	NOUN
aji-10	252	27	.	.	PUNCT
aji-10	253	1	obesity	obesity	NOUN
aji-10	253	2	;	;	PUNCT
aji-10	253	3	2012;20(5):1041–7	2012;20(5):1041–7	NUM
aji-10	253	4	.	.	NOUN
aji-10	253	5	8	8	NUM
aji-10	253	6	.	.	X
aji-10	253	7	tanju	tanju	PROPN
aji-10	253	8	a	a	PRON
aji-10	253	9	,	,	PUNCT
aji-10	253	10	cekmez	cekmez	NOUN
aji-10	253	11	f	f	PROPN
aji-10	253	12	,	,	PUNCT
aji-10	253	13	aydinoz	aydinoz	PROPN
aji-10	253	14	s	s	PROPN
aji-10	253	15	,	,	PUNCT
aji-10	253	16	karademir	karademir	PROPN
aji-10	253	17	f	f	PROPN
aji-10	253	18	,	,	PUNCT
aji-10	253	19	suleymanoglu	suleymanoglu	PROPN
aji-10	253	20	s	s	PROPN
aji-10	253	21	,	,	PUNCT
aji-10	253	22	gocmen	gocmen	PROPN
aji-10	253	23	i.	i.	PROPN
aji-10	253	24	association	association	PROPN
aji-10	253	25	between	between	ADP
aji-10	253	26	clinical	clinical	ADJ
aji-10	253	27	severity	severity	NOUN
aji-10	253	28	of	of	ADP
aji-10	253	29	childhood	childhood	NOUN
aji-10	253	30	asthma	asthma	NOUN
aji-10	253	31	and	and	CCONJ
aji-10	253	32	serum	serum	NOUN
aji-10	253	33	leptin	leptin	NOUN
aji-10	253	34	levels	level	NOUN
aji-10	253	35	.	.	PUNCT
aji-10	254	1	indian	indian	PROPN
aji-10	254	2	j	j	PROPN
aji-10	254	3	pediatr	pediatr	PROPN
aji-10	254	4	.	.	PUNCT
aji-10	255	1	2011;78(3):291–5	2011;78(3):291–5	NUM
aji-10	255	2	.	.	NOUN
aji-10	255	3	9	9	NUM
aji-10	255	4	.	.	X
aji-10	255	5	assad	assad	PROPN
aji-10	255	6	na	na	PROPN
aji-10	255	7	,	,	PUNCT
aji-10	255	8	sood	sood	PROPN
aji-10	255	9	a.	a.	NOUN
aji-10	255	10	leptin	leptin	PROPN
aji-10	255	11	,	,	PUNCT
aji-10	255	12	adiponectin	adiponectin	NOUN
aji-10	255	13	and	and	CCONJ
aji-10	255	14	pulmonary	pulmonary	ADJ
aji-10	255	15	diseases	disease	NOUN
aji-10	255	16	.	.	PUNCT
aji-10	256	1	biochimie	biochimie	PROPN
aji-10	256	2	.	.	PUNCT
aji-10	257	1	2012;94(10):2180–9	2012;94(10):2180–9	X
aji-10	257	2	.	.	NOUN
aji-10	257	3	10	10	NUM
aji-10	257	4	.	.	PUNCT
aji-10	258	1	baek	baek	PROPN
aji-10	258	2	hs	hs	PROPN
aji-10	258	3	,	,	PUNCT
aji-10	258	4	kim	kim	PROPN
aji-10	258	5	yd	yd	PROPN
aji-10	258	6	,	,	PUNCT
aji-10	258	7	shin	shin	PROPN
aji-10	258	8	jh	jh	PROPN
aji-10	258	9	,	,	PUNCT
aji-10	258	10	kim	kim	PROPN
aji-10	258	11	jh	jh	PROPN
aji-10	258	12	,	,	PUNCT
aji-10	258	13	oh	oh	INTJ
aji-10	258	14	jw	jw	PROPN
aji-10	258	15	,	,	PUNCT
aji-10	258	16	lee	lee	PROPN
aji-10	258	17	hb	hb	PROPN
aji-10	258	18	.	.	PROPN
aji-10	258	19	serum	serum	PROPN
aji-10	258	20	leptin	leptin	NOUN
aji-10	258	21	and	and	CCONJ
aji-10	258	22	adiponectin	adiponectin	NOUN
aji-10	258	23	levels	level	NOUN
aji-10	258	24	correlate	correlate	VERB
aji-10	258	25	with	with	ADP
aji-10	258	26	exercise	exercise	NOUN
aji-10	258	27	-	-	PUNCT
aji-10	258	28	induced	induce	VERB
aji-10	258	29	bronchoconstriction	bronchoconstriction	NOUN
aji-10	258	30	in	in	ADP
aji-10	258	31	children	child	NOUN
aji-10	258	32	with	with	ADP
aji-10	258	33	asthma	asthma	NOUN
aji-10	258	34	.	.	PUNCT
aji-10	259	1	ann	ann	PROPN
aji-10	259	2	allergy	allergy	PROPN
aji-10	259	3	asthma	asthma	PROPN
aji-10	259	4	immunol	immunol	PROPN
aji-10	259	5	.	.	PUNCT
aji-10	260	1	united	united	PROPN
aji-10	260	2	states	states	PROPN
aji-10	260	3	.	.	PUNCT
aji-10	261	1	2011;107(1):14–21	2011;107(1):14–21	X
aji-10	261	2	.	.	NOUN
aji-10	262	1	11	11	NUM
aji-10	262	2	.	.	PUNCT
aji-10	263	1	ziora	ziora	PROPN
aji-10	263	2	d	d	PROPN
aji-10	263	3	,	,	PUNCT
aji-10	263	4	sitek	sitek	PROPN
aji-10	263	5	p	p	X
aji-10	263	6	,	,	PUNCT
aji-10	263	7	machura	machura	NOUN
aji-10	263	8	e	e	NOUN
aji-10	263	9	,	,	PUNCT
aji-10	263	10	ziora	ziora	PROPN
aji-10	263	11	k.	k.	PROPN
aji-10	263	12	bronchial	bronchial	PROPN
aji-10	263	13	asthma	asthma	NOUN
aji-10	263	14	in	in	ADP
aji-10	263	15	obesity	obesity	NOUN
aji-10	263	16	—	—	PUNCT
aji-10	263	17	a	a	DET
aji-10	263	18	distinct	distinct	ADJ
aji-10	263	19	phenotype	phenotype	NOUN
aji-10	263	20	of	of	ADP
aji-10	263	21	asthma	asthma	NOUN
aji-10	263	22	?	?	PUNCT
aji-10	264	1	adv	adv	PROPN
aji-10	264	2	respir	respir	VERB
aji-10	264	3	med	me	VERB
aji-10	264	4	.	.	PUNCT
aji-10	265	1	2012;80(5):454–62	2012;80(5):454–62	NUM
aji-10	265	2	.	.	NOUN
aji-10	266	1	12	12	NUM
aji-10	266	2	.	.	PUNCT
aji-10	267	1	malli	malli	PROPN
aji-10	267	2	f	f	PROPN
aji-10	267	3	,	,	PUNCT
aji-10	267	4	papaioannou	papaioannou	PROPN
aji-10	267	5	ai	ai	VERB
aji-10	267	6	,	,	PUNCT
aji-10	267	7	gourgoulianis	gourgoulianis	PROPN
aji-10	267	8	ki	ki	PROPN
aji-10	267	9	,	,	PUNCT
aji-10	267	10	daniil	daniil	VERB
aji-10	267	11	z.	z.	PROPN
aji-10	268	1	the	the	DET
aji-10	268	2	role	role	NOUN
aji-10	268	3	of	of	ADP
aji-10	268	4	leptin	leptin	NOUN
aji-10	268	5	in	in	ADP
aji-10	268	6	the	the	DET
aji-10	268	7	respiratory	respiratory	ADJ
aji-10	268	8	system	system	NOUN
aji-10	268	9	.	.	PUNCT
aji-10	269	1	respir	respir	VERB
aji-10	269	2	res	re	NOUN
aji-10	269	3	.	.	PUNCT
aji-10	270	1	2010;11(1):152	2010;11(1):152	NUM
aji-10	270	2	.	.	PUNCT
aji-10	271	1	13	13	NUM
aji-10	271	2	.	.	NUM
aji-10	271	3	yosif	yosif	PROPN
aji-10	271	4	,	,	PUNCT
aji-10	271	5	hoda	hoda	PROPN
aji-10	271	6	abu	abu	PROPN
aji-10	271	7	kamel	kamel	PROPN
aji-10	271	8	,	,	PUNCT
aji-10	271	9	mohamed	mohamed	PROPN
aji-10	271	10	mahmed	mahmed	PROPN
aji-10	271	11	nb	nb	PROPN
aji-10	271	12	.	.	PROPN
aji-10	271	13	study	study	PROPN
aji-10	271	14	of	of	ADP
aji-10	271	15	body	body	NOUN
aji-10	271	16	mass	mass	NOUN
aji-10	271	17	index	index	NOUN
aji-10	271	18	and	and	CCONJ
aji-10	271	19	serum	serum	NOUN
aji-10	271	20	leptin	leptin	NOUN
aji-10	271	21	in	in	ADP
aji-10	271	22	asthmatics	asthmatic	NOUN
aji-10	271	23	.	.	PUNCT
aji-10	272	1	j	j	PROPN
aji-10	272	2	allergy	allergy	PROPN
aji-10	272	3	clin	clin	PROPN
aji-10	272	4	immunol	immunol	PROPN
aji-10	272	5	.	.	PUNCT
aji-10	273	1	2010;12(8):34–41	2010;12(8):34–41	NOUN
aji-10	273	2	.	.	PUNCT
aji-10	274	1	14	14	NUM
aji-10	274	2	.	.	PUNCT
aji-10	275	1	deng	deng	PROPN
aji-10	275	2	x	x	PROPN
aji-10	275	3	,	,	PUNCT
aji-10	275	4	ma	ma	PROPN
aji-10	275	5	j	j	PROPN
aji-10	275	6	,	,	PUNCT
aji-10	275	7	yuan	yuan	PROPN
aji-10	275	8	y	y	PROPN
aji-10	275	9	,	,	PUNCT
aji-10	275	10	zhang	zhang	PROPN
aji-10	275	11	z	z	PROPN
aji-10	275	12	,	,	PUNCT
aji-10	275	13	niu	niu	PROPN
aji-10	275	14	w.	w.	PROPN
aji-10	275	15	association	association	PROPN
aji-10	275	16	between	between	ADP
aji-10	275	17	overweight	overweight	NOUN
aji-10	275	18	or	or	CCONJ
aji-10	275	19	obesity	obesity	NOUN
aji-10	275	20	and	and	CCONJ
aji-10	275	21	the	the	DET
aji-10	275	22	risk	risk	NOUN
aji-10	275	23	for	for	ADP
aji-10	275	24	childhood	childhood	NOUN
aji-10	275	25	asthma	asthma	NOUN
aji-10	275	26	and	and	CCONJ
aji-10	275	27	wheeze	wheeze	VERB
aji-10	275	28	:	:	PUNCT
aji-10	275	29	an	an	DET
aji-10	275	30	updated	update	VERB
aji-10	275	31	meta	meta	ADJ
aji-10	275	32	-	-	PUNCT
aji-10	275	33	analysis	analysis	NOUN
aji-10	275	34	on	on	ADP
aji-10	275	35	18	18	NUM
aji-10	275	36	articles	article	NOUN
aji-10	275	37	and	and	CCONJ
aji-10	275	38	73	73	NUM
aji-10	275	39	252	252	NUM
aji-10	275	40	children	child	NOUN
aji-10	275	41	.	.	PUNCT
aji-10	276	1	pediatr	pediatr	ADJ
aji-10	276	2	obes	obes	PROPN
aji-10	276	3	.	.	PUNCT
aji-10	277	1	2019;e12532	2019;e12532	NUM
aji-10	277	2	.	.	PUNCT
aji-10	278	1	doi	doi	NOUN
aji-10	278	2	:	:	PUNCT
aji-10	279	1	10.1111	10.1111	NUM
aji-10	279	2	/	/	SYM
aji-10	279	3	ijpo.12532	ijpo.12532	NOUN
aji-10	279	4	[	[	X
aji-10	279	5	epub	epub	NOUN
aji-10	279	6	ahead	ahead	ADV
aji-10	279	7	of	of	ADP
aji-10	279	8	print	print	NOUN
aji-10	279	9	]	]	PUNCT
aji-10	279	10	15	15	NUM
aji-10	279	11	.	.	PUNCT
aji-10	279	12	guler	guler	NOUN
aji-10	279	13	n	n	CCONJ
aji-10	279	14	,	,	PUNCT
aji-10	279	15	kirerleri	kirerleri	PROPN
aji-10	279	16	e	e	PROPN
aji-10	279	17	,	,	PUNCT
aji-10	279	18	ones	one	NOUN
aji-10	279	19	u	u	NOUN
aji-10	279	20	,	,	PUNCT
aji-10	279	21	tamay	tamay	PROPN
aji-10	279	22	z	z	PROPN
aji-10	279	23	,	,	PUNCT
aji-10	279	24	salmayenli	salmayenli	PROPN
aji-10	279	25	n	n	CCONJ
aji-10	279	26	,	,	PUNCT
aji-10	279	27	darendeliler	darendeliler	PROPN
aji-10	279	28	f.	f.	PROPN
aji-10	279	29	leptin	leptin	PROPN
aji-10	279	30	:	:	PUNCT
aji-10	279	31	does	do	AUX
aji-10	279	32	it	it	PRON
aji-10	279	33	have	have	VERB
aji-10	279	34	any	any	DET
aji-10	279	35	role	role	NOUN
aji-10	279	36	in	in	ADP
aji-10	279	37	childhood	childhood	NOUN
aji-10	279	38	asthma	asthma	NOUN
aji-10	279	39	?	?	PUNCT
aji-10	280	1	j	j	PROPN
aji-10	280	2	allergy	allergy	PROPN
aji-10	280	3	clin	clin	PROPN
aji-10	280	4	immunol	immunol	PROPN
aji-10	280	5	.	.	PUNCT
aji-10	281	1	2004;114(2):254–9	2004;114(2):254–9	NUM
aji-10	281	2	.	.	PUNCT
aji-10	282	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=deng%20x%5bauthor%5d&cauthor=true&cauthor_uid=31033249	https://www.ncbi.nlm.nih.gov/pubmed/?term=deng%20x%5bauthor%5d&cauthor=true&cauthor_uid=31033249	PROPN
aji-10	282	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=ma%20j%5bauthor%5d&cauthor=true&cauthor_uid=31033249	https://www.ncbi.nlm.nih.gov/pubmed/?term=ma%20j%5bauthor%5d&cauthor=true&cauthor_uid=31033249	X
aji-10	283	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=yuan%20y%5bauthor%5d&cauthor=true&cauthor_uid=31033249	https://www.ncbi.nlm.nih.gov/pubmed/?term=yuan%20y%5bauthor%5d&cauthor=true&cauthor_uid=31033249	PROPN
aji-10	283	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20z%5bauthor%5d&cauthor=true&cauthor_uid=31033249	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20z%5bauthor%5d&cauthor=true&cauthor_uid=31033249	PROPN
aji-10	283	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=niu%20w%5bauthor%5d&cauthor=true&cauthor_uid=31033249	https://www.ncbi.nlm.nih.gov/pubmed/?term=niu%20w%5bauthor%5d&cauthor=true&cauthor_uid=31033249	PROPN
aji-10	283	4	https://www.ncbi.nlm.nih.gov/pubmed/31033249	https://www.ncbi.nlm.nih.gov/pubmed/31033249	NOUN
aji-10	283	5	https://www.ncbi.nlm.nih.gov/pubmed/31033249	https://www.ncbi.nlm.nih.gov/pubmed/31033249	NOUN
aji-10	283	6	elngar	elngar	NOUN
aji-10	283	7	et	et	PROPN
aji-10	283	8	al	al	PROPN
aji-10	283	9	.	.	PROPN
aji-10	283	10	;	;	PUNCT
aji-10	283	11	aji	aji	PROPN
aji-10	283	12	,	,	PUNCT
aji-10	283	13	2(1	2(1	NUM
aji-10	283	14	):	):	PUNCT
aji-10	283	15	26	26	NUM
aji-10	283	16	-	-	SYM
aji-10	283	17	33	33	NUM
aji-10	283	18	,	,	PUNCT
aji-10	283	19	2019	2019	NUM
aji-10	283	20	;	;	PUNCT
aji-10	283	21	article	article	NOUN
aji-10	283	22	no.aji.53002	no.aji.53002	NOUN
aji-10	283	23	33	33	NUM
aji-10	283	24	16	16	NUM
aji-10	283	25	.	.	PUNCT
aji-10	284	1	gurkan	gurkan	PROPN
aji-10	284	2	f	f	PROPN
aji-10	284	3	,	,	PUNCT
aji-10	284	4	atamer	atamer	PROPN
aji-10	284	5	y	y	PROPN
aji-10	284	6	,	,	PUNCT
aji-10	284	7	ece	ece	PROPN
aji-10	284	8	a	a	PROPN
aji-10	284	9	,	,	PUNCT
aji-10	284	10	kocyigit	kocyigit	PROPN
aji-10	284	11	y	y	PROPN
aji-10	284	12	,	,	PUNCT
aji-10	284	13	tuzun	tuzun	PROPN
aji-10	284	14	h	h	PROPN
aji-10	284	15	,	,	PUNCT
aji-10	284	16	mete	mete	ADJ
aji-10	284	17	n.	n.	PROPN
aji-10	284	18	serum	serum	PROPN
aji-10	284	19	leptin	leptin	NOUN
aji-10	284	20	levels	level	NOUN
aji-10	284	21	in	in	ADP
aji-10	284	22	asthmatic	asthmatic	ADJ
aji-10	284	23	children	child	NOUN
aji-10	284	24	treated	treat	VERB
aji-10	284	25	with	with	ADP
aji-10	284	26	an	an	DET
aji-10	284	27	inhaled	inhaled	ADJ
aji-10	284	28	corticosteroid	corticosteroid	NOUN
aji-10	284	29	.	.	PUNCT
aji-10	285	1	ann	ann	PROPN
aji-10	285	2	allergy	allergy	PROPN
aji-10	285	3	,	,	PUNCT
aji-10	285	4	asthma	asthma	PROPN
aji-10	285	5	immunol	immunol	NOUN
aji-10	285	6	.	.	PUNCT
aji-10	286	1	2004;93(3):277–80	2004;93(3):277–80	PROPN
aji-10	286	2	.	.	PROPN
aji-10	287	1	17	17	NUM
aji-10	287	2	.	.	X
aji-10	287	3	vijayakanthi	vijayakanthi	PROPN
aji-10	287	4	n	n	CCONJ
aji-10	287	5	,	,	PUNCT
aji-10	287	6	greally	greally	ADV
aji-10	287	7	jm	jm	PROPN
aji-10	287	8	,	,	PUNCT
aji-10	287	9	rastogi	rastogi	PROPN
aji-10	287	10	d.	d.	PROPN
aji-10	287	11	pediatric	pediatric	PROPN
aji-10	287	12	obesity	obesity	NOUN
aji-10	287	13	-	-	PUNCT
aji-10	287	14	related	relate	VERB
aji-10	287	15	asthma	asthma	NOUN
aji-10	287	16	:	:	PUNCT
aji-10	287	17	the	the	DET
aji-10	287	18	role	role	NOUN
aji-10	287	19	of	of	ADP
aji-10	287	20	metabolic	metabolic	NOUN
aji-10	287	21	dysregulation	dysregulation	NOUN
aji-10	287	22	.	.	PUNCT
aji-10	288	1	pediatrics	pediatric	NOUN
aji-10	288	2	.	.	PUNCT
aji-10	289	1	2016;137(5):e20150812	2016;137(5):e20150812	NUM
aji-10	289	2	.	.	NOUN
aji-10	289	3	18	18	NUM
aji-10	289	4	.	.	X
aji-10	289	5	shore	shore	PROPN
aji-10	289	6	sa	sa	PROPN
aji-10	289	7	.	.	PUNCT
aji-10	289	8	obesity	obesity	NOUN
aji-10	289	9	and	and	CCONJ
aji-10	289	10	asthma	asthma	NOUN
aji-10	289	11	:	:	PUNCT
aji-10	289	12	possible	possible	ADJ
aji-10	289	13	mechanisms	mechanism	NOUN
aji-10	289	14	.	.	PUNCT
aji-10	290	1	j	j	PROPN
aji-10	290	2	allergy	allergy	PROPN
aji-10	290	3	clin	clin	PROPN
aji-10	290	4	immunol	immunol	PROPN
aji-10	290	5	;	;	PUNCT
aji-10	290	6	2008;121(5):1087–93	2008;121(5):1087–93	X
aji-10	290	7	.	.	PROPN
aji-10	290	8	19	19	NUM
aji-10	290	9	.	.	PUNCT
aji-10	291	1	desai	desai	PROPN
aji-10	291	2	d	d	X
aji-10	291	3	,	,	PUNCT
aji-10	291	4	newby	newby	ADV
aji-10	291	5	c	c	NOUN
aji-10	291	6	,	,	PUNCT
aji-10	291	7	symon	symon	PROPN
aji-10	291	8	fa	fa	PROPN
aji-10	291	9	,	,	PUNCT
aji-10	291	10	haldar	haldar	NOUN
aji-10	291	11	p	p	NOUN
aji-10	291	12	,	,	PUNCT
aji-10	291	13	shah	shah	PROPN
aji-10	291	14	s	s	PROPN
aji-10	291	15	,	,	PUNCT
aji-10	291	16	gupta	gupta	PROPN
aji-10	291	17	s	s	PART
aji-10	291	18	,	,	PUNCT
aji-10	291	19	et	et	PROPN
aji-10	291	20	al	al	PROPN
aji-10	291	21	.	.	PROPN
aji-10	291	22	elevated	elevate	VERB
aji-10	291	23	sputum	sputum	NOUN
aji-10	291	24	interleukin-5	interleukin-5	PROPN
aji-10	291	25	and	and	CCONJ
aji-10	291	26	submucosal	submucosal	PROPN
aji-10	291	27	eosinophilia	eosinophilia	PROPN
aji-10	291	28	in	in	ADP
aji-10	291	29	obese	obese	ADJ
aji-10	291	30	individuals	individual	NOUN
aji-10	291	31	with	with	ADP
aji-10	291	32	severe	severe	ADJ
aji-10	291	33	asthma	asthma	NOUN
aji-10	291	34	.	.	PUNCT
aji-10	292	1	am	be	AUX
aji-10	292	2	j	j	PROPN
aji-10	292	3	respir	respir	NOUN
aji-10	292	4	crit	crit	PROPN
aji-10	292	5	care	care	NOUN
aji-10	292	6	med	med	PROPN
aji-10	292	7	.	.	PUNCT
aji-10	293	1	united	united	PROPN
aji-10	293	2	states	states	PROPN
aji-10	293	3	.	.	PUNCT
aji-10	294	1	2013;188(6):657–63	2013;188(6):657–63	NUM
aji-10	294	2	.	.	NOUN
aji-10	294	3	20	20	NUM
aji-10	294	4	.	.	PUNCT
aji-10	295	1	black	black	PROPN
aji-10	295	2	mh	mh	PROPN
aji-10	295	3	,	,	PUNCT
aji-10	295	4	smith	smith	PROPN
aji-10	295	5	n	n	CCONJ
aji-10	295	6	,	,	PUNCT
aji-10	295	7	porter	porter	NOUN
aji-10	295	8	ah	ah	INTJ
aji-10	295	9	,	,	PUNCT
aji-10	295	10	jacobsen	jacobsen	PROPN
aji-10	295	11	sj	sj	PROPN
aji-10	295	12	,	,	PUNCT
aji-10	295	13	koebnick	koebnick	PROPN
aji-10	295	14	c.	c.	PROPN
aji-10	295	15	higher	high	ADJ
aji-10	295	16	prevalence	prevalence	NOUN
aji-10	295	17	of	of	ADP
aji-10	295	18	obesity	obesity	NOUN
aji-10	295	19	among	among	ADP
aji-10	295	20	children	child	NOUN
aji-10	295	21	with	with	ADP
aji-10	295	22	asthma	asthma	NOUN
aji-10	295	23	.	.	PUNCT
aji-10	296	1	obesity	obesity	NOUN
aji-10	296	2	.	.	PUNCT
aji-10	297	1	2012;20(5):1041–7	2012;20(5):1041–7	NUM
aji-10	297	2	.	.	NOUN
aji-10	297	3	21	21	NUM
aji-10	297	4	.	.	PUNCT
aji-10	297	5	musaad	musaad	PROPN
aji-10	297	6	sma	sma	PROPN
aji-10	297	7	,	,	PUNCT
aji-10	297	8	patterson	patterson	PROPN
aji-10	297	9	t	t	PROPN
aji-10	297	10	,	,	PUNCT
aji-10	297	11	ericksen	ericksen	PROPN
aji-10	297	12	m	m	PROPN
aji-10	297	13	,	,	PUNCT
aji-10	297	14	lindsey	lindsey	PROPN
aji-10	297	15	m	m	PROPN
aji-10	297	16	,	,	PUNCT
aji-10	297	17	dietrich	dietrich	PROPN
aji-10	297	18	k	k	PROPN
aji-10	297	19	,	,	PUNCT
aji-10	297	20	succop	succop	VERB
aji-10	297	21	p	p	PRON
aji-10	297	22	,	,	PUNCT
aji-10	297	23	et	et	PROPN
aji-10	297	24	al	al	PROPN
aji-10	297	25	.	.	PROPN
aji-10	297	26	comparison	comparison	NOUN
aji-10	297	27	of	of	ADP
aji-10	297	28	anthropometric	anthropometric	ADJ
aji-10	297	29	measures	measure	NOUN
aji-10	297	30	of	of	ADP
aji-10	297	31	obesity	obesity	NOUN
aji-10	297	32	in	in	ADP
aji-10	297	33	childhood	childhood	ADJ
aji-10	297	34	allergic	allergic	ADJ
aji-10	297	35	asthma	asthma	NOUN
aji-10	297	36	:	:	PUNCT
aji-10	297	37	central	central	ADJ
aji-10	297	38	obesity	obesity	NOUN
aji-10	297	39	is	be	AUX
aji-10	297	40	most	most	ADV
aji-10	297	41	relevant	relevant	ADJ
aji-10	297	42	.	.	PUNCT
aji-10	298	1	j	j	PROPN
aji-10	298	2	allergy	allergy	PROPN
aji-10	298	3	clin	clin	PROPN
aji-10	298	4	immunol	immunol	NOUN
aji-10	298	5	.	.	PUNCT
aji-10	299	1	2009;123(6):1321–7	2009;123(6):1321–7	X
aji-10	299	2	.	.	NOUN
aji-10	299	3	22	22	NUM
aji-10	299	4	.	.	PUNCT
aji-10	300	1	ling	ling	PROPN
aji-10	300	2	j.	j.	PROPN
aji-10	300	3	increased	increase	VERB
aji-10	300	4	leptin	leptin	NOUN
aji-10	300	5	levels	level	NOUN
aji-10	300	6	linked	link	VERB
aji-10	300	7	to	to	ADP
aji-10	300	8	asthma	asthma	NOUN
aji-10	300	9	.	.	PUNCT
aji-10	301	1	j	j	PROPN
aji-10	301	2	allergy	allergy	PROPN
aji-10	301	3	clin	clin	PROPN
aji-10	301	4	immunol	immunol	PROPN
aji-10	301	5	.	.	PUNCT
aji-10	302	1	2017	2017	NUM
aji-10	302	2	;	;	PUNCT
aji-10	303	1	12(11):32–41	12(11):32–41	NUM
aji-10	303	2	.	.	PUNCT
aji-10	304	1	23	23	NUM
aji-10	304	2	.	.	PUNCT
aji-10	305	1	loffreda	loffreda	PROPN
aji-10	305	2	s	s	PROPN
aji-10	305	3	,	,	PUNCT
aji-10	305	4	yang	yang	PROPN
aji-10	305	5	sq	sq	PROPN
aji-10	305	6	,	,	PUNCT
aji-10	305	7	lin	lin	PROPN
aji-10	305	8	hz	hz	VERB
aji-10	305	9	,	,	PUNCT
aji-10	305	10	et	et	PROPN
aji-10	305	11	al	al	PROPN
aji-10	305	12	.	.	PROPN
aji-10	305	13	leptin	leptin	PROPN
aji-10	305	14	regulates	regulate	VERB
aji-10	305	15	pro	pro	ADJ
aji-10	305	16	-	-	ADJ
aji-10	305	17	inflammatory	inflammatory	ADJ
aji-10	305	18	immune	immune	ADJ
aji-10	305	19	responses	response	NOUN
aji-10	305	20	.	.	PUNCT
aji-10	306	1	faseb	faseb	PROPN
aji-10	306	2	j.	j.	PROPN
aji-10	306	3	1998;12	1998;12	PROPN
aji-10	306	4	.	.	PUNCT
aji-10	307	1	24	24	NUM
aji-10	307	2	.	.	PUNCT
aji-10	308	1	li	li	PROPN
aji-10	308	2	z	z	PROPN
aji-10	308	3	,	,	PUNCT
aji-10	308	4	leynaert	leynaert	PROPN
aji-10	308	5	b	b	PROPN
aji-10	308	6	,	,	PUNCT
aji-10	308	7	dumas	dumas	PROPN
aji-10	308	8	o	o	PROPN
aji-10	308	9	,	,	PUNCT
aji-10	308	10	diaz	diaz	PROPN
aji-10	308	11	gil	gil	PROPN
aji-10	308	12	o	o	PROPN
aji-10	308	13	,	,	PUNCT
aji-10	308	14	et	et	PROPN
aji-10	308	15	al	al	PROPN
aji-10	308	16	.	.	PUNCT
aji-10	308	17	role	role	NOUN
aji-10	308	18	of	of	ADP
aji-10	308	19	leptin	leptin	NOUN
aji-10	308	20	in	in	ADP
aji-10	308	21	the	the	DET
aji-10	308	22	association	association	NOUN
aji-10	308	23	between	between	ADP
aji-10	308	24	body	body	NOUN
aji-10	308	25	adiposity	adiposity	NOUN
aji-10	308	26	and	and	CCONJ
aji-10	308	27	persistent	persistent	ADJ
aji-10	308	28	asthma	asthma	NOUN
aji-10	308	29	:	:	PUNCT
aji-10	308	30	a	a	DET
aji-10	308	31	longitudinal	longitudinal	ADJ
aji-10	308	32	study	study	NOUN
aji-10	308	33	.	.	PUNCT
aji-10	309	1	obesity	obesity	NOUN
aji-10	309	2	(	(	PUNCT
aji-10	309	3	silver	silver	ADJ
aji-10	309	4	spring	spring	NOUN
aji-10	309	5	)	)	PUNCT
aji-10	309	6	.	.	PUNCT
aji-10	310	1	2019;27(6):894	2019;27(6):894	NUM
aji-10	310	2	-	-	SYM
aji-10	310	3	898	898	NUM
aji-10	310	4	.	.	PUNCT
aji-10	311	1	doi	doi	NOUN
aji-10	311	2	:	:	PUNCT
aji-10	311	3	10.1002	10.1002	NUM
aji-10	311	4	/	/	SYM
aji-10	311	5	oby.22466	oby.22466	NOUN
aji-10	311	6	tilg	tilg	NOUN
aji-10	311	7	h	h	NOUN
aji-10	311	8	,	,	PUNCT
aji-10	311	9	moschen	moschen	PROPN
aji-10	311	10	ar	ar	PROPN
aji-10	311	11	.	.	PROPN
aji-10	311	12	adipocytokines	adipocytokine	NOUN
aji-10	311	13	:	:	PUNCT
aji-10	312	1	mediators	mediator	NOUN
aji-10	312	2	linking	link	VERB
aji-10	312	3	adipose	adipose	ADP
aji-10	312	4	tissue	tissue	NOUN
aji-10	312	5	,	,	PUNCT
aji-10	312	6	inflammation	inflammation	NOUN
aji-10	312	7	and	and	CCONJ
aji-10	312	8	immunity	immunity	NOUN
aji-10	312	9	.	.	PUNCT
aji-10	313	1	nat	nat	PROPN
aji-10	313	2	rev	rev	PROPN
aji-10	313	3	immunol	immunol	NOUN
aji-10	313	4	.	.	PUNCT
aji-10	314	1	2006;6:772	2006;6:772	X
aji-10	315	1	-	-	PUNCT
aji-10	315	2	783	783	NUM
aji-10	315	3	.	.	PUNCT
aji-10	316	1	25	25	NUM
aji-10	316	2	.	.	PUNCT
aji-10	316	3	sin	sin	PROPN
aji-10	316	4	dd	dd	PROPN
aji-10	316	5	,	,	PUNCT
aji-10	316	6	man	man	NOUN
aji-10	316	7	sfp	sfp	NOUN
aji-10	316	8	.	.	PUNCT
aji-10	317	1	impaired	impaired	ADJ
aji-10	317	2	lung	lung	NOUN
aji-10	317	3	function	function	NOUN
aji-10	317	4	and	and	CCONJ
aji-10	317	5	serum	serum	NOUN
aji-10	317	6	leptin	leptin	NOUN
aji-10	317	7	in	in	ADP
aji-10	317	8	men	man	NOUN
aji-10	317	9	and	and	CCONJ
aji-10	317	10	women	woman	NOUN
aji-10	317	11	with	with	ADP
aji-10	317	12	normal	normal	ADJ
aji-10	317	13	body	body	NOUN
aji-10	317	14	weight	weight	NOUN
aji-10	317	15	:	:	PUNCT
aji-10	317	16	a	a	DET
aji-10	317	17	population	population	NOUN
aji-10	317	18	based	base	VERB
aji-10	317	19	study	study	NOUN
aji-10	317	20	.	.	PUNCT
aji-10	318	1	thorax	thorax	NOUN
aji-10	318	2	.	.	PUNCT
aji-10	319	1	2003;58(8):695–8	2003;58(8):695–8	NUM
aji-10	319	2	.	.	PUNCT
aji-10	320	1	26	26	NUM
aji-10	320	2	.	.	X
aji-10	321	1	samra	samra	PROPN
aji-10	321	2	nm	nm	PROPN
aji-10	321	3	,	,	PUNCT
aji-10	321	4	ei	ei	PROPN
aji-10	321	5	-	-	PUNCT
aji-10	321	6	sharkawi	sharkawi	PROPN
aji-10	321	7	sz	sz	PROPN
aji-10	321	8	,	,	PUNCT
aji-10	321	9	abd	abd	PROPN
aji-10	321	10	el	el	PROPN
aji-10	321	11	-	-	PUNCT
aji-10	321	12	ghany	ghany	NOUN
aji-10	321	13	hm	hm	PROPN
aji-10	321	14	,	,	PUNCT
aji-10	321	15	mohammed	mohammed	PROPN
aji-10	321	16	zt	zt	PROPN
aji-10	321	17	.	.	PROPN
aji-10	321	18	relationship	relationship	NOUN
aji-10	321	19	between	between	ADP
aji-10	321	20	concentration	concentration	NOUN
aji-10	321	21	of	of	ADP
aji-10	321	22	serum	serum	NOUN
aji-10	321	23	leptin	leptin	NOUN
aji-10	321	24	and	and	CCONJ
aji-10	321	25	childhood	childhood	NOUN
aji-10	321	26	asthma	asthma	NOUN
aji-10	321	27	in	in	ADP
aji-10	321	28	egypt	egypt	PROPN
aji-10	321	29	.	.	PUNCT
aji-10	322	1	res	res	PROPN
aji-10	322	2	j	j	PROPN
aji-10	322	3	med	med	PROPN
aji-10	322	4	med	med	PROPN
aji-10	322	5	sci	sci	PROPN
aji-10	322	6	.	.	PUNCT
aji-10	323	1	2009;4(2):249–56	2009;4(2):249–56	NUM
aji-10	323	2	.	.	NOUN
aji-10	324	1	27	27	NUM
aji-10	324	2	.	.	PUNCT
aji-10	325	1	tanju	tanju	PROPN
aji-10	325	2	a	a	PRON
aji-10	325	3	,	,	PUNCT
aji-10	325	4	cekmez	cekmez	NOUN
aji-10	325	5	f	f	PROPN
aji-10	325	6	,	,	PUNCT
aji-10	325	7	aydinoz	aydinoz	PROPN
aji-10	325	8	s	s	PROPN
aji-10	325	9	,	,	PUNCT
aji-10	325	10	karademir	karademir	PROPN
aji-10	325	11	f	f	PROPN
aji-10	325	12	,	,	PUNCT
aji-10	325	13	suleymanoglu	suleymanoglu	PROPN
aji-10	325	14	s	s	PROPN
aji-10	325	15	,	,	PUNCT
aji-10	325	16	gocmen	gocmen	PROPN
aji-10	325	17	i.	i.	PROPN
aji-10	325	18	association	association	PROPN
aji-10	325	19	between	between	ADP
aji-10	325	20	clinical	clinical	ADJ
aji-10	325	21	severity	severity	NOUN
aji-10	325	22	of	of	ADP
aji-10	325	23	childhood	childhood	NOUN
aji-10	325	24	asthma	asthma	NOUN
aji-10	325	25	and	and	CCONJ
aji-10	325	26	serum	serum	NOUN
aji-10	325	27	leptin	leptin	NOUN
aji-10	325	28	levels	level	NOUN
aji-10	325	29	.	.	PUNCT
aji-10	326	1	indian	indian	PROPN
aji-10	326	2	j	j	PROPN
aji-10	326	3	pediatr	pediatr	PROPN
aji-10	326	4	.	.	PUNCT
aji-10	327	1	2011;78(3):291–5	2011;78(3):291–5	NUM
aji-10	327	2	.	.	NOUN
aji-10	328	1	28	28	NUM
aji-10	328	2	.	.	PUNCT
aji-10	329	1	shore	shore	PROPN
aji-10	329	2	sa	sa	PROPN
aji-10	329	3	,	,	PUNCT
aji-10	329	4	fredberg	fredberg	PROPN
aji-10	329	5	jj	jj	PROPN
aji-10	329	6	.	.	PROPN
aji-10	329	7	obesity	obesity	PROPN
aji-10	329	8	,	,	PUNCT
aji-10	329	9	smooth	smooth	ADJ
aji-10	329	10	muscle	muscle	NOUN
aji-10	329	11	,	,	PUNCT
aji-10	329	12	and	and	CCONJ
aji-10	329	13	airway	airway	NOUN
aji-10	329	14	hyper	hyper	ADJ
aji-10	329	15	responsiveness	responsiveness	NOUN
aji-10	329	16	.	.	PUNCT
aji-10	330	1	j	j	PROPN
aji-10	330	2	allergy	allergy	PROPN
aji-10	330	3	clin	clin	PROPN
aji-10	330	4	immunol	immunol	PROPN
aji-10	330	5	.	.	PUNCT
aji-10	331	1	2005;115(5):925	2005;115(5):925	NUM
aji-10	331	2	–	–	PUNCT
aji-10	331	3	7	7	NUM
aji-10	331	4	.	.	X
aji-10	332	1	_	_	PUNCT
aji-10	333	1	_	_	PUNCT
aji-10	334	1	_	_	PUNCT
aji-10	335	1	_	_	PUNCT
aji-10	336	1	_	_	PUNCT
aji-10	337	1	_	_	PUNCT
aji-10	338	1	_	_	PUNCT
aji-10	339	1	_	_	PUNCT
aji-10	340	1	_	_	PUNCT
aji-10	341	1	_	_	PUNCT
aji-10	342	1	_	_	PUNCT
aji-10	343	1	_	_	PUNCT
aji-10	344	1	_	_	PUNCT
aji-10	345	1	_	_	PUNCT
aji-10	346	1	_	_	PUNCT
aji-10	347	1	_	_	PUNCT
aji-10	348	1	_	_	PUNCT
aji-10	349	1	_	_	PUNCT
aji-10	350	1	_	_	PUNCT
aji-10	351	1	_	_	PUNCT
aji-10	352	1	_	_	PUNCT
aji-10	353	1	_	_	PUNCT
aji-10	354	1	_	_	PUNCT
aji-10	355	1	_	_	PUNCT
aji-10	356	1	_	_	PUNCT
aji-10	357	1	_	_	PUNCT
aji-10	358	1	_	_	PUNCT
aji-10	359	1	_	_	PUNCT
aji-10	360	1	_	_	PUNCT
aji-10	361	1	_	_	PUNCT
aji-10	362	1	_	_	PUNCT
aji-10	363	1	_	_	PUNCT
aji-10	364	1	_	_	PUNCT
aji-10	365	1	_	_	PUNCT
aji-10	366	1	_	_	PUNCT
aji-10	367	1	_	_	PUNCT
aji-10	368	1	_	_	PUNCT
aji-10	369	1	_	_	PUNCT
aji-10	370	1	_	_	PUNCT
aji-10	371	1	_	_	PUNCT
aji-10	372	1	_	_	PUNCT
aji-10	373	1	_	_	PUNCT
aji-10	374	1	_	_	PUNCT
aji-10	375	1	_	_	PUNCT
aji-10	376	1	_	_	PUNCT
aji-10	377	1	_	_	PUNCT
aji-10	378	1	_	_	PUNCT
aji-10	379	1	_	_	PUNCT
aji-10	380	1	_	_	PUNCT
aji-10	381	1	_	_	PUNCT
aji-10	382	1	_	_	PUNCT
aji-10	383	1	_	_	PUNCT
aji-10	384	1	_	_	PUNCT
aji-10	385	1	_	_	PUNCT
aji-10	386	1	_	_	PUNCT
aji-10	387	1	_	_	PUNCT
aji-10	388	1	_	_	PUNCT
aji-10	389	1	_	_	PUNCT
aji-10	390	1	_	_	PUNCT
aji-10	391	1	_	_	PUNCT
aji-10	392	1	_	_	PUNCT
aji-10	393	1	_	_	PUNCT
aji-10	394	1	_	_	PUNCT
aji-10	395	1	_	_	PUNCT
aji-10	396	1	_	_	PUNCT
aji-10	397	1	_	_	PUNCT
aji-10	398	1	_	_	PUNCT
aji-10	399	1	_	_	PUNCT
aji-10	400	1	_	_	PUNCT
aji-10	401	1	_	_	PUNCT
aji-10	402	1	_	_	PUNCT
aji-10	403	1	_	_	PUNCT
aji-10	404	1	_	_	PUNCT
aji-10	405	1	_	_	PUNCT
aji-10	406	1	_	_	PUNCT
aji-10	407	1	_	_	PUNCT
aji-10	408	1	_	_	PUNCT
aji-10	409	1	_	_	PUNCT
aji-10	410	1	_	_	PUNCT
aji-10	411	1	_	_	PUNCT
aji-10	412	1	_	_	PUNCT
aji-10	413	1	©	©	ADP
aji-10	413	2	2019	2019	NUM
aji-10	413	3	elngar	elngar	NOUN
aji-10	413	4	et	et	PROPN
aji-10	413	5	al	al	PROPN
aji-10	413	6	.	.	PROPN
aji-10	413	7	;	;	PUNCT
aji-10	413	8	this	this	PRON
aji-10	413	9	is	be	AUX
aji-10	413	10	an	an	DET
aji-10	413	11	open	open	ADJ
aji-10	413	12	access	access	NOUN
aji-10	413	13	article	article	NOUN
aji-10	413	14	distributed	distribute	VERB
aji-10	413	15	under	under	ADP
aji-10	413	16	the	the	DET
aji-10	413	17	terms	term	NOUN
aji-10	413	18	of	of	ADP
aji-10	413	19	the	the	DET
aji-10	413	20	creative	creative	ADJ
aji-10	413	21	commons	common	NOUN
aji-10	413	22	attribution	attribution	NOUN
aji-10	413	23	license	license	NOUN
aji-10	413	24	(	(	PUNCT
aji-10	413	25	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-10	413	26	)	)	PUNCT
aji-10	413	27	,	,	PUNCT
aji-10	413	28	which	which	PRON
aji-10	413	29	permits	permit	VERB
aji-10	413	30	unrestricted	unrestricted	ADJ
aji-10	413	31	use	use	NOUN
aji-10	413	32	,	,	PUNCT
aji-10	413	33	distribution	distribution	NOUN
aji-10	413	34	,	,	PUNCT
aji-10	413	35	and	and	CCONJ
aji-10	413	36	reproduction	reproduction	NOUN
aji-10	413	37	in	in	ADP
aji-10	413	38	any	any	DET
aji-10	413	39	medium	medium	NOUN
aji-10	413	40	,	,	PUNCT
aji-10	413	41	provided	provide	VERB
aji-10	413	42	the	the	DET
aji-10	413	43	original	original	ADJ
aji-10	413	44	work	work	NOUN
aji-10	413	45	is	be	AUX
aji-10	413	46	properly	properly	ADV
aji-10	413	47	cited	cite	VERB
aji-10	413	48	.	.	PUNCT
aji-10	414	1	peer	peer	NOUN
aji-10	414	2	-	-	PUNCT
aji-10	414	3	review	review	NOUN
aji-10	414	4	history	history	NOUN
aji-10	414	5	:	:	PUNCT
aji-10	414	6	the	the	DET
aji-10	414	7	peer	peer	NOUN
aji-10	414	8	review	review	NOUN
aji-10	414	9	history	history	NOUN
aji-10	414	10	for	for	ADP
aji-10	414	11	this	this	DET
aji-10	414	12	paper	paper	NOUN
aji-10	414	13	can	can	AUX
aji-10	414	14	be	be	AUX
aji-10	414	15	accessed	access	VERB
aji-10	414	16	here	here	ADV
aji-10	414	17	:	:	PUNCT
aji-10	414	18	http://www.sdiarticle4.com/review-history/53002	http://www.sdiarticle4.com/review-history/53002	NOUN
aji-10	414	19	https://www.ncbi.nlm.nih.gov/pubmed/?term=li%20z%5bauthor%5d&cauthor=true&cauthor_uid=31004416	https://www.ncbi.nlm.nih.gov/pubmed/?term=li%20z%5bauthor%5d&cauthor=true&cauthor_uid=31004416	VERB
aji-10	414	20	https://www.ncbi.nlm.nih.gov/pubmed/?term=leynaert%20b%5bauthor%5d&cauthor=true&cauthor_uid=31004416	https://www.ncbi.nlm.nih.gov/pubmed/?term=leynaert%20b%5bauthor%5d&cauthor=true&cauthor_uid=31004416	X
aji-10	415	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=dumas%20o%5bauthor%5d&cauthor=true&cauthor_uid=31004416	https://www.ncbi.nlm.nih.gov/pubmed/?term=dumas%20o%5bauthor%5d&cauthor=true&cauthor_uid=31004416	PROPN
aji-10	415	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=diaz%20gil%20o%5bauthor%5d&cauthor=true&cauthor_uid=31004416	https://www.ncbi.nlm.nih.gov/pubmed/?term=diaz%20gil%20o%5bauthor%5d&cauthor=true&cauthor_uid=31004416	NUM
aji-10	415	3	https://www.ncbi.nlm.nih.gov/pubmed/31004416	https://www.ncbi.nlm.nih.gov/pubmed/31004416	NUM
aji-10	415	4	https://www.ncbi.nlm.nih.gov/pubmed/31004416	https://www.ncbi.nlm.nih.gov/pubmed/31004416	NUM
aji-10	415	5	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN